data_19113 ####################### # Entry information # ####################### save_entry_information _Entry.Sf_category entry_information _Entry.Sf_framecode entry_information _Entry.ID 19113 _Entry.Title ; Chemical shifts of human beta-2 microglobulin bound to HLA-B2709 complexed with the nonamer peptide pVIPR (RRKWRRWHL) ; _Entry.Type macromolecule _Entry.Version_type original _Entry.Submission_date 2013-03-27 _Entry.Accession_date 2013-03-27 _Entry.Last_release_date . _Entry.Original_release_date . _Entry.Origination author _Entry.NMR_STAR_version 3.1.1.61 _Entry.Original_NMR_STAR_version 3.1 _Entry.Experimental_method NMR _Entry.Experimental_method_subtype solution _Entry.Details ; 1H 15N chemical shifts of human beta-2 microglobulin bound to HLA-B2705 or HLA-B2709, each complexed with nonamer peptides pVIPR (RRKWRRWHL, derived from vasoactive intestinal peptide type 1 receptor), TIS (RRLPIFSRL, derived from epidermal growth factor response factor 1), pLMP2 (RRRWRRLTV, derived from latent membrane proteine of Epstein-Barr virus) and pGR (RRRWHRWRL, derived from glucagon receptor). Backbone 13C chemical shifts are provided for beta-2 microglobulin bound to HLA-B2709 complexed with the pVIPR peptide. ; _Entry.BMRB_internal_directory_name . loop_ _Entry_author.Ordinal _Entry_author.Given_name _Entry_author.Family_name _Entry_author.First_initial _Entry_author.Middle_initials _Entry_author.Family_title _Entry_author.Entry_ID 1 Monika Beerbaum . . . 19113 2 Martin Ballaschk . . . 19113 3 Natalja Erdmann . . . 19113 4 Christina Schnick . . . 19113 5 Anne Diehl . . . 19113 6 Barbara Uchanska-Ziegler . . . 19113 7 Andreas Ziegler . . . 19113 8 Peter Schmieder . . . 19113 stop_ loop_ _Entry_src.ID _Entry_src.Project_name _Entry_src.Organization_full_name _Entry_src.Organization_initials _Entry_src.Entry_ID 1 . 'Schmieder group, FMP Berlin' . 19113 2 . 'Ziegler group, Free University of Berlin' . 19113 stop_ loop_ _Data_set.Type _Data_set.Count _Data_set.Entry_ID assigned_chemical_shifts 2 19113 stop_ loop_ _Datum.Type _Datum.Count _Datum.Entry_ID '13C chemical shifts' 262 19113 '15N chemical shifts' 177 19113 '1H chemical shifts' 178 19113 stop_ loop_ _Release.Release_number _Release.Format_type _Release.Format_version _Release.Date _Release.Submission_date _Release.Type _Release.Author _Release.Detail _Release.Entry_ID 2 . . 2014-02-07 2013-05-01 update BMRB 'update entry citation' 19113 1 . . 2014-01-02 2013-05-01 original author 'original release' 19113 stop_ loop_ _Related_entries.Database_name _Related_entries.Database_accession_code _Related_entries.Relationship _Related_entries.Entry_ID BMRB 19099 'human beta-2 microglobulin, free protein' 19113 BMRB 19116 'bound to the HLA-B2709, complex with Peptide 2 (TIS)' 19113 BMRB 19118 'bound to the HLA-B2709, complex with Peptide 3 (pLMP2)' 19113 BMRB 19119 'bound to the HLA-B2709, complex with Peptide 4 (pGR)' 19113 BMRB 19120 'bound to the HLA-B2705, complex with Peptide 1 (pVIPR)' 19113 BMRB 19121 'bound to the HLA-B2705, complex with Peptide 2 (TIS)' 19113 BMRB 19122 'bound to the HLA-B2705, complex with Peptide 3 (pLMP2)' 19113 BMRB 19123 'bound to the HLA-B2705, complex with Peptide 4 (pGR)' 19113 stop_ save_ ############### # Citations # ############### save_entry_citation _Citation.Sf_category citations _Citation.Sf_framecode entry_citation _Citation.Entry_ID 19113 _Citation.ID 1 _Citation.Class 'entry citation' _Citation.CAS_abstract_code . _Citation.MEDLINE_UI_code . _Citation.DOI . _Citation.PubMed_ID 24006098 _Citation.Full_citation . _Citation.Title 'NMR spectroscopy reveals unexpected structural variation at the protein-protein interface in MHC class I molecules.' _Citation.Status published _Citation.Type journal _Citation.Journal_abbrev 'J. Biomol. NMR' _Citation.Journal_name_full 'Journal of biomolecular NMR' _Citation.Journal_volume 57 _Citation.Journal_issue 2 _Citation.Journal_ASTM . _Citation.Journal_ISSN . _Citation.Journal_CSD . _Citation.Book_title . _Citation.Book_chapter_title . _Citation.Book_volume . _Citation.Book_series . _Citation.Book_publisher . _Citation.Book_publisher_city . _Citation.Book_ISBN . _Citation.Conference_title . _Citation.Conference_site . _Citation.Conference_state_province . _Citation.Conference_country . _Citation.Conference_start_date . _Citation.Conference_end_date . _Citation.Conference_abstract_number . _Citation.Thesis_institution . _Citation.Thesis_institution_city . _Citation.Thesis_institution_country . _Citation.WWW_URL . _Citation.Page_first 167 _Citation.Page_last 178 _Citation.Year 2013 _Citation.Details . loop_ _Citation_author.Ordinal _Citation_author.Given_name _Citation_author.Family_name _Citation_author.First_initial _Citation_author.Middle_initials _Citation_author.Family_title _Citation_author.Entry_ID _Citation_author.Citation_ID 1 Monika Beerbaum . . . 19113 1 2 Martin Ballaschk . . . 19113 1 3 Natalja Erdmann . . . 19113 1 4 Christina Schnick . . . 19113 1 5 Anne Diehl . . . 19113 1 6 Barbara Uchanska-Ziegler . . . 19113 1 7 Andreas Ziegler . . . 19113 1 8 Peter Schmieder . . . 19113 1 stop_ save_ ############################################# # Molecular system (assembly) description # ############################################# save_assembly_1 _Assembly.Sf_category assembly _Assembly.Sf_framecode assembly_1 _Assembly.Entry_ID 19113 _Assembly.ID 1 _Assembly.Name 'B2709-b2m-pVIPR complex' _Assembly.BMRB_code . _Assembly.Number_of_components 3 _Assembly.Organic_ligands . _Assembly.Metal_ions . _Assembly.Non_standard_bonds . _Assembly.Ambiguous_conformational_states . _Assembly.Ambiguous_chem_comp_sites . _Assembly.Molecules_in_chemical_exchange . _Assembly.Paramagnetic no _Assembly.Thiol_state . _Assembly.Molecular_mass . _Assembly.Enzyme_commission_number . _Assembly.Details 'The HLA-B2709 complex including beta-2 microglobulin and the pVIPR peptide' _Assembly.DB_query_date . _Assembly.DB_query_revised_last_date . loop_ _Entity_assembly.ID _Entity_assembly.Entity_assembly_name _Entity_assembly.Entity_ID _Entity_assembly.Entity_label _Entity_assembly.Asym_ID _Entity_assembly.PDB_chain_ID _Entity_assembly.Experimental_data_reported _Entity_assembly.Physical_state _Entity_assembly.Conformational_isomer _Entity_assembly.Chemical_exchange_state _Entity_assembly.Magnetic_equivalence_group_code _Entity_assembly.Role _Entity_assembly.Details _Entity_assembly.Entry_ID _Entity_assembly.Assembly_ID 1 'beta-2 microglobulin' 1 $human_beta-2_microglobulin A . yes native no no . . . 19113 1 2 'pVIPR peptide' 2 $pVIPR_peptide B . no native no no . . . 19113 1 3 'HLA-B2709 protein' 3 $HLA-B2709 C . no native no no . . . 19113 1 stop_ loop_ _Bond.ID _Bond.Type _Bond.Value_order _Bond.Assembly_atom_ID_1 _Bond.Entity_assembly_ID_1 _Bond.Entity_assembly_name_1 _Bond.Entity_ID_1 _Bond.Comp_ID_1 _Bond.Comp_index_ID_1 _Bond.Seq_ID_1 _Bond.Atom_ID_1 _Bond.Assembly_atom_ID_2 _Bond.Entity_assembly_ID_2 _Bond.Entity_assembly_name_2 _Bond.Entity_ID_2 _Bond.Comp_ID_2 _Bond.Comp_index_ID_2 _Bond.Seq_ID_2 _Bond.Atom_ID_2 _Bond.Auth_entity_assembly_ID_1 _Bond.Auth_entity_assembly_name_1 _Bond.Auth_seq_ID_1 _Bond.Auth_comp_ID_1 _Bond.Auth_atom_ID_1 _Bond.Auth_entity_assembly_ID_2 _Bond.Auth_entity_assembly_name_2 _Bond.Auth_seq_ID_2 _Bond.Auth_comp_ID_2 _Bond.Auth_atom_ID_2 _Bond.Entry_ID _Bond.Assembly_ID 1 disulfide single . 1 . 1 CYS 26 26 SG . 1 . 1 CYS 81 81 SG . . . . . . . . . . 19113 1 2 disulfide single . 3 . 3 CYS 101 101 SG . 3 . 3 CYS 164 164 SG . . . . . . . . . . 19113 1 3 disulfide single . 3 . 3 CYS 203 203 SG . 3 . 3 CYS 259 259 SG . . . . . . . . . . 19113 1 stop_ save_ #################################### # Biological polymers and ligands # #################################### save_human_beta-2_microglobulin _Entity.Sf_category entity _Entity.Sf_framecode human_beta-2_microglobulin _Entity.Entry_ID 19113 _Entity.ID 1 _Entity.BMRB_code . _Entity.Name human_beta-2_microglobulin _Entity.Type polymer _Entity.Polymer_common_type . _Entity.Polymer_type polypeptide(L) _Entity.Polymer_type_details . _Entity.Polymer_strand_ID . _Entity.Polymer_seq_one_letter_code_can . _Entity.Polymer_seq_one_letter_code ; MIQRTPKIQVYSRHPAENGK SNFLNCYVSGFHPSDIEVDL LKNGERIEKVEHSDLSFSKD WSFYLLYYTEFTPTEKDEYA CRVNHVTLSQPKIVKWDRDM ; _Entity.Target_identifier . _Entity.Polymer_author_defined_seq . _Entity.Polymer_author_seq_details . _Entity.Ambiguous_conformational_states no _Entity.Ambiguous_chem_comp_sites no _Entity.Nstd_monomer no _Entity.Nstd_chirality no _Entity.Nstd_linkage no _Entity.Nonpolymer_comp_ID . _Entity.Nonpolymer_comp_label . _Entity.Number_of_monomers 100 _Entity.Number_of_nonpolymer_components . _Entity.Paramagnetic no _Entity.Thiol_state 'all disulfide bound' _Entity.Src_method . _Entity.Parent_entity_ID . _Entity.Fragment . _Entity.Mutation . _Entity.EC_number . _Entity.Calc_isoelectric_point . _Entity.Formula_weight . _Entity.Formula_weight_exptl . _Entity.Formula_weight_exptl_meth . _Entity.Details . _Entity.DB_query_date . _Entity.DB_query_revised_last_date 2015-11-25 loop_ _Entity_db_link.Ordinal _Entity_db_link.Author_supplied _Entity_db_link.Database_code _Entity_db_link.Accession_code _Entity_db_link.Entry_mol_code _Entity_db_link.Entry_mol_name _Entity_db_link.Entry_experimental_method _Entity_db_link.Entry_structure_resolution _Entity_db_link.Entry_relation_type _Entity_db_link.Entry_details _Entity_db_link.Chimera_segment_ID _Entity_db_link.Seq_query_to_submitted_percent _Entity_db_link.Seq_subject_length _Entity_db_link.Seq_identity _Entity_db_link.Seq_positive _Entity_db_link.Seq_homology_expectation_val _Entity_db_link.Seq_align_begin _Entity_db_link.Seq_align_end _Entity_db_link.Seq_difference_details _Entity_db_link.Seq_alignment_details _Entity_db_link.Entry_ID _Entity_db_link.Entity_ID 1 no BMRB 15480 . w60g-b2m . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 19113 1 2 no BMRB 16587 . "W60G beta2-microglobulin" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 19113 1 3 no BMRB 17165 . WT . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 4 no BMRB 17166 . dN6 . . . . . 93.00 94 100.00 100.00 1.55e-62 . . . . 19113 1 5 no BMRB 19099 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 6 no BMRB 19116 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 7 no BMRB 19118 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 8 no BMRB 19119 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 9 no BMRB 19120 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 10 no BMRB 19121 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 11 no BMRB 19122 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 12 no BMRB 19123 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 13 no BMRB 3078 . microglobulin . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 14 no BMRB 3079 . microglobulin . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 15 no PDB 1A1M . "Mhc Class I Molecule B5301 Complexed With Peptide Tpydinqml From Gag Protein Of Hiv2" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 16 no PDB 1A1N . "Mhc Class I Molecule B3501 Complexed With Peptide Vplrpmty From The Nef Protein (75-82) Of Hiv1" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 17 no PDB 1A1O . "Mhc Class I Molecule B5301 Complexed With Peptide Ls6 (Kpivqydnf) From The Malaria Parasite P. Falciparum" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 18 no PDB 1A6Z . "Hfe (Human) Hemochromatosis Protein" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 19 no PDB 1A9B . "Decamer-Like Conformation Of A Nano-Peptide Bound To Hla- B3501 Due To Nonstandard Positioning Of The C-Terminus" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 20 no PDB 1A9E . "Decamer-Like Conformation Of A Nano-Peptide Bound To Hla- B3501 Due To Nonstandard Positioning Of The C-Terminus" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 21 no PDB 1AGB . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggrkkykl-3r Mutation)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 22 no PDB 1AGC . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkyql-7q Mutation)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 23 no PDB 1AGD . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkykl-Index Peptide)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 24 no PDB 1AGE . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkyrl-7r Mutation)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 25 no PDB 1AGF . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkrykl-5r Mutation)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 26 no PDB 1AKJ . "Complex Of The Human Mhc Class I Glycoprotein Hla-A2 And The T Cell Coreceptor Cd8" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 27 no PDB 1AO7 . "Complex Between Human T-Cell Receptor, Viral Peptide (Tax), And Hla-A 0201" . . . . . 100.00 100 98.00 98.00 6.71e-66 . . . . 19113 1 28 no PDB 1B0G . "Class I Histocompatibility Antigen (hla-a2.1)/beta 2- Microglobulin/peptide P1049 Complex" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 29 no PDB 1B0R . "Crystal Structure Of Hla-A0201 Complexed With A Peptide With The Carboxyl-Terminal Group Substituted By A Methyl Group" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 30 no PDB 1BD2 . "Complex Between Human T-Cell Receptor B7, Viral Peptide (Tax) And Mhc Class I Molecule Hla-A 0201" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 31 no PDB 1C16 . "Crystal Structure Analysis Of The GammaDELTA T CELL LIGAND T22" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 32 no PDB 1CE6 . "Mhc Class I H-2db Complexed With A Sendai Virus Nucleoprotein Peptide" . . . . . 99.00 108 100.00 100.00 4.01e-67 . . . . 19113 1 33 no PDB 1CG9 . "Complex Recognition Of The Supertypic Bw6-Determinant On Hla-B And-C Molecules By The Monoclonal Antibody Sfr8-B6" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 34 no PDB 1DE4 . "Hemochromatosis Protein Hfe Complexed With Transferrin Receptor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 35 no PDB 1DUY . "Crystal Structure Of Hla-A0201OCTAMERIC TAX PEPTIDE Complex" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 36 no PDB 1DUZ . "Human Class I Histocompatibility Antigen (Hla-A 0201) In Complex With A Nonameric Peptide From Htlv-1 Tax Protein" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 37 no PDB 1E27 . "Nonstandard Peptide Binding Of Hla-B5101 Complexed With Hiv Immunodominant Epitope Km1(Lppvvakei)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 38 no PDB 1E28 . "Nonstandard Peptide Binding Of Hla-B5101 Complexed With Hiv Immunodominant Epitope Km2(Taftipsi)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 39 no PDB 1EEY . "Crystal Structure Determination Of Hla A2 Complexed To Peptide Gp2 With The Substitution (I2lV5LL9V)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 40 no PDB 1EEZ . "Crystal Structure Determination Of Hla-A2.1 Complexed To Gp2 Peptide Variant(I2lV5L)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 41 no PDB 1EFX . "Structure Of A Complex Between The Human Natural Killer Cell Receptor Kir2dl2 And A Class I Mhc Ligand Hla-Cw3" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 42 no PDB 1EXU . "Crystal Structure Of The Human Mhc-Related Fc Receptor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 43 no PDB 1GZP . "Cd1b In Complex With Gm2 Ganglioside" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 44 no PDB 1GZQ . "Cd1b In Complex With Phophatidylinositol" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 45 no PDB 1HHG . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 46 no PDB 1HHH . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 47 no PDB 1HHI . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 48 no PDB 1HHJ . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 49 no PDB 1HHK . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 50 no PDB 1HLA . "Structure Of The Human Class I Histocompatibility Antigen, Hla-A2" . . . . . 97.00 97 100.00 100.00 1.47e-65 . . . . 19113 1 51 no PDB 1HSA . "The Three-Dimensional Structure Of Hla-B27 At 2.1 Angstroms Resolution Suggests A General Mechanism For Tight Peptide Binding T" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 52 no PDB 1HSB . "Different Length Peptides Bind To Hla-Aw68 Similarly At Their Ends But Bulge Out In The Middle" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 53 no PDB 1I1F . "Crystal Structure Of Human Class I Mhc (Hla-A2.1) Complexed With Beta 2-Microglobulin And Hiv-Rt Variant Peptide I1y" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 54 no PDB 1I1Y . "Crystal Structure Of Human Class I Mhc (Hla-A2.1) Complexed With Beta 2-Microglobulin And Hiv-Rt Variant Peptide I1y" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 55 no PDB 1I4F . "Crystal Structure Of Hla-A0201MAGE-A4-Peptide Complex" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 56 no PDB 1I7R . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1058" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 57 no PDB 1I7T . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1049-5v" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 58 no PDB 1I7U . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1049-6v" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 59 no PDB 1IM3 . "Crystal Structure Of The Human Cytomegalovirus Protein Us2 Bound To The Mhc Class I Molecule Hla-A2TAX" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 60 no PDB 1IM9 . "Crystal Structure Of The Human Natural Killer Cell Inhibitory Receptor Kir2dl1 Bound To Its Mhc Ligand Hla-Cw4" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 61 no PDB 1JF1 . "Crystal Structure Of Hla-A20201 In Complex With A Decameric Altered Peptide Ligand From The Mart-1MELAN-A" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 62 no PDB 1JGD . "Hla-B2709 Bound To Deca-Peptide S10r" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 63 no PDB 1JGE . "Hla-B2705 Bound To Nona-Peptide M9" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 64 no PDB 1JHT . "Crystal Structure Of Hla-A20201 In Complex With A Nonameric Altered Peptide Ligand (Algigiltv) From The Mart- 1MELAN-A." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 65 no PDB 1JNJ . "Nmr Solution Structure Of The Human Beta2-Microglobulin" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 66 no PDB 1K5N . "Hla-B2709 Bound To Nona-Peptide M9" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 67 no PDB 1KPR . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 68 no PDB 1KTL . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 69 no PDB 1LDS . "Crystal Structure Of Monomeric Human Beta-2-Microglobulin" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 70 no PDB 1LP9 . "Xenoreactive Complex Ahiii 12.2 Tcr Bound To P1049HLA-A2.1" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 71 no PDB 1M05 . "Hla B8 In Complex With An Epstein Barr Virus Determinant" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 72 no PDB 1M6O . "Crystal Structure Of Hla B4402 In Complex With Hla Dpa0201 Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 73 no PDB 1MHE . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 74 no PDB 1MI5 . "The Crystal Structure Of Lc13 Tcr In Complex With Hlab8-Ebv Peptide Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 75 no PDB 1N2R . "A Natural Selected Dimorphism In Hla B44 Alters Self, Peptide Reportoire And T Cell Recognition." . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 76 no PDB 1OF2 . "Crystal Structure Of Hla-B2709 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 77 no PDB 1OGA . "A Structural Basis For Immunodominant Human T-Cell Receptor Recognition." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 78 no PDB 1OGT . "Crystal Structure Of Hla-B2705 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 79 no PDB 1ONQ . "Crystal Structure Of Cd1a In Complex With A Sulfatide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 80 no PDB 1P7Q . "Crystal Structure Of Hla-A2 Bound To Lir-1, A Host And Viral Mhc Receptor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 81 no PDB 1PY4 . "Beta2 Microglobulin Mutant H31y Displays Hints For Amyloid Formations" . . . . . 100.00 100 99.00 100.00 1.68e-67 . . . . 19113 1 82 no PDB 1Q94 . "Structures Of Hla-A1101 In Complex With Immunodominant Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The Presence Of A Midd" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 83 no PDB 1QEW . "Human Class I Histocompatibility Antigen (Hla-A 0201) Complex With A Nonameric Peptide From Melanoma-Associated Antigen 3 (Resi" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 84 no PDB 1QLF . "Mhc Class I H-2db Complexed With Glycopeptide K3g" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 85 no PDB 1QQD . "Crystal Structure Of Hla-Cw4, A Ligand For The Kir2d Natural Killer Cell Inhibitory Receptor" . . . . . 99.00 99 98.99 98.99 1.82e-66 . . . . 19113 1 86 no PDB 1QR1 . "Poor Binding Of A Her-2NEU EPITOPE (GP2) TO HLA-A2.1 Is Due To A Lack Of Interactions In The Center Of The Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 87 no PDB 1QRN . "Crystal Structure Of Human A6 Tcr Complexed With Hla-A2 Bound To Altered Htlv-1 Tax Peptide P6a" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 88 no PDB 1QSE . "Structure Of Human A6-Tcr Bound To Hla-A2 Complexed With Altered Htlv-1 Tax Peptide V7r" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 89 no PDB 1QSF . "Structure Of A6-Tcr Bound To Hla-A2 Complexed With Altered Htlv-1 Tax Peptide Y8a" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 90 no PDB 1QVO . "Structures Of Hla-A1101 In Complex With Immunodominant Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The Presence Of A Midd" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 91 no PDB 1R3H . "Crystal Structure Of T10" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 92 no PDB 1S8D . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-3a" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 93 no PDB 1S9W . "Crystal Structure Analysis Of Ny-eso-1 Epitope, Sllmwitqc, In Complex With Hla-a2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 94 no PDB 1S9X . "Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue, Sllmwitqa, In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 95 no PDB 1S9Y . "Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue, Sllmwitqs, In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 96 no PDB 1SYS . "Crystal Structure Of Hla, B4403, And Peptide Eeptvikky" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 97 no PDB 1SYV . "Hla-B4405 Complexed To The Dominant Self Ligand Eefgraygf" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 98 no PDB 1T1W . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-3f6i8v" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 99 no PDB 1T1X . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-4l" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 100 no PDB 1T1Y . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-5v" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 101 no PDB 1T1Z . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-6a" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 102 no PDB 1T20 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-6i" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 103 no PDB 1T21 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9, Monoclinic Crystal" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 104 no PDB 1T22 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9, Orthorhombic Crystal" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 105 no PDB 1TMC . "The Three-Dimensional Structure Of A Class I Major Histocompatibility Complex Molecule Missing The Alpha3 Domain Of The Heavy C" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 106 no PDB 1TVB . "Crystal Structure Of Melanoma Antigen Gp100(209-217) Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 107 no PDB 1TVH . "Crystal Structure Of Modified Melanoma Antigen Gp100(209-T2m) Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 108 no PDB 1UQS . "The Crystal Structure Of Human Cd1b With A Bound Bacterial Glycolipid" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 109 no PDB 1UXS . "Crystal Structure Of Hla-B2705 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2)of Epstein-Barr Virus" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 110 no PDB 1UXW . "Crystal Structure Of Hla-B2709 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Virus" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 111 no PDB 1VGK . "The Crystal Structure Of Class I Major Histocompatibility Complex, H-2kd At 2.0 A Resolution" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 112 no PDB 1W0V . "Crystal Structure Of Hla-B2705 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 113 no PDB 1W0W . "Crystal Structure Of Hla-B2709 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 114 no PDB 1W72 . "Crystal Structure Of Hla-A1:mage-A1 In Complex With Fab- Hyb3" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 115 no PDB 1X7Q . "Crystal Structure Of Hla-A1101 With Sars Nucleocapsid Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 116 no PDB 1XH3 . "Conformational Restraints And Flexibility Of 14-Meric Peptides In Complex With Hla-B3501" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 117 no PDB 1XR8 . "Crystal Structures Of Hla-B1501 In Complex With Peptides From Human Ubch6 And Epstein-Barr Virus Ebna-3" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 118 no PDB 1XR9 . "Crystal Structures Of Hla-B1501 In Complex With Peptides From Human Ubch6 And Epstein-Barr Virus Ebna-3" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 119 no PDB 1XZ0 . "Crystal Structure Of Cd1a In Complex With A Synthetic Mycobactin Lipopeptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 120 no PDB 1YDP . "1.9a Crystal Structure Of Hla-G" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 121 no PDB 1YPZ . "Immune Receptor" . . . . . 99.00 102 100.00 100.00 2.62e-67 . . . . 19113 1 122 no PDB 1ZHK . "Crystal Structure Of Hla-b*3501 Presenting 13-mer Ebv Antigen Lpeplpqgqltay" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 123 no PDB 1ZHL . "Crystal Structure Of Hla-b*3508 Presenting 13-mer Ebv Antigen Lpeplpqgqltay" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 124 no PDB 1ZS8 . "Crystal Structure Of The Murine Mhc Class Ib Molecule M10.5" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 125 no PDB 1ZSD . "Crystal Structure Of Hla-B3501 Presenting An 11-Mer Ebv Antigen Eplpqgqltay" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 126 no PDB 1ZT4 . "The Crystal Structure Of Human Cd1d With And Without Alpha- Galactosylceramide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 127 no PDB 1ZVS . "Crystal Structure Of The First Class Mhc Mamu And Tat-Tl8 Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 128 no PDB 2A83 . "Crystal Structure Of Hla-B2705 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 129 no PDB 2AK4 . "Crystal Structure Of Sb27 Tcr In Complex With Hla-B3508- 13mer Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 130 no PDB 2AV1 . "Crystal Structure Of Htlv-1 Tax Peptide Bound To Human Class I Mhc Hla-A2 With The E63q And K66a Mutations In The Heavy Chain." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 131 no PDB 2AV7 . "Crystal Structure Of Htlv-1 Tax Peptide Bound To Human Class I Mhc Hla-A2 With The K66a Mutation In The Heavy Chain." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 132 no PDB 2AXF . "The Immunogenicity Of A Viral Cytotoxic T Cell Epitope Is Controlled By Its Mhc-Bound Conformation" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 133 no PDB 2AXG . "The Immunogenicity Of A Viral Cytotoxic T Cell Epitope Is Controlled By Its Mhc-Bound Conformation" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 134 no PDB 2BCK . "Crystal Structure Of Hla-A2402 Complexed With A Telomerase Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 135 no PDB 2BNQ . "Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 136 no PDB 2BNR . "Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 137 no PDB 2BSR . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 138 no PDB 2BSS . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 139 no PDB 2BST . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-b2705" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 140 no PDB 2BVO . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 141 no PDB 2BVP . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 142 no PDB 2BVQ . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 143 no PDB 2C7U . "Conflicting Selective Forces Affect Cd8 T-Cell Receptor Contact Sites In An Hla-A2 Immunodominant Hiv Epitope." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 144 no PDB 2CII . "The Crystal Structure Of H-2db Complexed With A Partial Peptide Epitope Suggests An Mhc Class I Assembly- Intermediate" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 145 no PDB 2CIK . "Insights Into Crossreactivity In Human Allorecognition: The Structure Of Hla-B35011 Presenting An Epitope Derived From Cytochro" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 146 no PDB 2CLR . "Three Dimensional Structure Of A Peptide Extending Out One End Of A Class I Mhc Binding Site" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 147 no PDB 2D31 . "Crystal Structure Of Disulfide-Linked Hla-G Dimer" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 148 no PDB 2D4D . "The Crystal Structure Of Human Beta2-Microglobulin, L39w W60f W95f Mutant" . . . . . 100.00 100 97.00 99.00 7.98e-65 . . . . 19113 1 149 no PDB 2D4F . "The Crystal Structure Of Human Beta2-Microglobulin" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 150 no PDB 2DYP . "Crystal Structure Of Lilrb2(Lir2ILT4CD85D) COMPLEXED WITH Hla-G" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 151 no PDB 2ESV . "Structure Of The Hla-E-VmaprtlilKK50.4 TCR COMPLEX" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 152 no PDB 2F53 . "Directed Evolution Of Human T-Cell Receptor Cdr2 Residues By Phage Display Dramatically Enhances Affinity For Cognate Peptide-M" . . . . . 100.00 100 99.00 99.00 4.49e-67 . . . . 19113 1 153 no PDB 2F54 . "Directed Evolution Of Human T Cell Receptor Cdr2 Residues By Phage Display Dramatically Enhances Affinity For Cognate Peptide-M" . . . . . 100.00 100 98.00 98.00 6.71e-66 . . . . 19113 1 154 no PDB 2F74 . "Murine Mhc Class I H-2db In Complex With Human B2-Microglobulin And Lcmv-Derived Immunodminant Peptide Gp33" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 155 no PDB 2F8O . "A Native To Amyloidogenic Transition Regulated By A Backbone Trigger" . . . . . 100.00 100 99.00 99.00 1.72e-67 . . . . 19113 1 156 no PDB 2FYY . "The Role Of T Cell Receptor Alpha Genes In Directing Human Mhc Restriction" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 157 no PDB 2FZ3 . "The Role Of T Cell Receptor Alpha Genes In Directing Human Mhc Restriction" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 158 no PDB 2GIT . "Human Class I Mhc Hla-A2 In Complex With The Modified Htlv-1 Tax (Y5k- 4-[3-Indolyl]-Butyric Acid) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 159 no PDB 2GJ6 . "The Complex Between Tcr A6 And Human Class I Mhc Hla-a2 With The Modified Htlv-1 Tax (y5k-4-[3-indolyl]-butyric Acid) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 160 no PDB 2GT9 . "Human Class I Mhc Hla-A2 In Complex With The Decameric Melan-AMART- 1(26-35) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 161 no PDB 2GTW . "Human Class I Mhc Hla-A2 In Complex With The Nonameric Melan-AMART- 1(27-35) Peptide Having A27l Substitution" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 162 no PDB 2GTZ . "Human Class I Mhc Hla-A2 In Complex With The Nonameric Melan-AMART- 1(27-35) Peptide Having A28l Substitution" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 163 no PDB 2GUO . "Human Class I Mhc Hla-A2 In Complex With The Native Nonameric Melan- AMART-1(27-35) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 164 no PDB 2H26 . "Human Cd1b In Complex With Endogenous Phosphatidylcholine And Spacer" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 165 no PDB 2H6P . "Crystal Structure Of Hla-B3501 Presenting The Human Cytochrome P450 Derived Peptide, Kpivvlhgy" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 166 no PDB 2HJK . "Crystal Structure Of Hla-B5703 And Hiv-1 Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 167 no PDB 2HJL . "Crystal Structure Of Hla-B5703 And Hiv-1 Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 168 no PDB 2HLA . "Specificity Pockets For The Side Chains Of Peptide Antigens In Hla-Aw68" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 169 no PDB 2HN7 . "Hla-A1101 In Complex With Hbv Peptide Homologue" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 170 no PDB 2J8U . "Large Cdr3a Loop Alteration As A Function Of Mhc Mutation." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 171 no PDB 2JCC . "Ah3 Recognition Of Mutant Hla-A2 W167a" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 172 no PDB 2NW3 . "Crystal Structure Of Hla-B3508 Presenting Ebv Peptide Eplpqgqltay At 1.7a" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 173 no PDB 2NX5 . "Crystal Structure Of Els4 Tcr Bound To Hla-B3501 Presenting Peptide Eplpqgqltay At 1.7a" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 174 no PDB 2P5E . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Reveal Native Diagonal Binding Geometry" . . . . . 100.00 100 99.00 99.00 4.49e-67 . . . . 19113 1 175 no PDB 2P5W . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Reveal Native Diagonal Binding Geometry" . . . . . 100.00 100 99.00 99.00 4.49e-67 . . . . 19113 1 176 no PDB 2PO6 . "Crystal Structure Of Cd1d-lipid-antigen Complexed With Beta-2- Microglobulin, Nkt15 Alpha-chain And Nkt15 Beta-chain" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 177 no PDB 2PYE . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Revealnative Diagonal Binding Geometry Tcr Clone C5c1 " . . . . . 100.00 100 99.00 99.00 4.49e-67 . . . . 19113 1 178 no PDB 2RFX . "Crystal Structure Of Hla-B5701, Presenting The Self Peptide, Lsspvtksf" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 179 no PDB 2UWE . "Large Cdr3a Loop Alteration As A Function Of Mhc Mutation" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 180 no PDB 2V2W . "T Cell Cross-Reactivity And Conformational Changes During Tcr Engagement" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 181 no PDB 2V2X . "T Cell Cross-Reactivity And Conformational Changes During Tcr Engagement." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 182 no PDB 2VB5 . "Solution Structure Of W60g Mutant Of Human Beta2- Microglobulin" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 19113 1 183 no PDB 2VLJ . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 184 no PDB 2VLK . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 185 no PDB 2VLL . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 186 no PDB 2VLR . "The Structural Dynamics And Energetics Of An Immunodominant T-cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 187 no PDB 2X4N . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Residual Fragments Of A Photocleavable Peptide That Is Cleaved Upon Uv-Light" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 188 no PDB 2X4O . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1 Envelope Peptide Env120-128" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 189 no PDB 2X4P . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 190 no PDB 2X4Q . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 98.00 100 100.00 100.00 2.16e-66 . . . . 19113 1 191 no PDB 2X4R . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Cytomegalovirus (Cmv) Pp65 Epitope" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 192 no PDB 2X4S . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Peptide Representing The Epitope Of The H5n1 (Avian Flu) Nucleoprotein" . . . . . 98.00 100 100.00 100.00 2.16e-66 . . . . 19113 1 193 no PDB 2X4T . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Peiodate-Cleavable Peptide" . . . . . 98.00 100 100.00 100.00 2.16e-66 . . . . 19113 1 194 no PDB 2X4U . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1 Peptide Rt468-476" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 195 no PDB 2X70 . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 196 no PDB 2X89 . "Structure Of The Beta2_microglobulin Involved In Amyloidogenesis" . . . . . 93.00 94 100.00 100.00 1.55e-62 . . . . 19113 1 197 no PDB 2XKS . "Prion-Like Conversion During Amyloid Formation At Atomic Resolution" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 198 no PDB 2XKU . "Prion-Like Conversion During Amyloid Formation At Atomic Resolution" . . . . . 93.00 94 100.00 100.00 1.55e-62 . . . . 19113 1 199 no PDB 2XPG . "Crystal Structure Of A Mhc Class I-Peptide Complex" . . . . . 97.00 98 100.00 100.00 8.66e-66 . . . . 19113 1 200 no PDB 2YPK . "Structural Features Underlying T-cell Receptor Sensitivity To Concealed Mhc Class I Micropolymorphisms" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 201 no PDB 2YPL . "Structural Features Underlying T-cell Receptor Sensitivity To Concealed Mhc Class I Micropolymorphisms" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 202 no PDB 2YXF . "The High Resolution Crystal Structure Of Beta2- Microglobulin Under Physiological Conditions" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 203 no PDB 2Z9T . "Crystal Structure Of The Human Beta-2 Microglobulin Mutant W60g" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 19113 1 204 no PDB 3AM8 . "Crystal Structure Of A Human Major Histocompatibilty Complex" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 205 no PDB 3B3I . "Citrullination-dependent Differential Presentation Of A Self-peptide By Hla-b27 Subtypes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 206 no PDB 3B6S . "Crystal Structure Of Hla-B2705 Complexed With The Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (R" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 207 no PDB 3BGM . "Crystal Structure Of Pkd2 Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 208 no PDB 3BH8 . "Crystal Structure Of Rqa_m Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 209 no PDB 3BH9 . "Crystal Structure Of Rty Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 210 no PDB 3BHB . "Crystal Structure Of Kmd Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 211 no PDB 3BO8 . "The High Resolution Crystal Structure Of Hla-A1 Complexed With The Mage-A1 Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 212 no PDB 3BP4 . "The High Resolution Crystal Structure Of Hla-B2705 In Complex With A Cathepsin A Signal Sequence Peptide Pcata" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 213 no PDB 3BP7 . "The High Resolution Crystal Structure Of Hla-b*2709 In Complex With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 214 no PDB 3BVN . "High Resolution Crystal Structure Of Hla-B1402 In Complex With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Vir" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 215 no PDB 3BW9 . "Crystal Structure Of Hla B3508 In Complex With A Hcmv 12- Mer Peptide From The Pp65 Protein" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 216 no PDB 3BWA . "Crystal Structure Of Hla B3508 In Complex With A Hcmv 8- Mer Peptide From The Pp65 Protein" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 217 no PDB 3BXN . "The High Resolution Crystal Structure Of Hla-b*1402 Complexed With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 218 no PDB 3BZE . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla- E" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 219 no PDB 3BZF . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 97.00 97 100.00 100.00 8.40e-66 . . . . 19113 1 220 no PDB 3C9N . "Crystal Structure Of A Sars Corona Virus Derived Peptide Bound To The Human Major Histocompatibility Complex Class I Molecule H" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 221 no PDB 3CDG . "Human Cd94NKG2A IN COMPLEX WITH HLA-E" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 222 no PDB 3CII . "Structure Of Nkg2aCD94 BOUND TO HLA-E" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 223 no PDB 3CIQ . "A Regulatable Switch Mediates Self-Association In An Immunoglobulin Fold" . . . . . 100.00 100 99.00 99.00 4.34e-67 . . . . 19113 1 224 no PDB 3CZF . "Crystal Structure Of Hla-B2709 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 225 no PDB 3D18 . "Crystal Structure Of Hla-B2709 Complexed With A Variant Of The Latent Membrane Protein 2 Peptide (Lmp2(L)) Of Epstein-Barr Viru" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 226 no PDB 3D25 . "Crystal Structure Of Ha-1 Minor Histocompatibility Antigen Bound To Human Class I Mhc Hla-A2" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 227 no PDB 3D2U . "Structure Of Ul18, A Peptide-binding Viral Mhc Mimic, Bound To A Host Inhibitory Receptor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 228 no PDB 3D39 . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Modified Htlv-1 Tax (Y5(4-Fluorophenylalanine)) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 229 no PDB 3D3V . "The Complex Between Tcr A6 And Human Class I Mhc Hla-a2 With The Modified Htlv-1 Tax (y5(3,4-difluorophenylalanine)) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 230 no PDB 3DBX . "Structure Of Chicken Cd1-2 With Bound Fatty Acid" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 231 no PDB 3DHJ . "Beta 2 Microglobulin Mutant W60c" . . . . . 100.00 100 99.00 99.00 7.66e-67 . . . . 19113 1 232 no PDB 3DHM . "Beta 2 Microglobulin Mutant D59p" . . . . . 100.00 100 99.00 99.00 3.49e-67 . . . . 19113 1 233 no PDB 3DTX . "Crystal Structure Of Hla-B2705 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 234 no PDB 3DX6 . "Crystal Structure Of B4402 Presenting A 10mer Ebv Epitope" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 235 no PDB 3DX7 . "Crystal Structure Of Hla-B4403 Presenting 10mer Ebv Antigen" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 236 no PDB 3DX8 . "Crystal Structure Of B4405 Presenting A 10mer Ebv Epitope" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 237 no PDB 3DXA . "Crystal Structure Of The Dm1 Tcr In Complex With Hla-B4405 And Decamer Ebv Antigen" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 238 no PDB 3EKC . "Structure Of W60v Beta-2 Microglobulin Mutant" . . . . . 100.00 100 99.00 99.00 7.41e-67 . . . . 19113 1 239 no PDB 3FFC . "Crystal Structure Of Cf34 Tcr In Complex With Hla-b8/flr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 240 no PDB 3FQN . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 241 no PDB 3FQR . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 242 no PDB 3FQT . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 243 no PDB 3FQU . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 244 no PDB 3FQW . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 245 no PDB 3FQX . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 246 no PDB 3FT2 . "Crystal Structure Of A Citrulline Peptide Variant Of The Minor Histocompatibility Peptide Ha-1 In Complex With Hla- A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 247 no PDB 3FT3 . "Crystal Structure Of The Minor Histocompatibility Peptide Ha-1his In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 248 no PDB 3FT4 . "Crystal Structure Of The Minor Histocompatibility Peptide Ha-1arg In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 249 no PDB 3GIV . "Antigen Processing Influences Hiv-Specific Cytotoxic T Lymphocyte Immunodominance" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 250 no PDB 3GJF . "Rational Development Of High-Affinity T-Cell Receptor-Like Antibodies" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 251 no PDB 3GSN . "Crystal Structure Of The Public Ra14 Tcr In Complex With The Hcmv Dominant NlvHLA-A2 Epitope" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 252 no PDB 3GSO . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 253 no PDB 3GSQ . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5s Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 254 no PDB 3GSR . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5v Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 255 no PDB 3GSU . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5t Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 256 no PDB 3GSV . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5q Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 257 no PDB 3GSW . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-T8a Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 258 no PDB 3GSX . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-T8v Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 259 no PDB 3H7B . "Human Class I Mhc Hla-a2 In Complex With The Tel1p Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 260 no PDB 3H9H . "Human Class I Mhc Hla-A2(A150p) In Complex With The Tel1p Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 261 no PDB 3H9S . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Bound Tel1p Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 262 no PDB 3HAE . "Rational Development Of High-Affinity T-Cell Receptor-Like Antibodies" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 263 no PDB 3HCV . "Crystal Structure Of Hla-B2709 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 264 no PDB 3HG1 . "Germline-governed Recognition Of A Cancer Epitope By An Immunodominant Human T Cell Receptor" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 265 no PDB 3HLA . "Human Class I Histocompatibility Antigen A2.1" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 266 no PDB 3HPJ . "Human Class I Mhc Hla-a2 In Complex With The Wt-1 (126-134) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 267 no PDB 3HUJ . "Crystal Structure Of Human Cd1d-Alpha-Galactosylceramide In Complex With Semi-Invariant Nkt Cell Receptor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 268 no PDB 3I6G . "Newly Identified Epitope Mn2 From Sars-Cov M Protein Complexed Withhla-A0201" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 269 no PDB 3I6K . "Newly Identified Epitope From Sars-Cov Membrane Protein Complexed With Hla-A0201" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 270 no PDB 3I6L . "Newly Identified Epitope N1 Derived From Sars-Cov N Protein Complexed With Hla-A2402" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 271 no PDB 3IB4 . "The Double Mutant Of Beta-2 Microglobulin K58p-W60g" . . . . . 100.00 100 97.00 97.00 1.87e-64 . . . . 19113 1 272 no PDB 3IXA . "Human Class I Mhc Hla-A2(A150p) In Complex With The Tax Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 273 no PDB 3JTS . Gy9-Mamu-A02-Hb2m . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 274 no PDB 3KLA . "Ca2+ Release From The Endoplasmic Reticulum Of Ny-Eso-1 Specific T Cells Is Modulated By The Affinity Of T Cell Receptor And By" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 275 no PDB 3KPL . "Crystal Structure Of Hla B4402 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 276 no PDB 3KPM . "Crystal Structure Of Hla B4402 In Complex With Eeylkawtf, A Mimotope" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 277 no PDB 3KPN . "Crystal Structure Of Hla B4403 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 278 no PDB 3KPO . "Crystal Structure Of Hla B*4403 In Complex With Eeylkawtf, A Mimotope" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 279 no PDB 3KPP . "Crystal Structure Of Hla B4405 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 280 no PDB 3KPQ . "Crystal Structure Of Hla B*4405 In Complex With Eeylkawtf, A Mimotope" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 281 no PDB 3KPR . "Crystal Structure Of The Lc13 Tcr In Complex With Hla B4405 Bound To Eeylkawtf A Mimotope" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 282 no PDB 3KPS . "Crystal Structure Of The Lc13 Tcr In Complex With Hla B4405 Bound To Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 283 no PDB 3KWW . "Crystal Structure Of The 'restriction Triad' Mutant Of Hla B Beta-2-Microglobulin And Ebv Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 284 no PDB 3KXF . "Crystal Structure Of Sb27 Tcr In Complex With The 'restriction Triad' Mutant Hla-b*3508-13mer" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 285 no PDB 3KYN . "Crystal Structure Of Hla-g Presenting Kgppaaltl Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 286 no PDB 3KYO . "Crystal Structure Of Hla-g Presenting Klpaqfyil Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 287 no PDB 3L3D . "Crystal Structure Of Hla-b*4402 In Complex With The F3a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 288 no PDB 3L3G . "Crystal Structure Of Hla-b*4402 In Complex With The R5a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 289 no PDB 3L3I . "Crystal Structure Of Hla-b*4402 In Complex With The F7a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 290 no PDB 3L3J . "Crystal Structure Of Hla-b*4402 In Complex With The F3a/r5a Double Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 291 no PDB 3L3K . "Crystal Structure Of Hla-b*4402 In Complex With The R5a/f7a Double Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 292 no PDB 3LKN . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1918 Strain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 293 no PDB 3LKO . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1934 Strain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 294 no PDB 3LKP . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1972 Strain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 295 no PDB 3LKQ . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1977 Strain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 296 no PDB 3LKR . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 2009 H1n1 Swine Origin Strain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 297 no PDB 3LKS . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1980 Strain" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 298 no PDB 3LN4 . "Crystal Structure Of Hla-B4103 In Complex With A 16mer Self-Peptide Derived From Heterogeneous Nuclear Ribonucleoproteins C1C2" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 299 no PDB 3LN5 . "Crystal Structure Of Hla-B4104 In Complex With A 11mer Self-Peptide Derived From S-Methyl-5-Thioadenosine Phosphorylase" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 300 no PDB 3LOW . "Crystal Structure Of Beta 2 Microglobulin Domain-Swapped Dimer" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 301 no PDB 3LV3 . "Crystal Structure Of Hla-B2705 Complexed With A Peptide Derived From The Human Voltage-Dependent Calcium Channel Alpha1 Subunit" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 302 no PDB 3M17 . "Crystal Structure Of Human Fcrn With A Monomeric Peptide Inhibitor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 303 no PDB 3M1B . "Crystal Structure Of Human Fcrn With A Dimeric Peptide Inhibitor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 304 no PDB 3MGO . "Crystal Structure Of A H5-Specific Ctl Epitope Derived From Influenza Virus In Complex With Hla-A0201" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 305 no PDB 3MGT . "Crystal Structure Of A H5-Specific Ctl Epitope Variant Deriv H5n1 Influenza Virus In Complex With Hla-A0201" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 306 no PDB 3MR9 . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide M5a Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 307 no PDB 3MRB . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide A7h Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 308 no PDB 3MRC . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide V6c Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 309 no PDB 3MRD . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide V6g Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 310 no PDB 3MRE . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Ebv Bmlf1-280-288 Nonapeptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 311 no PDB 3MRF . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Ebv Bmlf1-280-288 Nonapeptide T4p Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 312 no PDB 3MRG . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 313 no PDB 3MRH . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide N3s Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 314 no PDB 3MRI . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide G4m-V5w Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 315 no PDB 3MRJ . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide V5m Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 316 no PDB 3MRK . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Afp137 Nonapeptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 317 no PDB 3MRL . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide C6v Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 318 no PDB 3MRM . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1406-1415 Decapeptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 319 no PDB 3MRN . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns4b-1807-1816 Decapeptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 320 no PDB 3MRO . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 321 no PDB 3MRP . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 322 no PDB 3MRQ . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 323 no PDB 3MRR . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Human Prostaglandin Transporter Decapeptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 324 no PDB 3MV7 . "Crystal Structure Of The Tk3 Tcr In Complex With Hla-B3501HPVG" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 325 no PDB 3MV8 . "Crystal Structure Of The Tk3-Gln55his Tcr In Complex With Hla- B3501HPVG" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 326 no PDB 3MV9 . "Crystal Structure Of The Tk3-Gln55ala Tcr In Complex With Hla- B3501HPVG" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 327 no PDB 3MYJ . "Human Class I Mhc Hla-a2 In Complex With The Wt-1 (126-134) (r1y) Peptide Variant." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 328 no PDB 3MYZ . "Protein Induced Photophysical Changes To The Amyloid Indicator Dye, Thioflavin T" . . . . . 100.00 100 99.00 99.00 4.34e-67 . . . . 19113 1 329 no PDB 3MZT . "Protein-Induced Photophysical Changes To The Amyloid Indicator Dye, Thioflavin T" . . . . . 100.00 100 99.00 99.00 4.34e-67 . . . . 19113 1 330 no PDB 3NA4 . "D53p Beta-2 Microglobulin Mutant" . . . . . 100.00 100 98.00 98.00 8.26e-66 . . . . 19113 1 331 no PDB 3NFN . "Recognition Of Peptide-mhc By A V-delta/v-beta Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 332 no PDB 3O3A . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-1" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 333 no PDB 3O3B . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-1.1" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 334 no PDB 3O3D . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-2" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 335 no PDB 3O3E . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-2.1" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 336 no PDB 3O4L . "Genetic And Structural Basis For Selection Of A Ubiquitous T Cell Receptor Deployed In Epstein-barr Virus" . . . . . 100.00 100 99.00 99.00 4.49e-67 . . . . 19113 1 337 no PDB 3OV6 . "Cd1c In Complex With Mpm (Mannosyl-Beta1-Phosphomycoketide)" . . . . . 99.00 397 100.00 100.00 2.05e-64 . . . . 19113 1 338 no PDB 3OX8 . "Crystal Structure Of Hla A02:03 Bound To Hbv Core 18-27" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 339 no PDB 3OXR . "Crystal Structure Of Hla A02:06 Bound To Hbv Core 18-27" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 340 no PDB 3OXS . "Crystal Structure Of Hla A02:07 Bound To Hbv Core 18-27" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 341 no PDB 3PWJ . "Human Class I Mhc Hla-A2 In Complex With The Hud (G2l,I9v) Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 342 no PDB 3PWL . "Human Class I Mhc Hla-A2 In Complex With The Hud Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 343 no PDB 3PWN . "Human Class I Mhc Hla-A2 In Complex With The Hud (G2l) Peptide Variant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 344 no PDB 3PWP . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Bound Hud Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 345 no PDB 3QDA . "Crystal Structure Of W95l Beta-2 Microglobulin" . . . . . 100.00 100 99.00 99.00 4.79e-67 . . . . 19113 1 346 no PDB 3QDG . "The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2 With The Bound Mart-1(26-35)(A27l) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 347 no PDB 3QDJ . "The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2 With The Bound Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 348 no PDB 3QDM . "The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2 With The Bound Mart-1(26-35)(A27l) Decameric Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 349 no PDB 3QEQ . "The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2 With The Bound Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 350 no PDB 3QFD . "Human Class I Mhc Hla-A2 In Complex With Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 351 no PDB 3QFJ . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Modified Tax (Y5f) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 352 no PDB 3QZW . "Plasticity Of Human Cd8 Binding To Peptide-hla-a*2402" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 353 no PDB 3REW . "Crystal Structure Of An Lmp2a-Derived Peptide Bound To Human Class I Mhc Hla-A2" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 354 no PDB 3RL1 . "Hiv Rt Derived Peptide Complexed To Hla-A0301" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 355 no PDB 3RL2 . "Hiv Nef Derived Peptide Nef73 Complexed To Hla-A0301" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 356 no PDB 3RWJ . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Hw8" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 357 no PDB 3SDX . "Crystal Structure Of Human Autoreactive-Valpha24 Nkt Tcr In Complex With Cd1d-Beta-Galactosylceramide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 358 no PDB 3SJV . "Crystal Structure Of The Rl42 Tcr In Complex With Hla-B8-Flr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 359 no PDB 3SKM . "Crystal Structure Of The Hla-B8flrgrayvl, Mutant G8v Of The Flr Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 360 no PDB 3SKO . "Crystal Structure Of The Hla-B8-A66-Flr, Mutant A66 Of The Hla B8" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 361 no PDB 3SPV . "Crystal Structure Of A Peptide-Hla Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 362 no PDB 3T8X . "Crystal Structure Of Human Cd1b In Complex With Synthetic Antigenic Diacylsulfoglycolipid Sgl12 And Endogenous Spacer" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 363 no PDB 3TID . "Crystal Structure Of The Lcmv Derived Peptide Gp34 In Complex With The Murine Mhc Class I H-2 Kb" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 364 no PDB 3TIE . "Crystal Structure Of The Vaccinia Derived Peptide A11r In Complex With The Murine Mhc Class I H-2 Kb" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 365 no PDB 3TLR . "Crystal Structure Of The Tetrameric Beta-2 Microglobulin Dimc20 Mutant" . . . . . 100.00 100 99.00 99.00 1.81e-67 . . . . 19113 1 366 no PDB 3TM6 . "Crystal Structure Of The Beta-2 Microglobulin Dimc50 Disulphide-linked Homodimer Mutant" . . . . . 100.00 100 99.00 99.00 5.77e-67 . . . . 19113 1 367 no PDB 3TO2 . "Structure Of Hla-A0201 Complexed With Peptide Md3-C9 Derived From A Clustering Region Of Restricted Cytotoxic T Lymphocyte Epit" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 368 no PDB 3TZV . "Crystal Structure Of An Inkt Tcr In Complex With Cd1d- Lysophosphatidylcholine" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 369 no PDB 3U0P . "Crystal Structure Of Human Cd1d-Lysophosphatidylcholine" . . . . . 99.00 102 100.00 100.00 2.62e-67 . . . . 19113 1 370 no PDB 3UPR . "Hla-B57:01 Complexed To Pep-V And Abacavir" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 371 no PDB 3UTQ . "Human Hla-A0201-Alwgpdpaaa" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 372 no PDB 3UTS . "1e6-A0201-Alwgpdpaaa Complex, Monoclinic" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 373 no PDB 3UTT . "1e6-A0201-Alwgpdpaaa Complex, Triclinic" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 374 no PDB 3V5D . "Hla-A2.1 Kvaelvhfl" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 375 no PDB 3V5H . "Hla-A2.1 Kvaeivhfl" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 376 no PDB 3V5K . "Hla2.1 Kvaelvwfl" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 377 no PDB 3VCL . "Crystal Structure Of Hla-B7 With The Hcmv Pp65 Peptide Rpherngftvl" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 378 no PDB 3VFM . "Crystal Structure Of Hla B3508 Lpep155a, Hla Mutant Ala155" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 379 no PDB 3VFN . "Crystal Structure Of Hla B3508lpep151a, Hla Mutant Ala151" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 380 no PDB 3VFO . "Crystal Structure Of Hla B3508 Lpep157a, Hla Mutant Ala157" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 381 no PDB 3VFP . "Crystal Structure Of Hla B3508 Lpep158g, Hla Mutant Gly158" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 382 no PDB 3VFR . "Crystal Structure Of Hla B3508lpep-P4ala, Peptide Mutant P4-Ala" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 383 no PDB 3VFS . "Crystal Structure Of Hla B3508lpep-P5ala , Peptide Mutant P5-Ala" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 384 no PDB 3VFT . "Crystal Structure Of Hla B3508lpep-P6ala, Peptide Mutant P6-Ala" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 385 no PDB 3VFU . "Crystal Structure Of Hla B3508 Lpep-P7ala, Peptide Mutant P7-Ala" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 386 no PDB 3VFV . "Crystal Structure Of Hla B3508 Lpep-P9ala, Peptide Mutant P9-Ala" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 387 no PDB 3VFW . "Crystal Structure Of Hla B3508 Lpep-P10ala, Peptide Mutant P10-Ala" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 388 no PDB 3VH8 . "Kir3dl1 In Complex With Hla-B5701" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 389 no PDB 3VRI . "Hla-B57:01-Rvaqlenvyi In Complex With Abacavir" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 390 no PDB 3VRJ . "Hla-B57:01-Lttkltntni In Complex With Abacavir" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 391 no PDB 3VWJ . "Ternary Crystal Structure Of The Human Nkt Tcr-cd1d-c20:2 Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 392 no PDB 3VWK . "Ternary Crystal Structure Of The Human Nkt Tcr-cd1d-4'deoxy-alpha- Galactosylceramide Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 393 no PDB 3VXM . "The Complex Between C1-28 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 394 no PDB 3VXN . "Hla-a24 In Complex With Hiv-1 Nef134-10(wt)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 395 no PDB 3VXO . "Hla-a24 In Complex With Hiv-1 Nef134-10(2f)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 396 no PDB 3VXP . "Hla-a24 In Complex With Hiv-1 Nef134-10(6l)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 397 no PDB 3VXR . "The Complex Between H27-14 Tcr And Hla-a24 Bound To Hiv-1 Nef134- 10(wt) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 398 no PDB 3VXS . "The Complex Between H27-14 Tcr And Hla-a24 Bound To Hiv-1 Nef134- 10(6l) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 399 no PDB 3VXU . "The Complex Between T36-5 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 400 no PDB 3W0W . "The Complex Between T36-5 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide In Space Group P212121" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 401 no PDB 3W39 . "Crystal Structure Of Hla-b*5201 In Complexed With Hiv Immunodominant Epitope (taftipsi)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 402 no PDB 3WL9 . "Hla-a24 In Complex With Hiv-1 Nef126-10(8i10f)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 403 no PDB 3WLB . "Hla-a24 In Complex With Hiv-1 Nef126-10(8t10f)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 404 no PDB 3WUW . "Kir3dl1 In Complex With Hla-b*57:01.i80t" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 405 no PDB 4E5X . "Crystal Structure Of A Complex Between The Human Adenovirus Type 2 E3- 19k Protein And Mhc Class I Molecule Hla-A2TAX" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 406 no PDB 4EN3 . "Crystal Structure Of A Human Valpha24(-) Nkt Tcr In Complex With Cd1d/alpha-galactosylceramide" . . . . . 99.00 100 100.00 100.00 3.23e-67 . . . . 19113 1 407 no PDB 4EUP . "The Complex Between Tcr Jkf6 And Human Class I Mhc Hla-a2 Presenting The Mart-1(27-35)(a27l) Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 408 no PDB 4F7M . "Crystal Structure Of Hla-A2402 Complexed With A Newly Identified Peptide From 2009 H1n1 Pa (649-658)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 409 no PDB 4F7P . "Crystal Structure Of Hla-a*2402 Complexed With A Newly Identified Peptide From 2009h1n1 Pb1 (496-505)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 410 no PDB 4F7T . "Crystal Structure Of Hla-A2402 Complexed With A Newly Identified Peptide From 2009 H1n1 Pb1 (498-505)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 411 no PDB 4FTV . "The Complex Between The High Affinity Version Of A6 Tcr (a6c134) And Human Class I Mhc Hla-a2 With The Bound Tax Nonameric Pept" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 412 no PDB 4FXL . "Crystal Structure Of The D76n Beta-2 Microglobulin Mutant" . . . . . 100.00 100 99.00 100.00 9.02e-68 . . . . 19113 1 413 no PDB 4G8G . "Crystal Structure Of C12c Tcr-ha B2705-kk10" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 414 no PDB 4G8I . "Crystal Structure Of Hla B2705-kk10-l6m" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 415 no PDB 4G9D . "Crystal Structure Of Hla B2705-kk10" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 416 no PDB 4G9F . "Crystal Structure Of C12c Tcr-hlab2705-kk10-l6m" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 417 no PDB 4GKN . "A2-Mhc Complex Carrying Fatgigiitv" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 418 no PDB 4GKS . "A2-Mhc Complex Carrying Fltgigiitv" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 419 no PDB 4GUP . "Structure Of Mhc-Class I Related Molecule Mr1" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 420 no PDB 4HKJ . "Structure Of Cowpox Cpxv203 In Complex With Mhci (H-2kb)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 421 no PDB 4HWZ . "Structure Of Hla-a68 Complexed With An Hiv Derived Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 422 no PDB 4HX1 . "Structure Of Hla-a68 Complexed With A Tumor Antigen Derived Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 423 no PDB 4I48 . "Structure Of Hla-a68 Complexed With An Hiv Env Derived Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 424 no PDB 4I4W . "Peptide Length Determines The Outcome Of T Cell Receptor/peptide-mhci Engagement" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 425 no PDB 4JFD . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 426 no PDB 4JFE . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 427 no PDB 4JFF . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 428 no PDB 4JFO . "A2 Hla Complex With E1a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 429 no PDB 4JFP . "A2 Hla Complex With G4a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 430 no PDB 4JFQ . "A2 Hla Complex With L8a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 431 no PDB 4JQV . "Hla-b*18:01 In Complex With Epstein-barr Virus Bzlf1-derived Peptide (residues 173-180)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 432 no PDB 4JQX . "Hla-b*44:03 In Complex With Epstein-barr Virus Bzlf1-derived Peptide (residues 169-180)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 433 no PDB 4JRX . "Crystal Structure Of Ca5 Tcr-hla B*3505-lpep Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 434 no PDB 4JRY . "Crystal Structure Of Sb47 Tcr-hla B*3505-lpep Complex" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 435 no PDB 4K71 . "Crystal Structure Of A High Affinity Human Serum Albumin Variant Bound To The Neonatal Fc Receptor" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 436 no PDB 4K7F . "Newly Identified Epitope V60 From Hbv Core Protein Complexed With Hla- A*0201" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 437 no PDB 4KDT . "Structure Of An Early Native-like Intermediate Of Beta2-microglobulin Amyloidosis" . . . . . 100.00 100 99.00 99.00 3.41e-67 . . . . 19113 1 438 no PDB 4L29 . "Structure Of Wtmhc Class I With Ny-eso1 Double Mutant" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 439 no PDB 4L3C . "Structure Of Hla-a2 In Complex With D76n B2m Mutant And Ny-eso1 Double Mutant" . . . . . 100.00 100 99.00 100.00 9.02e-68 . . . . 19113 1 440 no PDB 4L3E . "The Complex Between High Affinity Tcr Dmf5(alpha-d26y,beta-l98w) And Human Class I Mhc Hla-a2 With The Bound Mart-1(26-35)(a27l" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 441 no PDB 4L4T . "Structure Of Human Mait Tcr In Complex With Human Mr1-6-fp" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 442 no PDB 4L4V . "Structure Of Human Mait Tcr In Complex With Human Mr1-rl-6-me-7-oh" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 443 no PDB 4LCW . "The Structure Of Human Mait Tcr In Complex With Mr1-k43a-rl-6-me-7oh" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 444 no PDB 4LCY . "Crystal Structure Of Hla-b46 At 1.6 Angstrom Resolution" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 445 no PDB 4LHU . "Crystal Structure Of 9c2 Tcr Bound To Cd1d" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 446 no PDB 4LNR . "The Structure Of Hla-b*35:01 In Complex With The Peptide (rpqvplrpmty)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 447 no PDB 4M8V . "Crystal Structure Of Human Double Mutant Beta2-microglobulin Q8h-l65t" . . . . . 100.00 100 98.00 98.00 9.84e-67 . . . . 19113 1 448 no PDB 4MJ5 . "Hla-a11 Complexed With A Pepitde" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 449 no PDB 4MJ6 . "Hla-a11 Complexed With A Mutated Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 450 no PDB 4MJI . "T Cell Response To A Hiv Reverse Transcriptase Epitope Presented By The Protective Allele Hla-b*51:01" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 451 no PDB 4MNQ . "Tcr-peptide Specificity Overrides Affinity Enhancing Tcr-mhc Interactions" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 452 no PDB 4N0F . "Human Fcrn Complexed With Human Serum Albumin" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 453 no PDB 4N0U . "Ternary Complex Between Neonatal Fc Receptor, Serum Albumin And Fc" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 454 no PDB 4N8V . "Crystal Structure Of Killer Cell Immunoglobulin-like Receptor Kir2ds2 In Complex With Hla-a" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 455 no PDB 4NNX . "Crystal Structure Of Pkd2 Phosphopeptide Bound To Hla-a2" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 456 no PDB 4NNY . "Crystal Structure Of Non-phosphorylated Form Of Pkd2 Phosphopeptide Bound To Hla-a2" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 457 no PDB 4NO0 . "Crystal Structure Of Non-phosphorylated Form Of Rqa_v Phosphopeptide Bound To Hla-a2 In Complex With Lilrb1" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 458 no PDB 4NO2 . "Crystal Structure Of Rqa_v Phosphopeptide Bound To Hla-a2" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 459 no PDB 4NQC . "Crystal Structure Of Tcr-mr1 Ternary Complex And Covalently Bound 5- (2-oxopropylideneamino)-6-d-ribitylaminouracil" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 460 no PDB 4NQD . "Crystal Structure Of Tcr-mr1 Ternary Complex And Non-covalently Bound 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 461 no PDB 4NQE . "Crystal Structure Of Tcr-mr1 Ternary Complex Bound To 5-(2- Oxoethylideneamino)-6-d-ribitylaminouracil" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 462 no PDB 4NQV . "Crystal Structure Of Hla A*0101 In Complex With Np44, An 9-mer Influenza Epitope" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 463 no PDB 4NQX . "Crystal Structure Of Hla A*0101 In Complex With Np44-s7n, An 9-mer Influenza Epitope" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 464 no PDB 4NT6 . "Hla-c*0801 Crystal Structure" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 465 no PDB 4O2C . "An Nt-acetylated Peptide Complexed With Hla-b*3901" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 466 no PDB 4O2E . "A Peptide Complexed With Hla-b*3901" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 467 no PDB 4O2F . "A Peptide Complexed With Hla-b*3901" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 468 no PDB 4ONO . "Cd1c In Complex With Pm (phosphomycoketide)" . . . . . 99.00 395 100.00 100.00 2.22e-64 . . . . 19113 1 469 no PDB 4PJ5 . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait Trbv6-1 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 470 no PDB 4PJ7 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Trbv6-4 Tcr" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 471 no PDB 4PJ8 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Trbv20 Tcr" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 472 no PDB 4PJ9 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Traj20 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 473 no PDB 4PJA . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait B-b10 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 474 no PDB 4PJB . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait B-f3-c1 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 475 no PDB 4PJC . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait C-a11 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 476 no PDB 4PJD . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait C-c10 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 477 no PDB 4PJE . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-b10 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 478 no PDB 4PJF . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-c10 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 479 no PDB 4PJG . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-f3-c1 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 480 no PDB 4PJH . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-g8 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 481 no PDB 4PJI . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait C-c10 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 482 no PDB 4PJX . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait C-a11 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 483 no PDB 4PR5 . "Crystal Structure Of A Hla-b*35:01-hpvg-d5" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 484 no PDB 4PRA . "Crystal Structure Of A Hla-b*35:01-hpvg-q5" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 485 no PDB 4PRB . "Crystal Structure Of A Hla-b*35:08-hpvg-a4" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 486 no PDB 4PRD . "Crystal Structure Of A Hla-b*35:08-hpvg-d5" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 487 no PDB 4PRE . "Crystal Structure Of A Hla-b*35:08-hpvg-q5" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 488 no PDB 4PRH . "Crystal Structure Of Tk3 Tcr-hla-b*35:08-hpvg-d5 Complex" . . . . . 100.00 100 99.00 100.00 5.52e-68 . . . . 19113 1 489 no PDB 4PRI . "Crystal Structure Of Tk3 Tcr-hla-b*35:08-hpvg Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 490 no PDB 4PRN . "Crystal Structure Of A Hla-b*35:01-hpvg-a4" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 491 no PDB 4PRP . "Crystal Structure Of Tk3 Tcr-hla-b*35:01-hpvg-q5 Complex" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 492 no PDB 4QOK . "Structural Basis For Ineffective T-cell Responses To Mhc Anchor Residue Improved Heteroclitic Peptides" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 493 no PDB 4QRP . "Crystal Structure Of Hla B*0801 In Complex With Hskkkcdel And Dd31 Tcr" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 494 no PDB 4QRQ . "Crystal Structure Of Hla B*0801 In Complex With Hskkkcdel" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 495 no PDB 4QRR . "Crystal Structure Of Hla B*3501-ips In Complex With A Delta-beta Tcr, Clone 12 Tcr" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 496 no PDB 4QRS . "Crystal Structure Of Hla B*0801 In Complex With Elk_iym, Elkrkmiym" . . . . . 100.00 100 99.00 99.00 3.73e-67 . . . . 19113 1 497 no PDB 4QRT . "Crystal Structure Of Hla B*0801 In Complex With Eln_yym, Elnrkmiym" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 498 no PDB 4QRU . "Crystal Structure Of Hla B*0801 In Complex With Elr_mym, Elrrkmmym" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 499 no PDB 4R9H . "Crystal Structure Of Dimeric S33c Beta-2 Microglobulin Mutant At 1.9 Angstrom Resolution" . . . . . 100.00 100 99.00 99.00 1.81e-67 . . . . 19113 1 500 no PDB 4RA3 . "Crystal Structure Of Dimeric S33c Beta-2 Microglobulin Mutant In Complex With Thioflavin (tht) At 2.8 Angstrom Resolution" . . . . . 100.00 100 99.00 99.00 1.81e-67 . . . . 19113 1 501 no PDB 4RAH . "Crystal Structure Of Dimeric S33c Beta-2 Microglobulin Mutant At 1.4 Angstrom Resolution" . . . . . 100.00 100 99.00 99.00 1.81e-67 . . . . 19113 1 502 no PDB 4U1H . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 503 no PDB 4U1I . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 504 no PDB 4U1J . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 505 no PDB 4U1K . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 506 no PDB 4U1L . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 507 no PDB 4U1M . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 508 no PDB 4U1N . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 509 no PDB 4U1S . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 510 no PDB 4U6X . "Crystal Structure Of Hla-a*0201 In Complex With Alqda, A 15 Mer Self- Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 511 no PDB 4U6Y . "Crystal Structure Of Hla-a*0201 In Complex With Flndk, A 15 Mer Self- Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 512 no PDB 4UQ2 . "Crystal Structure Of Hla-a1101 In Complex With An Azobenzene-containing Peptide" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 513 no PDB 4UQ3 . "Crystal Structure Of Hla-a0201 In Complex With An Azobenzene-containing Peptide" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 514 no PDB 4WDI . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 515 no PDB 4WJ5 . "Structure Of Hla-a2 In Complex With An Altered Peptide Ligands Based On Mart-1 Variant Epitope" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 516 no PDB 4WO4 . "The Molecular Bases Of Delta/alpha Beta T Cell-mediated Antigen Recognition." . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 517 no PDB 4WU5 . "Hla-a24 In Complex With Hiv-1 Nef134-8(wt)" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 518 no PDB 4WU7 . "Hla-a24 In Complex With Hiv-1 Nef134-8(2f)" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 519 no PDB 4X6C . "Cd1a Ternary Complex With Lysophosphatidylcholine And Bk6 Tcr" . . . . . 99.00 105 100.00 100.00 2.46e-67 . . . . 19113 1 520 no PDB 4X6D . "Cd1a Ternary Complex With Endogenous Lipids And Bk6 Tcr" . . . . . 99.00 99 100.00 100.00 2.26e-67 . . . . 19113 1 521 no PDB 4X6E . "Cd1a Binary Complex With Lysophosphatidylcholine" . . . . . 99.00 105 100.00 100.00 2.46e-67 . . . . 19113 1 522 no PDB 4X6F . "Cd1a Binary Complex With Sphingomyelin" . . . . . 99.00 105 100.00 100.00 2.46e-67 . . . . 19113 1 523 no PDB 4XXC . "Hla-b*1801 In Complex With A Self-peptide, Deleikay" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 524 no PDB 4Z76 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 525 no PDB 4Z77 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 526 no PDB 4Z78 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 2.33e-68 . . . . 19113 1 527 no PDB 5BXF . "Apo Fcrn Structure At Ph 4.5" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 528 no DBJ BAA35182 . "beta 2-microglobulin [Homo sapiens]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 529 no DBJ BAG38125 . "unnamed protein product [Homo sapiens]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 530 no DBJ BAG64583 . "unnamed protein product [Homo sapiens]" . . . . . 97.00 122 96.91 97.94 3.20e-64 . . . . 19113 1 531 no DBJ BAG72952 . "beta-2-microglobulin [synthetic construct]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 532 no EMBL CAA23830 . "beta-2 microglobulin [Homo sapiens]" . . . . . 99.00 110 100.00 100.00 8.96e-68 . . . . 19113 1 533 no EMBL CAG33347 . "B2M [Homo sapiens]" . . . . . 99.00 119 98.99 100.00 1.41e-67 . . . . 19113 1 534 no EMBL CAH92078 . "hypothetical protein [Pongo abelii]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 535 no GB AAA51811 . "beta-2-microglobulin [Homo sapiens]" . . . . . 99.00 119 98.99 98.99 3.90e-67 . . . . 19113 1 536 no GB AAA87972 . "beta-2-microglobulin [Pan troglodytes]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 537 no GB AAA88008 . "beta-2-microglobulin [Gorilla gorilla]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 538 no GB AAB25312 . "beta 2-microglobulin [Homo sapiens]" . . . . . 75.00 101 100.00 100.00 1.65e-48 . . . . 19113 1 539 no GB AAB35347 . "pI 5.3 beta 2-microglobulin, BM [human, urine, chronic renal failure patient, Peptide, 98 aa]" . . . . . 98.00 98 100.00 100.00 1.22e-66 . . . . 19113 1 540 no REF NP_001009066 . "beta-2-microglobulin precursor [Pan troglodytes]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 541 no REF NP_001127503 . "beta-2-microglobulin precursor [Pongo abelii]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 542 no REF NP_004039 . "beta-2-microglobulin precursor [Homo sapiens]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 543 no REF XP_003266898 . "PREDICTED: beta-2-microglobulin isoform X2 [Nomascus leucogenys]" . . . . . 99.00 119 96.97 98.99 2.09e-66 . . . . 19113 1 544 no REF XP_004056148 . "PREDICTED: beta-2-microglobulin isoform 1 [Gorilla gorilla gorilla]" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 545 no SP P16213 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 546 no SP P61769 . "RecName: Full=Beta-2-microglobulin; Contains: RecName: Full=Beta-2-microglobulin form pI 5.3; Flags: Precursor" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 547 no SP P61770 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 548 no SP P61771 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 99.00 119 100.00 100.00 2.84e-68 . . . . 19113 1 stop_ loop_ _Entity_comp_index.ID _Entity_comp_index.Auth_seq_ID _Entity_comp_index.Comp_ID _Entity_comp_index.Comp_label _Entity_comp_index.Entry_ID _Entity_comp_index.Entity_ID 1 0 MET . 19113 1 2 1 ILE . 19113 1 3 2 GLN . 19113 1 4 3 ARG . 19113 1 5 4 THR . 19113 1 6 5 PRO . 19113 1 7 6 LYS . 19113 1 8 7 ILE . 19113 1 9 8 GLN . 19113 1 10 9 VAL . 19113 1 11 10 TYR . 19113 1 12 11 SER . 19113 1 13 12 ARG . 19113 1 14 13 HIS . 19113 1 15 14 PRO . 19113 1 16 15 ALA . 19113 1 17 16 GLU . 19113 1 18 17 ASN . 19113 1 19 18 GLY . 19113 1 20 19 LYS . 19113 1 21 20 SER . 19113 1 22 21 ASN . 19113 1 23 22 PHE . 19113 1 24 23 LEU . 19113 1 25 24 ASN . 19113 1 26 25 CYS . 19113 1 27 26 TYR . 19113 1 28 27 VAL . 19113 1 29 28 SER . 19113 1 30 29 GLY . 19113 1 31 30 PHE . 19113 1 32 31 HIS . 19113 1 33 32 PRO . 19113 1 34 33 SER . 19113 1 35 34 ASP . 19113 1 36 35 ILE . 19113 1 37 36 GLU . 19113 1 38 37 VAL . 19113 1 39 38 ASP . 19113 1 40 39 LEU . 19113 1 41 40 LEU . 19113 1 42 41 LYS . 19113 1 43 42 ASN . 19113 1 44 43 GLY . 19113 1 45 44 GLU . 19113 1 46 45 ARG . 19113 1 47 46 ILE . 19113 1 48 47 GLU . 19113 1 49 48 LYS . 19113 1 50 49 VAL . 19113 1 51 50 GLU . 19113 1 52 51 HIS . 19113 1 53 52 SER . 19113 1 54 53 ASP . 19113 1 55 54 LEU . 19113 1 56 55 SER . 19113 1 57 56 PHE . 19113 1 58 57 SER . 19113 1 59 58 LYS . 19113 1 60 59 ASP . 19113 1 61 60 TRP . 19113 1 62 61 SER . 19113 1 63 62 PHE . 19113 1 64 63 TYR . 19113 1 65 64 LEU . 19113 1 66 65 LEU . 19113 1 67 66 TYR . 19113 1 68 67 TYR . 19113 1 69 68 THR . 19113 1 70 69 GLU . 19113 1 71 70 PHE . 19113 1 72 71 THR . 19113 1 73 72 PRO . 19113 1 74 73 THR . 19113 1 75 74 GLU . 19113 1 76 75 LYS . 19113 1 77 76 ASP . 19113 1 78 77 GLU . 19113 1 79 78 TYR . 19113 1 80 79 ALA . 19113 1 81 80 CYS . 19113 1 82 81 ARG . 19113 1 83 82 VAL . 19113 1 84 83 ASN . 19113 1 85 84 HIS . 19113 1 86 85 VAL . 19113 1 87 86 THR . 19113 1 88 87 LEU . 19113 1 89 88 SER . 19113 1 90 89 GLN . 19113 1 91 90 PRO . 19113 1 92 91 LYS . 19113 1 93 92 ILE . 19113 1 94 93 VAL . 19113 1 95 94 LYS . 19113 1 96 95 TRP . 19113 1 97 96 ASP . 19113 1 98 97 ARG . 19113 1 99 98 ASP . 19113 1 100 99 MET . 19113 1 stop_ loop_ _Entity_poly_seq.Hetero _Entity_poly_seq.Mon_ID _Entity_poly_seq.Num _Entity_poly_seq.Comp_index_ID _Entity_poly_seq.Entry_ID _Entity_poly_seq.Entity_ID . MET 1 1 19113 1 . ILE 2 2 19113 1 . GLN 3 3 19113 1 . ARG 4 4 19113 1 . THR 5 5 19113 1 . PRO 6 6 19113 1 . LYS 7 7 19113 1 . ILE 8 8 19113 1 . GLN 9 9 19113 1 . VAL 10 10 19113 1 . TYR 11 11 19113 1 . SER 12 12 19113 1 . ARG 13 13 19113 1 . HIS 14 14 19113 1 . PRO 15 15 19113 1 . ALA 16 16 19113 1 . GLU 17 17 19113 1 . ASN 18 18 19113 1 . GLY 19 19 19113 1 . LYS 20 20 19113 1 . SER 21 21 19113 1 . ASN 22 22 19113 1 . PHE 23 23 19113 1 . LEU 24 24 19113 1 . ASN 25 25 19113 1 . CYS 26 26 19113 1 . TYR 27 27 19113 1 . VAL 28 28 19113 1 . SER 29 29 19113 1 . GLY 30 30 19113 1 . PHE 31 31 19113 1 . HIS 32 32 19113 1 . PRO 33 33 19113 1 . SER 34 34 19113 1 . ASP 35 35 19113 1 . ILE 36 36 19113 1 . GLU 37 37 19113 1 . VAL 38 38 19113 1 . ASP 39 39 19113 1 . LEU 40 40 19113 1 . LEU 41 41 19113 1 . LYS 42 42 19113 1 . ASN 43 43 19113 1 . GLY 44 44 19113 1 . GLU 45 45 19113 1 . ARG 46 46 19113 1 . ILE 47 47 19113 1 . GLU 48 48 19113 1 . LYS 49 49 19113 1 . VAL 50 50 19113 1 . GLU 51 51 19113 1 . HIS 52 52 19113 1 . SER 53 53 19113 1 . ASP 54 54 19113 1 . LEU 55 55 19113 1 . SER 56 56 19113 1 . PHE 57 57 19113 1 . SER 58 58 19113 1 . LYS 59 59 19113 1 . ASP 60 60 19113 1 . TRP 61 61 19113 1 . SER 62 62 19113 1 . PHE 63 63 19113 1 . TYR 64 64 19113 1 . LEU 65 65 19113 1 . LEU 66 66 19113 1 . TYR 67 67 19113 1 . TYR 68 68 19113 1 . THR 69 69 19113 1 . GLU 70 70 19113 1 . PHE 71 71 19113 1 . THR 72 72 19113 1 . PRO 73 73 19113 1 . THR 74 74 19113 1 . GLU 75 75 19113 1 . LYS 76 76 19113 1 . ASP 77 77 19113 1 . GLU 78 78 19113 1 . TYR 79 79 19113 1 . ALA 80 80 19113 1 . CYS 81 81 19113 1 . ARG 82 82 19113 1 . VAL 83 83 19113 1 . ASN 84 84 19113 1 . HIS 85 85 19113 1 . VAL 86 86 19113 1 . THR 87 87 19113 1 . LEU 88 88 19113 1 . SER 89 89 19113 1 . GLN 90 90 19113 1 . PRO 91 91 19113 1 . LYS 92 92 19113 1 . ILE 93 93 19113 1 . VAL 94 94 19113 1 . LYS 95 95 19113 1 . TRP 96 96 19113 1 . ASP 97 97 19113 1 . ARG 98 98 19113 1 . ASP 99 99 19113 1 . MET 100 100 19113 1 stop_ save_ save_pVIPR_peptide _Entity.Sf_category entity _Entity.Sf_framecode pVIPR_peptide _Entity.Entry_ID 19113 _Entity.ID 2 _Entity.BMRB_code . _Entity.Name pVIPR_peptide _Entity.Type polymer _Entity.Polymer_common_type . _Entity.Polymer_type polypeptide(L) _Entity.Polymer_type_details . _Entity.Polymer_strand_ID . _Entity.Polymer_seq_one_letter_code_can . _Entity.Polymer_seq_one_letter_code RRKWRRWHL _Entity.Target_identifier . _Entity.Polymer_author_defined_seq . _Entity.Polymer_author_seq_details . _Entity.Ambiguous_conformational_states no _Entity.Ambiguous_chem_comp_sites no _Entity.Nstd_monomer no _Entity.Nstd_chirality no _Entity.Nstd_linkage no _Entity.Nonpolymer_comp_ID . _Entity.Nonpolymer_comp_label . _Entity.Number_of_monomers 9 _Entity.Number_of_nonpolymer_components . _Entity.Paramagnetic no _Entity.Thiol_state 'not present' _Entity.Src_method . _Entity.Parent_entity_ID . _Entity.Fragment . _Entity.Mutation . _Entity.EC_number . _Entity.Calc_isoelectric_point . _Entity.Formula_weight . _Entity.Formula_weight_exptl . _Entity.Formula_weight_exptl_meth . _Entity.Details . _Entity.DB_query_date . _Entity.DB_query_revised_last_date . loop_ _Entity_comp_index.ID _Entity_comp_index.Auth_seq_ID _Entity_comp_index.Comp_ID _Entity_comp_index.Comp_label _Entity_comp_index.Entry_ID _Entity_comp_index.Entity_ID 1 . ARG . 19113 2 2 . ARG . 19113 2 3 . LYS . 19113 2 4 . TRP . 19113 2 5 . ARG . 19113 2 6 . ARG . 19113 2 7 . TRP . 19113 2 8 . HIS . 19113 2 9 . LEU . 19113 2 stop_ loop_ _Entity_poly_seq.Hetero _Entity_poly_seq.Mon_ID _Entity_poly_seq.Num _Entity_poly_seq.Comp_index_ID _Entity_poly_seq.Entry_ID _Entity_poly_seq.Entity_ID . ARG 1 1 19113 2 . ARG 2 2 19113 2 . LYS 3 3 19113 2 . TRP 4 4 19113 2 . ARG 5 5 19113 2 . ARG 6 6 19113 2 . TRP 7 7 19113 2 . HIS 8 8 19113 2 . LEU 9 9 19113 2 stop_ save_ save_HLA-B2709 _Entity.Sf_category entity _Entity.Sf_framecode HLA-B2709 _Entity.Entry_ID 19113 _Entity.ID 3 _Entity.BMRB_code . _Entity.Name HLA-B2709 _Entity.Type polymer _Entity.Polymer_common_type . _Entity.Polymer_type polypeptide(L) _Entity.Polymer_type_details . _Entity.Polymer_strand_ID . _Entity.Polymer_seq_one_letter_code_can . _Entity.Polymer_seq_one_letter_code ; GSHSMRYFHTSVSRPGRGEP RFITVGYVDDTLFVRFDSDA ASPREEPRAPWIEQEGPEYW DRETQICKAKAQTDREDLRT LLRYYNQSEAGSHTLQNMYG CDVGPDGRLLRGYHQDAYDG KDYIALNEDLSSWTAADTAA QITQRKWEAARVAEQLRAYL EGECVEWLRRYLENGKETLQ RADPPKTHVTHHPISDHEAT LRCWALGFYPAEITLTWQRD GEDQTQDTELVETRPAGDRT FQKWAAVVVPSGEEQRYTCH VQHEGLPKPLTLRWEP ; _Entity.Target_identifier . _Entity.Polymer_author_defined_seq . _Entity.Polymer_author_seq_details . _Entity.Ambiguous_conformational_states no _Entity.Ambiguous_chem_comp_sites no _Entity.Nstd_monomer no _Entity.Nstd_chirality no _Entity.Nstd_linkage no _Entity.Nonpolymer_comp_ID . _Entity.Nonpolymer_comp_label . _Entity.Number_of_monomers 276 _Entity.Number_of_nonpolymer_components . _Entity.Paramagnetic no _Entity.Thiol_state 'disulfide bound and free' _Entity.Src_method . _Entity.Parent_entity_ID . _Entity.Fragment . _Entity.Mutation . _Entity.EC_number . _Entity.Calc_isoelectric_point . _Entity.Formula_weight . _Entity.Formula_weight_exptl . _Entity.Formula_weight_exptl_meth . _Entity.Details . _Entity.DB_query_date . _Entity.DB_query_revised_last_date 2015-01-29 loop_ _Entity_db_link.Ordinal _Entity_db_link.Author_supplied _Entity_db_link.Database_code _Entity_db_link.Accession_code _Entity_db_link.Entry_mol_code _Entity_db_link.Entry_mol_name _Entity_db_link.Entry_experimental_method _Entity_db_link.Entry_structure_resolution _Entity_db_link.Entry_relation_type _Entity_db_link.Entry_details _Entity_db_link.Chimera_segment_ID _Entity_db_link.Seq_query_to_submitted_percent _Entity_db_link.Seq_subject_length _Entity_db_link.Seq_identity _Entity_db_link.Seq_positive _Entity_db_link.Seq_homology_expectation_val _Entity_db_link.Seq_align_begin _Entity_db_link.Seq_align_end _Entity_db_link.Seq_difference_details _Entity_db_link.Seq_alignment_details _Entity_db_link.Entry_ID _Entity_db_link.Entity_ID 1 no BMRB 19116 . HLA-B2709 . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 2 no BMRB 19118 . HLA-B2709 . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 3 no BMRB 19119 . HLA-B2709 . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 4 no BMRB 19120 . HLA-B2705 . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 5 no BMRB 19121 . HLA-B2705 . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 6 no BMRB 19122 . HLA-B2705 . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 7 no BMRB 19123 . HLA-B2705 . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 8 no PDB 1HSA . "The Three-Dimensional Structure Of Hla-B27 At 2.1 Angstroms Resolution Suggests A General Mechanism For Tight Peptide Binding T" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 9 no PDB 1JGD . "Hla-B2709 Bound To Deca-Peptide S10r" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 10 no PDB 1JGE . "Hla-B2705 Bound To Nona-Peptide M9" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 11 no PDB 1K5N . "Hla-B2709 Bound To Nona-Peptide M9" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 12 no PDB 1OF2 . "Crystal Structure Of Hla-B2709 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 13 no PDB 1OGT . "Crystal Structure Of Hla-B2705 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 14 no PDB 1UXS . "Crystal Structure Of Hla-B2705 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2)of Epstein-Barr Virus" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 15 no PDB 1UXW . "Crystal Structure Of Hla-B2709 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Virus" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 16 no PDB 1W0V . "Crystal Structure Of Hla-B2705 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 17 no PDB 1W0W . "Crystal Structure Of Hla-B2709 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 18 no PDB 2A83 . "Crystal Structure Of Hla-B2705 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 19 no PDB 2BSR . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 276 99.64 100.00 0.00e+00 . . . . 19113 3 20 no PDB 2BSS . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 276 99.64 100.00 0.00e+00 . . . . 19113 3 21 no PDB 2BST . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-b2705" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 22 no PDB 3B3I . "Citrullination-dependent Differential Presentation Of A Self-peptide By Hla-b27 Subtypes" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 23 no PDB 3B6S . "Crystal Structure Of Hla-B2705 Complexed With The Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (R" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 24 no PDB 3BP4 . "The High Resolution Crystal Structure Of Hla-B2705 In Complex With A Cathepsin A Signal Sequence Peptide Pcata" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 25 no PDB 3BP7 . "The High Resolution Crystal Structure Of Hla-B2709 In Complex With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 26 no PDB 3CZF . "Crystal Structure Of Hla-B2709 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 27 no PDB 3D18 . "Crystal Structure Of Hla-B2709 Complexed With A Variant Of The Latent Membrane Protein 2 Peptide (Lmp2(L)) Of Epstein-Barr Viru" . . . . . 100.00 276 99.28 99.64 0.00e+00 . . . . 19113 3 28 no PDB 3DTX . "Crystal Structure Of Hla-B2705 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 29 no PDB 3HCV . "Crystal Structure Of Hla-B2709 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 276 99.64 99.64 0.00e+00 . . . . 19113 3 30 no PDB 3LV3 . "Crystal Structure Of Hla-B2705 Complexed With A Peptide Derived From The Human Voltage-Dependent Calcium Channel Alpha1 Subunit" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 31 no PDB 4G8G . "Crystal Structure Of C12c Tcr-ha B2705-kk10" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 32 no PDB 4G8I . "Crystal Structure Of Hla B2705-kk10-l6m" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 33 no PDB 4G9D . "Crystal Structure Of Hla B2705-kk10" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 34 no PDB 4G9F . "Crystal Structure Of C12c Tcr-hlab2705-kk10-l6m" . . . . . 100.00 276 100.00 100.00 0.00e+00 . . . . 19113 3 35 no DBJ BAA11753 . "HLA-B [Homo sapiens]" . . . . . 100.00 362 97.83 98.91 0.00e+00 . . . . 19113 3 36 no DBJ BAJ83633 . "MHC class I antigen [Homo sapiens]" . . . . . 98.91 273 97.44 98.17 0.00e+00 . . . . 19113 3 37 no DBJ BAN59815 . "MHC class I antigen [Homo sapiens]" . . . . . 100.00 362 100.00 100.00 0.00e+00 . . . . 19113 3 38 no EMBL CAA27301 . "HLA-B27K [Homo sapiens]" . . . . . 100.00 362 98.91 99.28 0.00e+00 . . . . 19113 3 39 no EMBL CAA27302 . "HLA-B27W [Homo sapiens]" . . . . . 100.00 362 100.00 100.00 0.00e+00 . . . . 19113 3 40 no EMBL CAA27578 . "HLA-B27 [Homo sapiens]" . . . . . 100.00 362 100.00 100.00 0.00e+00 . . . . 19113 3 41 no EMBL CAA51980 . "HLA-B alpha chain (B*2706) [Homo sapiens]" . . . . . 100.00 362 98.19 98.19 0.00e+00 . . . . 19113 3 42 no EMBL CAA83876 . "human lymphocyte antigen HLA-B27 [Homo sapiens]" . . . . . 100.00 362 99.64 99.64 0.00e+00 . . . . 19113 3 43 no GB AAA36221 . "human lymphocyte antigen-b27 (HLA-b27) [Homo sapiens]" . . . . . 100.00 362 100.00 100.00 0.00e+00 . . . . 19113 3 44 no GB AAA59614 . "HLA-B27 peptide, partial [Homo sapiens]" . . . . . 100.00 359 99.64 99.64 0.00e+00 . . . . 19113 3 45 no GB AAA59616 . "MHC HLA-B27d [Homo sapiens]" . . . . . 100.00 362 99.64 100.00 0.00e+00 . . . . 19113 3 46 no GB AAA59643 . "HLA-B27 M2+, partial [Homo sapiens]" . . . . . 99.28 274 100.00 100.00 0.00e+00 . . . . 19113 3 47 no GB AAA59647 . "MHC HLA-B27-HS, partial [Homo sapiens]" . . . . . 100.00 338 98.19 99.28 0.00e+00 . . . . 19113 3 48 no PRF 1413302A . "HLA B27" . . . . . 99.28 274 100.00 100.00 0.00e+00 . . . . 19113 3 49 no SP P03989 . "RecName: Full=HLA class I histocompatibility antigen, B-27 alpha chain; AltName: Full=MHC class I antigen B*27; Flags: Precurso" . . . . . 100.00 362 100.00 100.00 0.00e+00 . . . . 19113 3 stop_ loop_ _Entity_comp_index.ID _Entity_comp_index.Auth_seq_ID _Entity_comp_index.Comp_ID _Entity_comp_index.Comp_label _Entity_comp_index.Entry_ID _Entity_comp_index.Entity_ID 1 . GLY . 19113 3 2 . SER . 19113 3 3 . HIS . 19113 3 4 . SER . 19113 3 5 . MET . 19113 3 6 . ARG . 19113 3 7 . TYR . 19113 3 8 . PHE . 19113 3 9 . HIS . 19113 3 10 . THR . 19113 3 11 . SER . 19113 3 12 . VAL . 19113 3 13 . SER . 19113 3 14 . ARG . 19113 3 15 . PRO . 19113 3 16 . GLY . 19113 3 17 . ARG . 19113 3 18 . GLY . 19113 3 19 . GLU . 19113 3 20 . PRO . 19113 3 21 . ARG . 19113 3 22 . PHE . 19113 3 23 . ILE . 19113 3 24 . THR . 19113 3 25 . VAL . 19113 3 26 . GLY . 19113 3 27 . TYR . 19113 3 28 . VAL . 19113 3 29 . ASP . 19113 3 30 . ASP . 19113 3 31 . THR . 19113 3 32 . LEU . 19113 3 33 . PHE . 19113 3 34 . VAL . 19113 3 35 . ARG . 19113 3 36 . PHE . 19113 3 37 . ASP . 19113 3 38 . SER . 19113 3 39 . ASP . 19113 3 40 . ALA . 19113 3 41 . ALA . 19113 3 42 . SER . 19113 3 43 . PRO . 19113 3 44 . ARG . 19113 3 45 . GLU . 19113 3 46 . GLU . 19113 3 47 . PRO . 19113 3 48 . ARG . 19113 3 49 . ALA . 19113 3 50 . PRO . 19113 3 51 . TRP . 19113 3 52 . ILE . 19113 3 53 . GLU . 19113 3 54 . GLN . 19113 3 55 . GLU . 19113 3 56 . GLY . 19113 3 57 . PRO . 19113 3 58 . GLU . 19113 3 59 . TYR . 19113 3 60 . TRP . 19113 3 61 . ASP . 19113 3 62 . ARG . 19113 3 63 . GLU . 19113 3 64 . THR . 19113 3 65 . GLN . 19113 3 66 . ILE . 19113 3 67 . CYS . 19113 3 68 . LYS . 19113 3 69 . ALA . 19113 3 70 . LYS . 19113 3 71 . ALA . 19113 3 72 . GLN . 19113 3 73 . THR . 19113 3 74 . ASP . 19113 3 75 . ARG . 19113 3 76 . GLU . 19113 3 77 . ASP . 19113 3 78 . LEU . 19113 3 79 . ARG . 19113 3 80 . THR . 19113 3 81 . LEU . 19113 3 82 . LEU . 19113 3 83 . ARG . 19113 3 84 . TYR . 19113 3 85 . TYR . 19113 3 86 . ASN . 19113 3 87 . GLN . 19113 3 88 . SER . 19113 3 89 . GLU . 19113 3 90 . ALA . 19113 3 91 . GLY . 19113 3 92 . SER . 19113 3 93 . HIS . 19113 3 94 . THR . 19113 3 95 . LEU . 19113 3 96 . GLN . 19113 3 97 . ASN . 19113 3 98 . MET . 19113 3 99 . TYR . 19113 3 100 . GLY . 19113 3 101 . CYS . 19113 3 102 . ASP . 19113 3 103 . VAL . 19113 3 104 . GLY . 19113 3 105 . PRO . 19113 3 106 . ASP . 19113 3 107 . GLY . 19113 3 108 . ARG . 19113 3 109 . LEU . 19113 3 110 . LEU . 19113 3 111 . ARG . 19113 3 112 . GLY . 19113 3 113 . TYR . 19113 3 114 . HIS . 19113 3 115 . GLN . 19113 3 116 . ASP . 19113 3 117 . ALA . 19113 3 118 . TYR . 19113 3 119 . ASP . 19113 3 120 . GLY . 19113 3 121 . LYS . 19113 3 122 . ASP . 19113 3 123 . TYR . 19113 3 124 . ILE . 19113 3 125 . ALA . 19113 3 126 . LEU . 19113 3 127 . ASN . 19113 3 128 . GLU . 19113 3 129 . ASP . 19113 3 130 . LEU . 19113 3 131 . SER . 19113 3 132 . SER . 19113 3 133 . TRP . 19113 3 134 . THR . 19113 3 135 . ALA . 19113 3 136 . ALA . 19113 3 137 . ASP . 19113 3 138 . THR . 19113 3 139 . ALA . 19113 3 140 . ALA . 19113 3 141 . GLN . 19113 3 142 . ILE . 19113 3 143 . THR . 19113 3 144 . GLN . 19113 3 145 . ARG . 19113 3 146 . LYS . 19113 3 147 . TRP . 19113 3 148 . GLU . 19113 3 149 . ALA . 19113 3 150 . ALA . 19113 3 151 . ARG . 19113 3 152 . VAL . 19113 3 153 . ALA . 19113 3 154 . GLU . 19113 3 155 . GLN . 19113 3 156 . LEU . 19113 3 157 . ARG . 19113 3 158 . ALA . 19113 3 159 . TYR . 19113 3 160 . LEU . 19113 3 161 . GLU . 19113 3 162 . GLY . 19113 3 163 . GLU . 19113 3 164 . CYS . 19113 3 165 . VAL . 19113 3 166 . GLU . 19113 3 167 . TRP . 19113 3 168 . LEU . 19113 3 169 . ARG . 19113 3 170 . ARG . 19113 3 171 . TYR . 19113 3 172 . LEU . 19113 3 173 . GLU . 19113 3 174 . ASN . 19113 3 175 . GLY . 19113 3 176 . LYS . 19113 3 177 . GLU . 19113 3 178 . THR . 19113 3 179 . LEU . 19113 3 180 . GLN . 19113 3 181 . ARG . 19113 3 182 . ALA . 19113 3 183 . ASP . 19113 3 184 . PRO . 19113 3 185 . PRO . 19113 3 186 . LYS . 19113 3 187 . THR . 19113 3 188 . HIS . 19113 3 189 . VAL . 19113 3 190 . THR . 19113 3 191 . HIS . 19113 3 192 . HIS . 19113 3 193 . PRO . 19113 3 194 . ILE . 19113 3 195 . SER . 19113 3 196 . ASP . 19113 3 197 . HIS . 19113 3 198 . GLU . 19113 3 199 . ALA . 19113 3 200 . THR . 19113 3 201 . LEU . 19113 3 202 . ARG . 19113 3 203 . CYS . 19113 3 204 . TRP . 19113 3 205 . ALA . 19113 3 206 . LEU . 19113 3 207 . GLY . 19113 3 208 . PHE . 19113 3 209 . TYR . 19113 3 210 . PRO . 19113 3 211 . ALA . 19113 3 212 . GLU . 19113 3 213 . ILE . 19113 3 214 . THR . 19113 3 215 . LEU . 19113 3 216 . THR . 19113 3 217 . TRP . 19113 3 218 . GLN . 19113 3 219 . ARG . 19113 3 220 . ASP . 19113 3 221 . GLY . 19113 3 222 . GLU . 19113 3 223 . ASP . 19113 3 224 . GLN . 19113 3 225 . THR . 19113 3 226 . GLN . 19113 3 227 . ASP . 19113 3 228 . THR . 19113 3 229 . GLU . 19113 3 230 . LEU . 19113 3 231 . VAL . 19113 3 232 . GLU . 19113 3 233 . THR . 19113 3 234 . ARG . 19113 3 235 . PRO . 19113 3 236 . ALA . 19113 3 237 . GLY . 19113 3 238 . ASP . 19113 3 239 . ARG . 19113 3 240 . THR . 19113 3 241 . PHE . 19113 3 242 . GLN . 19113 3 243 . LYS . 19113 3 244 . TRP . 19113 3 245 . ALA . 19113 3 246 . ALA . 19113 3 247 . VAL . 19113 3 248 . VAL . 19113 3 249 . VAL . 19113 3 250 . PRO . 19113 3 251 . SER . 19113 3 252 . GLY . 19113 3 253 . GLU . 19113 3 254 . GLU . 19113 3 255 . GLN . 19113 3 256 . ARG . 19113 3 257 . TYR . 19113 3 258 . THR . 19113 3 259 . CYS . 19113 3 260 . HIS . 19113 3 261 . VAL . 19113 3 262 . GLN . 19113 3 263 . HIS . 19113 3 264 . GLU . 19113 3 265 . GLY . 19113 3 266 . LEU . 19113 3 267 . PRO . 19113 3 268 . LYS . 19113 3 269 . PRO . 19113 3 270 . LEU . 19113 3 271 . THR . 19113 3 272 . LEU . 19113 3 273 . ARG . 19113 3 274 . TRP . 19113 3 275 . GLU . 19113 3 276 . PRO . 19113 3 stop_ loop_ _Entity_poly_seq.Hetero _Entity_poly_seq.Mon_ID _Entity_poly_seq.Num _Entity_poly_seq.Comp_index_ID _Entity_poly_seq.Entry_ID _Entity_poly_seq.Entity_ID . GLY 1 1 19113 3 . SER 2 2 19113 3 . HIS 3 3 19113 3 . SER 4 4 19113 3 . MET 5 5 19113 3 . ARG 6 6 19113 3 . TYR 7 7 19113 3 . PHE 8 8 19113 3 . HIS 9 9 19113 3 . THR 10 10 19113 3 . SER 11 11 19113 3 . VAL 12 12 19113 3 . SER 13 13 19113 3 . ARG 14 14 19113 3 . PRO 15 15 19113 3 . GLY 16 16 19113 3 . ARG 17 17 19113 3 . GLY 18 18 19113 3 . GLU 19 19 19113 3 . PRO 20 20 19113 3 . ARG 21 21 19113 3 . PHE 22 22 19113 3 . ILE 23 23 19113 3 . THR 24 24 19113 3 . VAL 25 25 19113 3 . GLY 26 26 19113 3 . TYR 27 27 19113 3 . VAL 28 28 19113 3 . ASP 29 29 19113 3 . ASP 30 30 19113 3 . THR 31 31 19113 3 . LEU 32 32 19113 3 . PHE 33 33 19113 3 . VAL 34 34 19113 3 . ARG 35 35 19113 3 . PHE 36 36 19113 3 . ASP 37 37 19113 3 . SER 38 38 19113 3 . ASP 39 39 19113 3 . ALA 40 40 19113 3 . ALA 41 41 19113 3 . SER 42 42 19113 3 . PRO 43 43 19113 3 . ARG 44 44 19113 3 . GLU 45 45 19113 3 . GLU 46 46 19113 3 . PRO 47 47 19113 3 . ARG 48 48 19113 3 . ALA 49 49 19113 3 . PRO 50 50 19113 3 . TRP 51 51 19113 3 . ILE 52 52 19113 3 . GLU 53 53 19113 3 . GLN 54 54 19113 3 . GLU 55 55 19113 3 . GLY 56 56 19113 3 . PRO 57 57 19113 3 . GLU 58 58 19113 3 . TYR 59 59 19113 3 . TRP 60 60 19113 3 . ASP 61 61 19113 3 . ARG 62 62 19113 3 . GLU 63 63 19113 3 . THR 64 64 19113 3 . GLN 65 65 19113 3 . ILE 66 66 19113 3 . CYS 67 67 19113 3 . LYS 68 68 19113 3 . ALA 69 69 19113 3 . LYS 70 70 19113 3 . ALA 71 71 19113 3 . GLN 72 72 19113 3 . THR 73 73 19113 3 . ASP 74 74 19113 3 . ARG 75 75 19113 3 . GLU 76 76 19113 3 . ASP 77 77 19113 3 . LEU 78 78 19113 3 . ARG 79 79 19113 3 . THR 80 80 19113 3 . LEU 81 81 19113 3 . LEU 82 82 19113 3 . ARG 83 83 19113 3 . TYR 84 84 19113 3 . TYR 85 85 19113 3 . ASN 86 86 19113 3 . GLN 87 87 19113 3 . SER 88 88 19113 3 . GLU 89 89 19113 3 . ALA 90 90 19113 3 . GLY 91 91 19113 3 . SER 92 92 19113 3 . HIS 93 93 19113 3 . THR 94 94 19113 3 . LEU 95 95 19113 3 . GLN 96 96 19113 3 . ASN 97 97 19113 3 . MET 98 98 19113 3 . TYR 99 99 19113 3 . GLY 100 100 19113 3 . CYS 101 101 19113 3 . ASP 102 102 19113 3 . VAL 103 103 19113 3 . GLY 104 104 19113 3 . PRO 105 105 19113 3 . ASP 106 106 19113 3 . GLY 107 107 19113 3 . ARG 108 108 19113 3 . LEU 109 109 19113 3 . LEU 110 110 19113 3 . ARG 111 111 19113 3 . GLY 112 112 19113 3 . TYR 113 113 19113 3 . HIS 114 114 19113 3 . GLN 115 115 19113 3 . ASP 116 116 19113 3 . ALA 117 117 19113 3 . TYR 118 118 19113 3 . ASP 119 119 19113 3 . GLY 120 120 19113 3 . LYS 121 121 19113 3 . ASP 122 122 19113 3 . TYR 123 123 19113 3 . ILE 124 124 19113 3 . ALA 125 125 19113 3 . LEU 126 126 19113 3 . ASN 127 127 19113 3 . GLU 128 128 19113 3 . ASP 129 129 19113 3 . LEU 130 130 19113 3 . SER 131 131 19113 3 . SER 132 132 19113 3 . TRP 133 133 19113 3 . THR 134 134 19113 3 . ALA 135 135 19113 3 . ALA 136 136 19113 3 . ASP 137 137 19113 3 . THR 138 138 19113 3 . ALA 139 139 19113 3 . ALA 140 140 19113 3 . GLN 141 141 19113 3 . ILE 142 142 19113 3 . THR 143 143 19113 3 . GLN 144 144 19113 3 . ARG 145 145 19113 3 . LYS 146 146 19113 3 . TRP 147 147 19113 3 . GLU 148 148 19113 3 . ALA 149 149 19113 3 . ALA 150 150 19113 3 . ARG 151 151 19113 3 . VAL 152 152 19113 3 . ALA 153 153 19113 3 . GLU 154 154 19113 3 . GLN 155 155 19113 3 . LEU 156 156 19113 3 . ARG 157 157 19113 3 . ALA 158 158 19113 3 . TYR 159 159 19113 3 . LEU 160 160 19113 3 . GLU 161 161 19113 3 . GLY 162 162 19113 3 . GLU 163 163 19113 3 . CYS 164 164 19113 3 . VAL 165 165 19113 3 . GLU 166 166 19113 3 . TRP 167 167 19113 3 . LEU 168 168 19113 3 . ARG 169 169 19113 3 . ARG 170 170 19113 3 . TYR 171 171 19113 3 . LEU 172 172 19113 3 . GLU 173 173 19113 3 . ASN 174 174 19113 3 . GLY 175 175 19113 3 . LYS 176 176 19113 3 . GLU 177 177 19113 3 . THR 178 178 19113 3 . LEU 179 179 19113 3 . GLN 180 180 19113 3 . ARG 181 181 19113 3 . ALA 182 182 19113 3 . ASP 183 183 19113 3 . PRO 184 184 19113 3 . PRO 185 185 19113 3 . LYS 186 186 19113 3 . THR 187 187 19113 3 . HIS 188 188 19113 3 . VAL 189 189 19113 3 . THR 190 190 19113 3 . HIS 191 191 19113 3 . HIS 192 192 19113 3 . PRO 193 193 19113 3 . ILE 194 194 19113 3 . SER 195 195 19113 3 . ASP 196 196 19113 3 . HIS 197 197 19113 3 . GLU 198 198 19113 3 . ALA 199 199 19113 3 . THR 200 200 19113 3 . LEU 201 201 19113 3 . ARG 202 202 19113 3 . CYS 203 203 19113 3 . TRP 204 204 19113 3 . ALA 205 205 19113 3 . LEU 206 206 19113 3 . GLY 207 207 19113 3 . PHE 208 208 19113 3 . TYR 209 209 19113 3 . PRO 210 210 19113 3 . ALA 211 211 19113 3 . GLU 212 212 19113 3 . ILE 213 213 19113 3 . THR 214 214 19113 3 . LEU 215 215 19113 3 . THR 216 216 19113 3 . TRP 217 217 19113 3 . GLN 218 218 19113 3 . ARG 219 219 19113 3 . ASP 220 220 19113 3 . GLY 221 221 19113 3 . GLU 222 222 19113 3 . ASP 223 223 19113 3 . GLN 224 224 19113 3 . THR 225 225 19113 3 . GLN 226 226 19113 3 . ASP 227 227 19113 3 . THR 228 228 19113 3 . GLU 229 229 19113 3 . LEU 230 230 19113 3 . VAL 231 231 19113 3 . GLU 232 232 19113 3 . THR 233 233 19113 3 . ARG 234 234 19113 3 . PRO 235 235 19113 3 . ALA 236 236 19113 3 . GLY 237 237 19113 3 . ASP 238 238 19113 3 . ARG 239 239 19113 3 . THR 240 240 19113 3 . PHE 241 241 19113 3 . GLN 242 242 19113 3 . LYS 243 243 19113 3 . TRP 244 244 19113 3 . ALA 245 245 19113 3 . ALA 246 246 19113 3 . VAL 247 247 19113 3 . VAL 248 248 19113 3 . VAL 249 249 19113 3 . PRO 250 250 19113 3 . SER 251 251 19113 3 . GLY 252 252 19113 3 . GLU 253 253 19113 3 . GLU 254 254 19113 3 . GLN 255 255 19113 3 . ARG 256 256 19113 3 . TYR 257 257 19113 3 . THR 258 258 19113 3 . CYS 259 259 19113 3 . HIS 260 260 19113 3 . VAL 261 261 19113 3 . GLN 262 262 19113 3 . HIS 263 263 19113 3 . GLU 264 264 19113 3 . GLY 265 265 19113 3 . LEU 266 266 19113 3 . PRO 267 267 19113 3 . LYS 268 268 19113 3 . PRO 269 269 19113 3 . LEU 270 270 19113 3 . THR 271 271 19113 3 . LEU 272 272 19113 3 . ARG 273 273 19113 3 . TRP 274 274 19113 3 . GLU 275 275 19113 3 . PRO 276 276 19113 3 stop_ save_ #################### # Natural source # #################### save_natural_source _Entity_natural_src_list.Sf_category natural_source _Entity_natural_src_list.Sf_framecode natural_source _Entity_natural_src_list.Entry_ID 19113 _Entity_natural_src_list.ID 1 loop_ _Entity_natural_src.ID _Entity_natural_src.Entity_ID _Entity_natural_src.Entity_label _Entity_natural_src.Entity_chimera_segment_ID _Entity_natural_src.NCBI_taxonomy_ID _Entity_natural_src.Type _Entity_natural_src.Common _Entity_natural_src.Organism_name_scientific _Entity_natural_src.Organism_name_common _Entity_natural_src.Organism_acronym _Entity_natural_src.ICTVdb_decimal_code _Entity_natural_src.Superkingdom _Entity_natural_src.Kingdom _Entity_natural_src.Genus _Entity_natural_src.Species _Entity_natural_src.Strain _Entity_natural_src.Variant _Entity_natural_src.Subvariant _Entity_natural_src.Organ _Entity_natural_src.Tissue _Entity_natural_src.Tissue_fraction _Entity_natural_src.Cell_line _Entity_natural_src.Cell_type _Entity_natural_src.ATCC_number _Entity_natural_src.Organelle _Entity_natural_src.Cellular_location _Entity_natural_src.Fragment _Entity_natural_src.Fraction _Entity_natural_src.Secretion _Entity_natural_src.Plasmid _Entity_natural_src.Plasmid_details _Entity_natural_src.Gene_mnemonic _Entity_natural_src.Dev_stage _Entity_natural_src.Details _Entity_natural_src.Citation_ID _Entity_natural_src.Citation_label _Entity_natural_src.Entry_ID _Entity_natural_src.Entity_natural_src_list_ID 1 1 $human_beta-2_microglobulin . 9606 organism . 'Homo sapiens' Human . . Eukaryota Metazoa Homo sapiens . . . . . . . . . . . . . . . . . . . . . 19113 1 2 2 $pVIPR_peptide . 9606 organism . 'Homo sapiens' Human . . Eukaryota Metazoa Homo sapiens . . . . . . . . . . . . . . . . . . . . . 19113 1 stop_ save_ ######################### # Experimental source # ######################### save_experimental_source _Entity_experimental_src_list.Sf_category experimental_source _Entity_experimental_src_list.Sf_framecode experimental_source _Entity_experimental_src_list.Entry_ID 19113 _Entity_experimental_src_list.ID 1 loop_ _Entity_experimental_src.ID _Entity_experimental_src.Entity_ID _Entity_experimental_src.Entity_label _Entity_experimental_src.Entity_chimera_segment_ID _Entity_experimental_src.Production_method _Entity_experimental_src.Host_org_scientific_name _Entity_experimental_src.Host_org_name_common _Entity_experimental_src.Host_org_details _Entity_experimental_src.Host_org_NCBI_taxonomy_ID _Entity_experimental_src.Host_org_genus _Entity_experimental_src.Host_org_species _Entity_experimental_src.Host_org_strain _Entity_experimental_src.Host_org_variant _Entity_experimental_src.Host_org_subvariant _Entity_experimental_src.Host_org_organ _Entity_experimental_src.Host_org_tissue _Entity_experimental_src.Host_org_tissue_fraction _Entity_experimental_src.Host_org_cell_line _Entity_experimental_src.Host_org_cell_type _Entity_experimental_src.Host_org_cellular_location _Entity_experimental_src.Host_org_organelle _Entity_experimental_src.Host_org_gene _Entity_experimental_src.Host_org_culture_collection _Entity_experimental_src.Host_org_ATCC_number _Entity_experimental_src.Vector_type _Entity_experimental_src.PDBview_host_org_vector_name _Entity_experimental_src.PDBview_plasmid_name _Entity_experimental_src.Vector_name _Entity_experimental_src.Vector_details _Entity_experimental_src.Vendor_name _Entity_experimental_src.Host_org_dev_stage _Entity_experimental_src.Details _Entity_experimental_src.Citation_ID _Entity_experimental_src.Citation_label _Entity_experimental_src.Entry_ID _Entity_experimental_src.Entity_experimental_src_list_ID 1 1 $human_beta-2_microglobulin . 'recombinant technology' 'Escherichia coli' . . . Escherichia coli K12 XA90 . . . . . . . . . . . . . . pHN1+ . . . . . . 19113 1 2 2 $pVIPR_peptide . 'chemical synthesis' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19113 1 stop_ save_ ##################################### # Sample contents and methodology # ##################################### ######################## # Sample description # ######################## save_sample_1 _Sample.Sf_category sample _Sample.Sf_framecode sample_1 _Sample.Entry_ID 19113 _Sample.ID 1 _Sample.Type solution _Sample.Sub_type . _Sample.Details . _Sample.Aggregate_sample_number . _Sample.Solvent_system '90% H2O/10% D2O' _Sample.Preparation_date . _Sample.Preparation_expiration_date . _Sample.Polycrystallization_protocol . _Sample.Single_crystal_protocol . _Sample.Crystal_grow_apparatus . _Sample.Crystal_grow_atmosphere . _Sample.Crystal_grow_details . _Sample.Crystal_grow_method . _Sample.Crystal_grow_method_cit_ID . _Sample.Crystal_grow_pH . _Sample.Crystal_grow_pH_range . _Sample.Crystal_grow_pressure . _Sample.Crystal_grow_pressure_esd . _Sample.Crystal_grow_seeding . _Sample.Crystal_grow_seeding_cit_ID . _Sample.Crystal_grow_temp . _Sample.Crystal_grow_temp_details . _Sample.Crystal_grow_temp_esd . _Sample.Crystal_grow_time . _Sample.Oriented_sample_prep_protocol . _Sample.Lyophilization_cryo_protectant . _Sample.Storage_protocol . loop_ _Sample_component.ID _Sample_component.Mol_common_name _Sample_component.Isotopic_labeling _Sample_component.Assembly_ID _Sample_component.Assembly_label _Sample_component.Entity_ID _Sample_component.Entity_label _Sample_component.Product_ID _Sample_component.Type _Sample_component.Concentration_val _Sample_component.Concentration_val_min _Sample_component.Concentration_val_max _Sample_component.Concentration_val_units _Sample_component.Concentration_val_err _Sample_component.Vendor _Sample_component.Vendor_product_name _Sample_component.Vendor_product_code _Sample_component.Entry_ID _Sample_component.Sample_ID 1 'beta-2 microglobulin' '[U-13C; U-15N]' . . 1 $human_beta-2_microglobulin . . 0.39 . . mM . . . . 19113 1 2 'pVIPR peptide' 'natural abundance' . . 2 $pVIPR_peptide . . 0.39 . . mM . . . . 19113 1 3 'HLA-B2709 protein' 'natural abundance' . . 3 $HLA-B2709 . . 0.39 . . mM . . . . 19113 1 4 'Sodium Phosphate' 'natural abundance' . . . . . . 10 . . mM . . . . 19113 1 5 'Sodium Chloride' 'natural abundance' . . . . . . 150 . . mM . . . . 19113 1 stop_ save_ ####################### # Sample conditions # ####################### save_sample_conditions_1 _Sample_condition_list.Sf_category sample_conditions _Sample_condition_list.Sf_framecode sample_conditions_1 _Sample_condition_list.Entry_ID 19113 _Sample_condition_list.ID 1 _Sample_condition_list.Details . loop_ _Sample_condition_variable.Type _Sample_condition_variable.Val _Sample_condition_variable.Val_err _Sample_condition_variable.Val_units _Sample_condition_variable.Entry_ID _Sample_condition_variable.Sample_condition_list_ID 'ionic strength' 160 . mM 19113 1 pH 7.5 . pH 19113 1 pressure 1 . atm 19113 1 temperature 310 . K 19113 1 stop_ save_ ############################ # Computer software used # ############################ save_TOPSPIN _Software.Sf_category software _Software.Sf_framecode TOPSPIN _Software.Entry_ID 19113 _Software.ID 1 _Software.Name TOPSPIN _Software.Version 2.1 _Software.Details . save_ ######################### # Experimental detail # ######################### ################################## # NMR Spectrometer definitions # ################################## save_600 _NMR_spectrometer.Sf_category NMR_spectrometer _NMR_spectrometer.Sf_framecode 600 _NMR_spectrometer.Entry_ID 19113 _NMR_spectrometer.ID 1 _NMR_spectrometer.Details . _NMR_spectrometer.Manufacturer Bruker _NMR_spectrometer.Model Avance _NMR_spectrometer.Serial_number . _NMR_spectrometer.Field_strength 600 save_ save_750 _NMR_spectrometer.Sf_category NMR_spectrometer _NMR_spectrometer.Sf_framecode 750 _NMR_spectrometer.Entry_ID 19113 _NMR_spectrometer.ID 2 _NMR_spectrometer.Details . _NMR_spectrometer.Manufacturer Bruker _NMR_spectrometer.Model Avance _NMR_spectrometer.Serial_number . _NMR_spectrometer.Field_strength 750 save_ save_NMR_spectrometer_list _NMR_spectrometer_list.Sf_category NMR_spectrometer_list _NMR_spectrometer_list.Sf_framecode NMR_spectrometer_list _NMR_spectrometer_list.Entry_ID 19113 _NMR_spectrometer_list.ID 1 loop_ _NMR_spectrometer_view.ID _NMR_spectrometer_view.Name _NMR_spectrometer_view.Manufacturer _NMR_spectrometer_view.Model _NMR_spectrometer_view.Serial_number _NMR_spectrometer_view.Field_strength _NMR_spectrometer_view.Details _NMR_spectrometer_view.Citation_ID _NMR_spectrometer_view.Citation_label _NMR_spectrometer_view.Entry_ID _NMR_spectrometer_view.NMR_spectrometer_list_ID 1 600 Bruker Avance . 600 . . . 19113 1 2 750 Bruker Avance . 750 . . . 19113 1 stop_ save_ ############################# # NMR applied experiments # ############################# save_experiment_list _Experiment_list.Sf_category experiment_list _Experiment_list.Sf_framecode experiment_list _Experiment_list.Entry_ID 19113 _Experiment_list.ID 1 _Experiment_list.Details . loop_ _Experiment.ID _Experiment.Name _Experiment.Raw_data_flag _Experiment.NMR_spec_expt_ID _Experiment.NMR_spec_expt_label _Experiment.MS_expt_ID _Experiment.MS_expt_label _Experiment.SAXS_expt_ID _Experiment.SAXS_expt_label _Experiment.FRET_expt_ID _Experiment.FRET_expt_label _Experiment.EMR_expt_ID _Experiment.EMR_expt_label _Experiment.Sample_ID _Experiment.Sample_label _Experiment.Sample_state _Experiment.Sample_volume _Experiment.Sample_volume_units _Experiment.Sample_condition_list_ID _Experiment.Sample_condition_list_label _Experiment.Sample_spinning_rate _Experiment.Sample_angle _Experiment.NMR_tube_type _Experiment.NMR_spectrometer_ID _Experiment.NMR_spectrometer_label _Experiment.NMR_spectrometer_probe_ID _Experiment.NMR_spectrometer_probe_label _Experiment.NMR_spectral_processing_ID _Experiment.NMR_spectral_processing_label _Experiment.Mass_spectrometer_ID _Experiment.Mass_spectrometer_label _Experiment.Xray_instrument_ID _Experiment.Xray_instrument_label _Experiment.Fluorescence_instrument_ID _Experiment.Fluorescence_instrument_label _Experiment.EMR_instrument_ID _Experiment.EMR_instrument_label _Experiment.Chromatographic_system_ID _Experiment.Chromatographic_system_label _Experiment.Chromatographic_column_ID _Experiment.Chromatographic_column_label _Experiment.Entry_ID _Experiment.Experiment_list_ID 1 '2D 1H-15N HSQC' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 2 '3D HNCA' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 3 '3D HN(CO)CA' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 4 '3D HNCACB' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 5 '3D HN(CO)CACB' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 6 '3D HNCO' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 7 '3D HCACO' no 1 $NMR_spectrometer_expt . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $600 . . . . . . . . . . . . . . . . 19113 1 stop_ save_ save_NMR_spectrometer_expt _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode NMR_spectrometer_expt _NMR_spec_expt.Entry_ID 19113 _NMR_spec_expt.ID 1 _NMR_spec_expt.Name . _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID . _NMR_spec_expt.NMR_spectrometer_label . _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID 1 _NMR_spec_expt.Software_label $TOPSPIN _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ #################### # NMR parameters # #################### ############################## # Assigned chemical shifts # ############################## ################################ # Chemical shift referencing # ################################ save_chemical_shift_reference_1 _Chem_shift_reference.Sf_category chem_shift_reference _Chem_shift_reference.Sf_framecode chemical_shift_reference_1 _Chem_shift_reference.Entry_ID 19113 _Chem_shift_reference.ID 1 _Chem_shift_reference.Details . loop_ _Chem_shift_ref.Atom_type _Chem_shift_ref.Atom_isotope_number _Chem_shift_ref.Mol_common_name _Chem_shift_ref.Atom_group _Chem_shift_ref.Concentration_val _Chem_shift_ref.Concentration_units _Chem_shift_ref.Solvent _Chem_shift_ref.Rank _Chem_shift_ref.Chem_shift_units _Chem_shift_ref.Chem_shift_val _Chem_shift_ref.Ref_method _Chem_shift_ref.Ref_type _Chem_shift_ref.Indirect_shift_ratio _Chem_shift_ref.External_ref_loc _Chem_shift_ref.External_ref_sample_geometry _Chem_shift_ref.External_ref_axis _Chem_shift_ref.Indirect_shift_ratio_cit_ID _Chem_shift_ref.Indirect_shift_ratio_cit_label _Chem_shift_ref.Ref_correction_type _Chem_shift_ref.Correction_val _Chem_shift_ref.Correction_val_cit_ID _Chem_shift_ref.Correction_val_cit_label _Chem_shift_ref.Entry_ID _Chem_shift_ref.Chem_shift_reference_ID C 13 DSS 'methyl protons' . . . . ppm 0 external direct 0.2514495300 . . . . . . . . . 19113 1 H 1 DSS 'methyl protons' . . . . ppm 0 external direct 1.0000000000 . . . . . . . . . 19113 1 N 15 DSS 'methyl protons' . . . . ppm 0 external direct 0.1013291180 . . . . . . . . . 19113 1 stop_ save_ ################################### # Assigned chemical shift lists # ################################### ################################################################### # Chemical Shift Ambiguity Index Value Definitions # # # # The values other than 1 are used for those atoms with different # # chemical shifts that cannot be assigned to stereospecific atoms # # or to specific residues or chains. # # # # Index Value Definition # # # # 1 Unique (including isolated methyl protons, # # geminal atoms, and geminal methyl # # groups with identical chemical shifts) # # (e.g. ILE HD11, HD12, HD13 protons) # # 2 Ambiguity of geminal atoms or geminal methyl # # proton groups (e.g. ASP HB2 and HB3 # # protons, LEU CD1 and CD2 carbons, or # # LEU HD11, HD12, HD13 and HD21, HD22, # # HD23 methyl protons) # # 3 Aromatic atoms on opposite sides of # # symmetrical rings (e.g. TYR HE1 and HE2 # # protons) # # 4 Intraresidue ambiguities (e.g. LYS HG and # # HD protons or TRP HZ2 and HZ3 protons) # # 5 Interresidue ambiguities (LYS 12 vs. LYS 27) # # 6 Intermolecular ambiguities (e.g. ASP 31 CA # # in monomer 1 and ASP 31 CA in monomer 2 # # of an asymmetrical homodimer, duplex # # DNA assignments, or other assignments # # that may apply to atoms in one or more # # molecule in the molecular assembly) # # 9 Ambiguous, specific ambiguity not defined # # # ################################################################### save_assigned_chemical_shifts_1 _Assigned_chem_shift_list.Sf_category assigned_chemical_shifts _Assigned_chem_shift_list.Sf_framecode assigned_chemical_shifts_1 _Assigned_chem_shift_list.Entry_ID 19113 _Assigned_chem_shift_list.ID 1 _Assigned_chem_shift_list.Sample_condition_list_ID 1 _Assigned_chem_shift_list.Sample_condition_list_label $sample_conditions_1 _Assigned_chem_shift_list.Chem_shift_reference_ID 1 _Assigned_chem_shift_list.Chem_shift_reference_label $chemical_shift_reference_1 _Assigned_chem_shift_list.Chem_shift_1H_err . _Assigned_chem_shift_list.Chem_shift_13C_err . _Assigned_chem_shift_list.Chem_shift_15N_err . _Assigned_chem_shift_list.Chem_shift_31P_err . _Assigned_chem_shift_list.Chem_shift_2H_err . _Assigned_chem_shift_list.Chem_shift_19F_err . _Assigned_chem_shift_list.Error_derivation_method . _Assigned_chem_shift_list.Details . _Assigned_chem_shift_list.Text_data_format . _Assigned_chem_shift_list.Text_data . loop_ _Chem_shift_experiment.Experiment_ID _Chem_shift_experiment.Experiment_name _Chem_shift_experiment.Sample_ID _Chem_shift_experiment.Sample_label _Chem_shift_experiment.Sample_state _Chem_shift_experiment.Entry_ID _Chem_shift_experiment.Assigned_chem_shift_list_ID 1 '2D 1H-15N HSQC' 1 $sample_1 isotropic 19113 1 2 '3D HNCA' 1 $sample_1 isotropic 19113 1 3 '3D HN(CO)CA' 1 $sample_1 isotropic 19113 1 4 '3D HNCACB' 1 $sample_1 isotropic 19113 1 5 '3D HN(CO)CACB' 1 $sample_1 isotropic 19113 1 6 '3D HNCO' 1 $sample_1 isotropic 19113 1 7 '3D HCACO' 1 $sample_1 isotropic 19113 1 stop_ loop_ _Atom_chem_shift.ID _Atom_chem_shift.Assembly_atom_ID _Atom_chem_shift.Entity_assembly_ID _Atom_chem_shift.Entity_ID _Atom_chem_shift.Comp_index_ID _Atom_chem_shift.Seq_ID _Atom_chem_shift.Comp_ID _Atom_chem_shift.Atom_ID _Atom_chem_shift.Atom_type _Atom_chem_shift.Atom_isotope_number _Atom_chem_shift.Val _Atom_chem_shift.Val_err _Atom_chem_shift.Assign_fig_of_merit _Atom_chem_shift.Ambiguity_code _Atom_chem_shift.Occupancy _Atom_chem_shift.Resonance_ID _Atom_chem_shift.Auth_entity_assembly_ID _Atom_chem_shift.Auth_asym_ID _Atom_chem_shift.Auth_seq_ID _Atom_chem_shift.Auth_comp_ID _Atom_chem_shift.Auth_atom_ID _Atom_chem_shift.Details _Atom_chem_shift.Entry_ID _Atom_chem_shift.Assigned_chem_shift_list_ID 1 . 1 1 1 1 MET CA C 13 55.889 0.000 . 1 . . . . 0 MET CA . 19113 1 2 . 1 1 2 2 ILE H H 1 8.102 0.012 . 1 . . . . 1 ILE H . 19113 1 3 . 1 1 2 2 ILE CA C 13 60.157 0.042 . 1 . . . . 1 ILE CA . 19113 1 4 . 1 1 2 2 ILE N N 15 123.285 0.163 . 1 . . . . 1 ILE N . 19113 1 5 . 1 1 3 3 GLN H H 1 8.246 0.010 . 1 . . . . 2 GLN H . 19113 1 6 . 1 1 3 3 GLN C C 13 175.564 0.042 . 1 . . . . 2 GLN C . 19113 1 7 . 1 1 3 3 GLN CA C 13 54.536 0.013 . 1 . . . . 2 GLN CA . 19113 1 8 . 1 1 3 3 GLN CB C 13 30.357 0.000 . 1 . . . . 2 GLN CB . 19113 1 9 . 1 1 3 3 GLN N N 15 122.460 0.060 . 1 . . . . 2 GLN N . 19113 1 10 . 1 1 4 4 ARG H H 1 9.691 0.005 . 1 . . . . 3 ARG H . 19113 1 11 . 1 1 4 4 ARG C C 13 175.317 0.059 . 1 . . . . 3 ARG C . 19113 1 12 . 1 1 4 4 ARG CA C 13 54.804 0.000 . 1 . . . . 3 ARG CA . 19113 1 13 . 1 1 4 4 ARG CB C 13 33.439 0.000 . 1 . . . . 3 ARG CB . 19113 1 14 . 1 1 4 4 ARG N N 15 123.486 0.115 . 1 . . . . 3 ARG N . 19113 1 15 . 1 1 5 5 THR H H 1 8.521 0.005 . 1 . . . . 4 THR H . 19113 1 16 . 1 1 5 5 THR CA C 13 59.168 0.000 . 1 . . . . 4 THR CA . 19113 1 17 . 1 1 5 5 THR CB C 13 70.767 0.000 . 1 . . . . 4 THR CB . 19113 1 18 . 1 1 5 5 THR N N 15 121.162 0.086 . 1 . . . . 4 THR N . 19113 1 19 . 1 1 6 6 PRO C C 13 176.681 0.000 . 1 . . . . 5 PRO C . 19113 1 20 . 1 1 6 6 PRO CA C 13 62.574 0.000 . 1 . . . . 5 PRO CA . 19113 1 21 . 1 1 6 6 PRO CB C 13 30.742 0.000 . 1 . . . . 5 PRO CB . 19113 1 22 . 1 1 7 7 LYS H H 1 9.347 0.009 . 1 . . . . 6 LYS H . 19113 1 23 . 1 1 7 7 LYS C C 13 176.670 0.012 . 1 . . . . 6 LYS C . 19113 1 24 . 1 1 7 7 LYS CA C 13 55.774 0.041 . 1 . . . . 6 LYS CA . 19113 1 25 . 1 1 7 7 LYS CB C 13 31.650 0.000 . 1 . . . . 6 LYS CB . 19113 1 26 . 1 1 7 7 LYS N N 15 124.268 0.077 . 1 . . . . 6 LYS N . 19113 1 27 . 1 1 8 8 ILE H H 1 8.390 0.008 . 1 . . . . 7 ILE H . 19113 1 28 . 1 1 8 8 ILE C C 13 176.159 0.011 . 1 . . . . 7 ILE C . 19113 1 29 . 1 1 8 8 ILE CA C 13 60.960 0.050 . 1 . . . . 7 ILE CA . 19113 1 30 . 1 1 8 8 ILE CB C 13 41.811 0.026 . 1 . . . . 7 ILE CB . 19113 1 31 . 1 1 8 8 ILE N N 15 122.425 0.074 . 1 . . . . 7 ILE N . 19113 1 32 . 1 1 9 9 GLN H H 1 9.046 0.016 . 1 . . . . 8 GLN H . 19113 1 33 . 1 1 9 9 GLN C C 13 173.943 0.035 . 1 . . . . 8 GLN C . 19113 1 34 . 1 1 9 9 GLN CA C 13 56.114 0.000 . 1 . . . . 8 GLN CA . 19113 1 35 . 1 1 9 9 GLN CB C 13 34.762 0.010 . 1 . . . . 8 GLN CB . 19113 1 36 . 1 1 9 9 GLN N N 15 124.221 0.091 . 1 . . . . 8 GLN N . 19113 1 37 . 1 1 10 10 VAL H H 1 9.437 0.007 . 1 . . . . 9 VAL H . 19113 1 38 . 1 1 10 10 VAL C C 13 174.795 0.022 . 1 . . . . 9 VAL C . 19113 1 39 . 1 1 10 10 VAL CA C 13 60.363 0.079 . 1 . . . . 9 VAL CA . 19113 1 40 . 1 1 10 10 VAL CB C 13 33.610 0.006 . 1 . . . . 9 VAL CB . 19113 1 41 . 1 1 10 10 VAL N N 15 124.194 0.094 . 1 . . . . 9 VAL N . 19113 1 42 . 1 1 11 11 TYR H H 1 8.720 0.012 . 1 . . . . 10 TYR H . 19113 1 43 . 1 1 11 11 TYR C C 13 172.642 0.036 . 1 . . . . 10 TYR C . 19113 1 44 . 1 1 11 11 TYR CA C 13 56.763 0.000 . 1 . . . . 10 TYR CA . 19113 1 45 . 1 1 11 11 TYR CB C 13 37.477 0.002 . 1 . . . . 10 TYR CB . 19113 1 46 . 1 1 11 11 TYR N N 15 123.426 0.054 . 1 . . . . 10 TYR N . 19113 1 47 . 1 1 12 12 SER H H 1 9.075 0.013 . 1 . . . . 11 SER H . 19113 1 48 . 1 1 12 12 SER C C 13 175.644 0.026 . 1 . . . . 11 SER C . 19113 1 49 . 1 1 12 12 SER CA C 13 56.349 0.027 . 1 . . . . 11 SER CA . 19113 1 50 . 1 1 12 12 SER CB C 13 65.493 0.068 . 1 . . . . 11 SER CB . 19113 1 51 . 1 1 12 12 SER N N 15 113.852 0.133 . 1 . . . . 11 SER N . 19113 1 52 . 1 1 13 13 ARG H H 1 8.920 0.006 . 1 . . . . 12 ARG H . 19113 1 53 . 1 1 13 13 ARG C C 13 174.358 0.061 . 1 . . . . 12 ARG C . 19113 1 54 . 1 1 13 13 ARG CA C 13 59.935 0.016 . 1 . . . . 12 ARG CA . 19113 1 55 . 1 1 13 13 ARG N N 15 122.798 0.056 . 1 . . . . 12 ARG N . 19113 1 56 . 1 1 14 14 HIS H H 1 8.337 0.016 . 1 . . . . 13 HIS H . 19113 1 57 . 1 1 14 14 HIS CA C 13 52.399 0.000 . 1 . . . . 13 HIS CA . 19113 1 58 . 1 1 14 14 HIS CB C 13 30.026 0.000 . 1 . . . . 13 HIS CB . 19113 1 59 . 1 1 14 14 HIS N N 15 114.415 0.213 . 1 . . . . 13 HIS N . 19113 1 60 . 1 1 15 15 PRO CA C 13 64.057 0.015 . 1 . . . . 14 PRO CA . 19113 1 61 . 1 1 15 15 PRO CB C 13 30.323 0.000 . 1 . . . . 14 PRO CB . 19113 1 62 . 1 1 16 16 ALA H H 1 9.004 0.014 . 1 . . . . 15 ALA H . 19113 1 63 . 1 1 16 16 ALA C C 13 177.035 0.006 . 1 . . . . 15 ALA C . 19113 1 64 . 1 1 16 16 ALA CA C 13 53.050 0.086 . 1 . . . . 15 ALA CA . 19113 1 65 . 1 1 16 16 ALA CB C 13 19.191 0.017 . 1 . . . . 15 ALA CB . 19113 1 66 . 1 1 16 16 ALA N N 15 127.549 0.038 . 1 . . . . 15 ALA N . 19113 1 67 . 1 1 17 17 GLU H H 1 9.028 0.004 . 1 . . . . 16 GLU H . 19113 1 68 . 1 1 17 17 GLU C C 13 175.291 0.037 . 1 . . . . 16 GLU C . 19113 1 69 . 1 1 17 17 GLU CA C 13 54.772 0.026 . 1 . . . . 16 GLU CA . 19113 1 70 . 1 1 17 17 GLU CB C 13 31.706 0.000 . 1 . . . . 16 GLU CB . 19113 1 71 . 1 1 17 17 GLU N N 15 124.724 0.079 . 1 . . . . 16 GLU N . 19113 1 72 . 1 1 18 18 ASN H H 1 8.903 0.004 . 1 . . . . 17 ASN H . 19113 1 73 . 1 1 18 18 ASN C C 13 177.749 0.042 . 1 . . . . 17 ASN C . 19113 1 74 . 1 1 18 18 ASN CA C 13 54.195 0.000 . 1 . . . . 17 ASN CA . 19113 1 75 . 1 1 18 18 ASN CB C 13 36.314 0.009 . 1 . . . . 17 ASN CB . 19113 1 76 . 1 1 18 18 ASN N N 15 123.538 0.102 . 1 . . . . 17 ASN N . 19113 1 77 . 1 1 19 19 GLY H H 1 8.954 0.010 . 1 . . . . 18 GLY H . 19113 1 78 . 1 1 19 19 GLY C C 13 173.556 0.033 . 1 . . . . 18 GLY C . 19113 1 79 . 1 1 19 19 GLY CA C 13 45.098 0.000 . 1 . . . . 18 GLY CA . 19113 1 80 . 1 1 19 19 GLY N N 15 109.331 0.107 . 1 . . . . 18 GLY N . 19113 1 81 . 1 1 20 20 LYS H H 1 7.988 0.001 . 1 . . . . 19 LYS H . 19113 1 82 . 1 1 20 20 LYS C C 13 175.572 0.025 . 1 . . . . 19 LYS C . 19113 1 83 . 1 1 20 20 LYS CA C 13 54.025 0.004 . 1 . . . . 19 LYS CA . 19113 1 84 . 1 1 20 20 LYS CB C 13 32.583 0.013 . 1 . . . . 19 LYS CB . 19113 1 85 . 1 1 20 20 LYS N N 15 121.818 0.065 . 1 . . . . 19 LYS N . 19113 1 86 . 1 1 21 21 SER H H 1 8.453 0.005 . 1 . . . . 20 SER H . 19113 1 87 . 1 1 21 21 SER CA C 13 59.677 0.024 . 1 . . . . 20 SER CA . 19113 1 88 . 1 1 21 21 SER CB C 13 62.626 0.050 . 1 . . . . 20 SER CB . 19113 1 89 . 1 1 21 21 SER N N 15 120.501 0.052 . 1 . . . . 20 SER N . 19113 1 90 . 1 1 22 22 ASN H H 1 9.022 0.007 . 1 . . . . 21 ASN H . 19113 1 91 . 1 1 22 22 ASN C C 13 174.133 0.036 . 1 . . . . 21 ASN C . 19113 1 92 . 1 1 22 22 ASN CA C 13 51.250 0.019 . 1 . . . . 21 ASN CA . 19113 1 93 . 1 1 22 22 ASN CB C 13 41.755 0.021 . 1 . . . . 21 ASN CB . 19113 1 94 . 1 1 22 22 ASN N N 15 127.164 0.112 . 1 . . . . 21 ASN N . 19113 1 95 . 1 1 23 23 PHE H H 1 10.546 0.005 . 1 . . . . 22 PHE H . 19113 1 96 . 1 1 23 23 PHE C C 13 173.300 0.035 . 1 . . . . 22 PHE C . 19113 1 97 . 1 1 23 23 PHE CA C 13 57.940 0.016 . 1 . . . . 22 PHE CA . 19113 1 98 . 1 1 23 23 PHE CB C 13 42.340 0.000 . 1 . . . . 22 PHE CB . 19113 1 99 . 1 1 23 23 PHE N N 15 120.949 0.033 . 1 . . . . 22 PHE N . 19113 1 100 . 1 1 24 24 LEU H H 1 9.022 0.003 . 1 . . . . 23 LEU H . 19113 1 101 . 1 1 24 24 LEU CA C 13 53.207 0.008 . 1 . . . . 23 LEU CA . 19113 1 102 . 1 1 24 24 LEU CB C 13 39.879 0.000 . 1 . . . . 23 LEU CB . 19113 1 103 . 1 1 24 24 LEU N N 15 127.381 0.088 . 1 . . . . 23 LEU N . 19113 1 104 . 1 1 25 25 ASN H H 1 8.502 0.012 . 1 . . . . 24 ASN H . 19113 1 105 . 1 1 25 25 ASN C C 13 174.031 0.013 . 1 . . . . 24 ASN C . 19113 1 106 . 1 1 25 25 ASN CA C 13 50.714 0.000 . 1 . . . . 24 ASN CA . 19113 1 107 . 1 1 25 25 ASN CB C 13 39.961 0.000 . 1 . . . . 24 ASN CB . 19113 1 108 . 1 1 25 25 ASN N N 15 122.503 0.058 . 1 . . . . 24 ASN N . 19113 1 109 . 1 1 26 26 CYS H H 1 9.724 0.006 . 1 . . . . 25 CYS H . 19113 1 110 . 1 1 26 26 CYS C C 13 172.080 0.007 . 1 . . . . 25 CYS C . 19113 1 111 . 1 1 26 26 CYS CA C 13 53.925 0.000 . 1 . . . . 25 CYS CA . 19113 1 112 . 1 1 26 26 CYS N N 15 120.603 0.095 . 1 . . . . 25 CYS N . 19113 1 113 . 1 1 27 27 TYR H H 1 9.810 0.004 . 1 . . . . 26 TYR H . 19113 1 114 . 1 1 27 27 TYR C C 13 174.799 0.013 . 1 . . . . 26 TYR C . 19113 1 115 . 1 1 27 27 TYR CA C 13 55.285 0.000 . 1 . . . . 26 TYR CA . 19113 1 116 . 1 1 27 27 TYR CB C 13 41.643 0.000 . 1 . . . . 26 TYR CB . 19113 1 117 . 1 1 27 27 TYR N N 15 129.660 0.051 . 1 . . . . 26 TYR N . 19113 1 118 . 1 1 28 28 VAL H H 1 8.995 0.012 . 1 . . . . 27 VAL H . 19113 1 119 . 1 1 28 28 VAL C C 13 174.502 0.007 . 1 . . . . 27 VAL C . 19113 1 120 . 1 1 28 28 VAL CA C 13 58.436 0.081 . 1 . . . . 27 VAL CA . 19113 1 121 . 1 1 28 28 VAL CB C 13 32.619 0.041 . 1 . . . . 27 VAL CB . 19113 1 122 . 1 1 28 28 VAL N N 15 126.588 0.115 . 1 . . . . 27 VAL N . 19113 1 123 . 1 1 29 29 SER H H 1 8.950 0.018 . 1 . . . . 28 SER H . 19113 1 124 . 1 1 29 29 SER C C 13 174.809 0.009 . 1 . . . . 28 SER C . 19113 1 125 . 1 1 29 29 SER CA C 13 56.654 0.024 . 1 . . . . 28 SER CA . 19113 1 126 . 1 1 29 29 SER CB C 13 66.146 0.031 . 1 . . . . 28 SER CB . 19113 1 127 . 1 1 29 29 SER N N 15 117.476 0.109 . 1 . . . . 28 SER N . 19113 1 128 . 1 1 30 30 GLY H H 1 8.444 0.016 . 1 . . . . 29 GLY H . 19113 1 129 . 1 1 30 30 GLY C C 13 174.104 0.037 . 1 . . . . 29 GLY C . 19113 1 130 . 1 1 30 30 GLY CA C 13 45.972 0.026 . 1 . . . . 29 GLY CA . 19113 1 131 . 1 1 30 30 GLY N N 15 108.361 0.132 . 1 . . . . 29 GLY N . 19113 1 132 . 1 1 31 31 PHE H H 1 7.405 0.013 . 1 . . . . 30 PHE H . 19113 1 133 . 1 1 31 31 PHE C C 13 174.532 0.000 . 1 . . . . 30 PHE C . 19113 1 134 . 1 1 31 31 PHE CA C 13 54.190 0.000 . 1 . . . . 30 PHE CA . 19113 1 135 . 1 1 31 31 PHE CB C 13 41.954 0.000 . 1 . . . . 30 PHE CB . 19113 1 136 . 1 1 31 31 PHE N N 15 111.113 0.117 . 1 . . . . 30 PHE N . 19113 1 137 . 1 1 34 34 SER H H 1 8.970 0.031 . 1 . . . . 33 SER H . 19113 1 138 . 1 1 34 34 SER CA C 13 61.263 0.003 . 1 . . . . 33 SER CA . 19113 1 139 . 1 1 34 34 SER N N 15 112.671 0.037 . 1 . . . . 33 SER N . 19113 1 140 . 1 1 35 35 ASP H H 1 7.388 0.007 . 1 . . . . 34 ASP H . 19113 1 141 . 1 1 35 35 ASP C C 13 174.419 0.020 . 1 . . . . 34 ASP C . 19113 1 142 . 1 1 35 35 ASP CA C 13 55.196 0.086 . 1 . . . . 34 ASP CA . 19113 1 143 . 1 1 35 35 ASP CB C 13 39.756 0.014 . 1 . . . . 34 ASP CB . 19113 1 144 . 1 1 35 35 ASP N N 15 121.502 0.029 . 1 . . . . 34 ASP N . 19113 1 145 . 1 1 36 36 ILE H H 1 7.948 0.007 . 1 . . . . 35 ILE H . 19113 1 146 . 1 1 36 36 ILE C C 13 172.061 0.029 . 1 . . . . 35 ILE C . 19113 1 147 . 1 1 36 36 ILE CA C 13 60.704 0.016 . 1 . . . . 35 ILE CA . 19113 1 148 . 1 1 36 36 ILE CB C 13 40.138 0.058 . 1 . . . . 35 ILE CB . 19113 1 149 . 1 1 36 36 ILE N N 15 123.875 0.067 . 1 . . . . 35 ILE N . 19113 1 150 . 1 1 37 37 GLU H H 1 8.202 0.006 . 1 . . . . 36 GLU H . 19113 1 151 . 1 1 37 37 GLU C C 13 174.570 0.069 . 1 . . . . 36 GLU C . 19113 1 152 . 1 1 37 37 GLU CA C 13 54.689 0.011 . 1 . . . . 36 GLU CA . 19113 1 153 . 1 1 37 37 GLU CB C 13 31.475 0.038 . 1 . . . . 36 GLU CB . 19113 1 154 . 1 1 37 37 GLU N N 15 126.275 0.093 . 1 . . . . 36 GLU N . 19113 1 155 . 1 1 38 38 VAL H H 1 7.861 0.012 . 1 . . . . 37 VAL H . 19113 1 156 . 1 1 38 38 VAL C C 13 173.849 0.039 . 1 . . . . 37 VAL C . 19113 1 157 . 1 1 38 38 VAL CA C 13 60.622 0.021 . 1 . . . . 37 VAL CA . 19113 1 158 . 1 1 38 38 VAL CB C 13 32.833 0.035 . 1 . . . . 37 VAL CB . 19113 1 159 . 1 1 38 38 VAL N N 15 125.181 0.052 . 1 . . . . 37 VAL N . 19113 1 160 . 1 1 39 39 ASP H H 1 8.932 0.011 . 1 . . . . 38 ASP H . 19113 1 161 . 1 1 39 39 ASP C C 13 174.524 0.009 . 1 . . . . 38 ASP C . 19113 1 162 . 1 1 39 39 ASP CA C 13 52.397 0.059 . 1 . . . . 38 ASP CA . 19113 1 163 . 1 1 39 39 ASP CB C 13 45.316 0.036 . 1 . . . . 38 ASP CB . 19113 1 164 . 1 1 39 39 ASP N N 15 123.281 0.099 . 1 . . . . 38 ASP N . 19113 1 165 . 1 1 40 40 LEU H H 1 9.071 0.015 . 1 . . . . 39 LEU H . 19113 1 166 . 1 1 40 40 LEU C C 13 174.766 0.010 . 1 . . . . 39 LEU C . 19113 1 167 . 1 1 40 40 LEU CA C 13 53.442 0.000 . 1 . . . . 39 LEU CA . 19113 1 168 . 1 1 40 40 LEU CB C 13 42.715 0.040 . 1 . . . . 39 LEU CB . 19113 1 169 . 1 1 40 40 LEU N N 15 121.551 0.082 . 1 . . . . 39 LEU N . 19113 1 170 . 1 1 41 41 LEU H H 1 9.031 0.010 . 1 . . . . 40 LEU H . 19113 1 171 . 1 1 41 41 LEU C C 13 175.654 0.046 . 1 . . . . 40 LEU C . 19113 1 172 . 1 1 41 41 LEU CA C 13 53.025 0.000 . 1 . . . . 40 LEU CA . 19113 1 173 . 1 1 41 41 LEU CB C 13 44.434 0.052 . 1 . . . . 40 LEU CB . 19113 1 174 . 1 1 41 41 LEU N N 15 120.635 0.085 . 1 . . . . 40 LEU N . 19113 1 175 . 1 1 42 42 LYS H H 1 8.920 0.011 . 1 . . . . 41 LYS H . 19113 1 176 . 1 1 42 42 LYS C C 13 176.604 0.012 . 1 . . . . 41 LYS C . 19113 1 177 . 1 1 42 42 LYS CA C 13 54.147 0.001 . 1 . . . . 41 LYS CA . 19113 1 178 . 1 1 42 42 LYS CB C 13 33.191 0.092 . 1 . . . . 41 LYS CB . 19113 1 179 . 1 1 42 42 LYS N N 15 121.298 0.031 . 1 . . . . 41 LYS N . 19113 1 180 . 1 1 43 43 ASN H H 1 9.863 0.004 . 1 . . . . 42 ASN H . 19113 1 181 . 1 1 43 43 ASN C C 13 175.862 0.029 . 1 . . . . 42 ASN C . 19113 1 182 . 1 1 43 43 ASN CA C 13 54.397 0.076 . 1 . . . . 42 ASN CA . 19113 1 183 . 1 1 43 43 ASN CB C 13 36.763 0.091 . 1 . . . . 42 ASN CB . 19113 1 184 . 1 1 43 43 ASN N N 15 128.595 0.116 . 1 . . . . 42 ASN N . 19113 1 185 . 1 1 44 44 GLY H H 1 8.922 0.007 . 1 . . . . 43 GLY H . 19113 1 186 . 1 1 44 44 GLY C C 13 173.268 0.026 . 1 . . . . 43 GLY C . 19113 1 187 . 1 1 44 44 GLY CA C 13 45.088 0.001 . 1 . . . . 43 GLY CA . 19113 1 188 . 1 1 44 44 GLY N N 15 102.880 0.187 . 1 . . . . 43 GLY N . 19113 1 189 . 1 1 45 45 GLU H H 1 7.894 0.013 . 1 . . . . 44 GLU H . 19113 1 190 . 1 1 45 45 GLU C C 13 175.986 0.019 . 1 . . . . 44 GLU C . 19113 1 191 . 1 1 45 45 GLU CA C 13 54.200 0.054 . 1 . . . . 44 GLU CA . 19113 1 192 . 1 1 45 45 GLU CB C 13 30.885 0.007 . 1 . . . . 44 GLU CB . 19113 1 193 . 1 1 45 45 GLU N N 15 121.175 0.078 . 1 . . . . 44 GLU N . 19113 1 194 . 1 1 46 46 ARG H H 1 8.771 0.006 . 1 . . . . 45 ARG H . 19113 1 195 . 1 1 46 46 ARG C C 13 176.492 0.019 . 1 . . . . 45 ARG C . 19113 1 196 . 1 1 46 46 ARG CA C 13 57.455 0.000 . 1 . . . . 45 ARG CA . 19113 1 197 . 1 1 46 46 ARG CB C 13 29.539 0.000 . 1 . . . . 45 ARG CB . 19113 1 198 . 1 1 46 46 ARG N N 15 124.804 0.063 . 1 . . . . 45 ARG N . 19113 1 199 . 1 1 47 47 ILE H H 1 8.932 0.004 . 1 . . . . 46 ILE H . 19113 1 200 . 1 1 47 47 ILE C C 13 176.341 0.041 . 1 . . . . 46 ILE C . 19113 1 201 . 1 1 47 47 ILE CA C 13 61.866 0.065 . 1 . . . . 46 ILE CA . 19113 1 202 . 1 1 47 47 ILE CB C 13 37.984 0.074 . 1 . . . . 46 ILE CB . 19113 1 203 . 1 1 47 47 ILE N N 15 129.116 0.042 . 1 . . . . 46 ILE N . 19113 1 204 . 1 1 48 48 GLU H H 1 8.583 0.007 . 1 . . . . 47 GLU H . 19113 1 205 . 1 1 48 48 GLU C C 13 177.457 0.004 . 1 . . . . 47 GLU C . 19113 1 206 . 1 1 48 48 GLU CA C 13 58.389 0.009 . 1 . . . . 47 GLU CA . 19113 1 207 . 1 1 48 48 GLU CB C 13 29.815 0.030 . 1 . . . . 47 GLU CB . 19113 1 208 . 1 1 48 48 GLU N N 15 126.542 0.067 . 1 . . . . 47 GLU N . 19113 1 209 . 1 1 49 49 LYS H H 1 8.126 0.016 . 1 . . . . 48 LYS H . 19113 1 210 . 1 1 49 49 LYS C C 13 174.698 0.003 . 1 . . . . 48 LYS C . 19113 1 211 . 1 1 49 49 LYS CA C 13 55.614 0.046 . 1 . . . . 48 LYS CA . 19113 1 212 . 1 1 49 49 LYS CB C 13 29.807 0.019 . 1 . . . . 48 LYS CB . 19113 1 213 . 1 1 49 49 LYS N N 15 119.752 0.084 . 1 . . . . 48 LYS N . 19113 1 214 . 1 1 50 50 VAL H H 1 7.925 0.007 . 1 . . . . 49 VAL H . 19113 1 215 . 1 1 50 50 VAL C C 13 175.387 0.019 . 1 . . . . 49 VAL C . 19113 1 216 . 1 1 50 50 VAL CA C 13 61.181 0.043 . 1 . . . . 49 VAL CA . 19113 1 217 . 1 1 50 50 VAL CB C 13 33.822 0.014 . 1 . . . . 49 VAL CB . 19113 1 218 . 1 1 50 50 VAL N N 15 124.248 0.118 . 1 . . . . 49 VAL N . 19113 1 219 . 1 1 51 51 GLU H H 1 8.441 0.017 . 1 . . . . 50 GLU H . 19113 1 220 . 1 1 51 51 GLU C C 13 174.256 0.015 . 1 . . . . 50 GLU C . 19113 1 221 . 1 1 51 51 GLU CA C 13 54.128 0.011 . 1 . . . . 50 GLU CA . 19113 1 222 . 1 1 51 51 GLU CB C 13 31.829 0.022 . 1 . . . . 50 GLU CB . 19113 1 223 . 1 1 51 51 GLU N N 15 126.988 0.082 . 1 . . . . 50 GLU N . 19113 1 224 . 1 1 52 52 HIS H H 1 8.178 0.014 . 1 . . . . 51 HIS H . 19113 1 225 . 1 1 52 52 HIS C C 13 175.347 0.024 . 1 . . . . 51 HIS C . 19113 1 226 . 1 1 52 52 HIS CA C 13 53.236 0.085 . 1 . . . . 51 HIS CA . 19113 1 227 . 1 1 52 52 HIS CB C 13 30.101 0.038 . 1 . . . . 51 HIS CB . 19113 1 228 . 1 1 52 52 HIS N N 15 111.639 0.128 . 1 . . . . 51 HIS N . 19113 1 229 . 1 1 53 53 SER H H 1 9.172 0.011 . 1 . . . . 52 SER H . 19113 1 230 . 1 1 53 53 SER C C 13 173.891 0.018 . 1 . . . . 52 SER C . 19113 1 231 . 1 1 53 53 SER CA C 13 57.501 0.005 . 1 . . . . 52 SER CA . 19113 1 232 . 1 1 53 53 SER CB C 13 64.434 0.060 . 1 . . . . 52 SER CB . 19113 1 233 . 1 1 53 53 SER N N 15 116.965 0.097 . 1 . . . . 52 SER N . 19113 1 234 . 1 1 54 54 ASP H H 1 8.630 0.023 . 1 . . . . 53 ASP H . 19113 1 235 . 1 1 54 54 ASP C C 13 176.856 0.000 . 1 . . . . 53 ASP C . 19113 1 236 . 1 1 54 54 ASP CA C 13 54.387 0.000 . 1 . . . . 53 ASP CA . 19113 1 237 . 1 1 54 54 ASP CB C 13 42.360 0.096 . 1 . . . . 53 ASP CB . 19113 1 238 . 1 1 54 54 ASP N N 15 118.908 0.187 . 1 . . . . 53 ASP N . 19113 1 239 . 1 1 55 55 LEU H H 1 8.716 0.013 . 1 . . . . 54 LEU H . 19113 1 240 . 1 1 55 55 LEU C C 13 173.658 0.034 . 1 . . . . 54 LEU C . 19113 1 241 . 1 1 55 55 LEU CA C 13 57.613 0.000 . 1 . . . . 54 LEU CA . 19113 1 242 . 1 1 55 55 LEU CB C 13 42.368 0.013 . 1 . . . . 54 LEU CB . 19113 1 243 . 1 1 55 55 LEU N N 15 126.112 0.084 . 1 . . . . 54 LEU N . 19113 1 244 . 1 1 56 56 SER H H 1 6.895 0.018 . 1 . . . . 55 SER H . 19113 1 245 . 1 1 56 56 SER C C 13 171.685 0.000 . 1 . . . . 55 SER C . 19113 1 246 . 1 1 56 56 SER CA C 13 54.580 0.080 . 1 . . . . 55 SER CA . 19113 1 247 . 1 1 56 56 SER CB C 13 64.155 0.024 . 1 . . . . 55 SER CB . 19113 1 248 . 1 1 56 56 SER N N 15 118.078 0.066 . 1 . . . . 55 SER N . 19113 1 249 . 1 1 57 57 PHE H H 1 6.881 0.010 . 1 . . . . 56 PHE H . 19113 1 250 . 1 1 57 57 PHE C C 13 174.102 0.004 . 1 . . . . 56 PHE C . 19113 1 251 . 1 1 57 57 PHE CA C 13 54.614 0.095 . 1 . . . . 56 PHE CA . 19113 1 252 . 1 1 57 57 PHE CB C 13 40.933 0.024 . 1 . . . . 56 PHE CB . 19113 1 253 . 1 1 57 57 PHE N N 15 112.542 0.116 . 1 . . . . 56 PHE N . 19113 1 254 . 1 1 58 58 SER H H 1 8.948 0.004 . 1 . . . . 57 SER H . 19113 1 255 . 1 1 58 58 SER CA C 13 57.100 0.000 . 1 . . . . 57 SER CA . 19113 1 256 . 1 1 58 58 SER CB C 13 64.001 0.000 . 1 . . . . 57 SER CB . 19113 1 257 . 1 1 58 58 SER N N 15 115.340 0.132 . 1 . . . . 57 SER N . 19113 1 258 . 1 1 60 60 ASP H H 1 7.552 0.008 . 1 . . . . 59 ASP H . 19113 1 259 . 1 1 60 60 ASP C C 13 176.262 0.027 . 1 . . . . 59 ASP C . 19113 1 260 . 1 1 60 60 ASP CA C 13 52.953 0.012 . 1 . . . . 59 ASP CA . 19113 1 261 . 1 1 60 60 ASP CB C 13 39.246 0.076 . 1 . . . . 59 ASP CB . 19113 1 262 . 1 1 60 60 ASP N N 15 117.164 0.050 . 1 . . . . 59 ASP N . 19113 1 263 . 1 1 61 61 TRP H H 1 7.839 0.009 . 1 . . . . 60 TRP H . 19113 1 264 . 1 1 61 61 TRP HE1 H 1 10.682 0.000 . 1 . . . . 60 TRP HE1 . 19113 1 265 . 1 1 61 61 TRP C C 13 175.260 0.004 . 1 . . . . 60 TRP C . 19113 1 266 . 1 1 61 61 TRP CA C 13 59.099 0.000 . 1 . . . . 60 TRP CA . 19113 1 267 . 1 1 61 61 TRP CB C 13 26.022 0.000 . 1 . . . . 60 TRP CB . 19113 1 268 . 1 1 61 61 TRP N N 15 111.269 0.204 . 1 . . . . 60 TRP N . 19113 1 269 . 1 1 61 61 TRP NE1 N 15 130.426 0.000 . 1 . . . . 60 TRP NE1 . 19113 1 270 . 1 1 62 62 SER H H 1 8.295 0.008 . 1 . . . . 61 SER H . 19113 1 271 . 1 1 62 62 SER CA C 13 59.048 0.024 . 1 . . . . 61 SER CA . 19113 1 272 . 1 1 62 62 SER CB C 13 62.886 0.074 . 1 . . . . 61 SER CB . 19113 1 273 . 1 1 62 62 SER N N 15 117.162 0.102 . 1 . . . . 61 SER N . 19113 1 274 . 1 1 63 63 PHE H H 1 8.395 0.015 . 1 . . . . 62 PHE H . 19113 1 275 . 1 1 63 63 PHE C C 13 174.283 0.046 . 1 . . . . 62 PHE C . 19113 1 276 . 1 1 63 63 PHE CA C 13 58.401 0.010 . 1 . . . . 62 PHE CA . 19113 1 277 . 1 1 63 63 PHE CB C 13 40.729 0.056 . 1 . . . . 62 PHE CB . 19113 1 278 . 1 1 63 63 PHE N N 15 121.367 0.041 . 1 . . . . 62 PHE N . 19113 1 279 . 1 1 64 64 TYR H H 1 7.628 0.016 . 1 . . . . 63 TYR H . 19113 1 280 . 1 1 64 64 TYR C C 13 174.840 0.007 . 1 . . . . 63 TYR C . 19113 1 281 . 1 1 64 64 TYR CA C 13 56.402 0.020 . 1 . . . . 63 TYR CA . 19113 1 282 . 1 1 64 64 TYR CB C 13 39.908 0.047 . 1 . . . . 63 TYR CB . 19113 1 283 . 1 1 64 64 TYR N N 15 110.033 0.091 . 1 . . . . 63 TYR N . 19113 1 284 . 1 1 65 65 LEU H H 1 9.456 0.008 . 1 . . . . 64 LEU H . 19113 1 285 . 1 1 65 65 LEU C C 13 173.048 0.000 . 1 . . . . 64 LEU C . 19113 1 286 . 1 1 65 65 LEU CA C 13 54.928 0.030 . 1 . . . . 64 LEU CA . 19113 1 287 . 1 1 65 65 LEU CB C 13 49.488 0.045 . 1 . . . . 64 LEU CB . 19113 1 288 . 1 1 65 65 LEU N N 15 120.859 0.116 . 1 . . . . 64 LEU N . 19113 1 289 . 1 1 66 66 LEU H H 1 8.669 0.005 . 1 . . . . 65 LEU H . 19113 1 290 . 1 1 66 66 LEU C C 13 175.270 0.028 . 1 . . . . 65 LEU C . 19113 1 291 . 1 1 66 66 LEU CA C 13 53.606 0.000 . 1 . . . . 65 LEU CA . 19113 1 292 . 1 1 66 66 LEU CB C 13 45.640 0.000 . 1 . . . . 65 LEU CB . 19113 1 293 . 1 1 66 66 LEU N N 15 121.979 0.097 . 1 . . . . 65 LEU N . 19113 1 294 . 1 1 67 67 TYR H H 1 9.322 0.010 . 1 . . . . 66 TYR H . 19113 1 295 . 1 1 67 67 TYR C C 13 175.454 0.038 . 1 . . . . 66 TYR C . 19113 1 296 . 1 1 67 67 TYR CA C 13 56.647 0.035 . 1 . . . . 66 TYR CA . 19113 1 297 . 1 1 67 67 TYR CB C 13 40.577 0.022 . 1 . . . . 66 TYR CB . 19113 1 298 . 1 1 67 67 TYR N N 15 127.893 0.086 . 1 . . . . 66 TYR N . 19113 1 299 . 1 1 68 68 TYR H H 1 8.982 0.017 . 1 . . . . 67 TYR H . 19113 1 300 . 1 1 68 68 TYR C C 13 174.058 0.017 . 1 . . . . 67 TYR C . 19113 1 301 . 1 1 68 68 TYR CA C 13 55.927 0.005 . 1 . . . . 67 TYR CA . 19113 1 302 . 1 1 68 68 TYR CB C 13 41.070 0.091 . 1 . . . . 67 TYR CB . 19113 1 303 . 1 1 68 68 TYR N N 15 116.470 0.124 . 1 . . . . 67 TYR N . 19113 1 304 . 1 1 69 69 THR H H 1 8.451 0.008 . 1 . . . . 68 THR H . 19113 1 305 . 1 1 69 69 THR C C 13 171.774 0.012 . 1 . . . . 68 THR C . 19113 1 306 . 1 1 69 69 THR CA C 13 60.020 0.036 . 1 . . . . 68 THR CA . 19113 1 307 . 1 1 69 69 THR CB C 13 69.964 0.021 . 1 . . . . 68 THR CB . 19113 1 308 . 1 1 69 69 THR N N 15 112.752 0.104 . 1 . . . . 68 THR N . 19113 1 309 . 1 1 70 70 GLU H H 1 8.530 0.002 . 1 . . . . 69 GLU H . 19113 1 310 . 1 1 70 70 GLU C C 13 175.917 0.030 . 1 . . . . 69 GLU C . 19113 1 311 . 1 1 70 70 GLU CA C 13 56.749 0.013 . 1 . . . . 69 GLU CA . 19113 1 312 . 1 1 70 70 GLU CB C 13 29.251 0.077 . 1 . . . . 69 GLU CB . 19113 1 313 . 1 1 70 70 GLU N N 15 129.323 0.054 . 1 . . . . 69 GLU N . 19113 1 314 . 1 1 71 71 PHE H H 1 8.690 0.018 . 1 . . . . 70 PHE H . 19113 1 315 . 1 1 71 71 PHE C C 13 172.105 0.043 . 1 . . . . 70 PHE C . 19113 1 316 . 1 1 71 71 PHE CA C 13 55.039 0.058 . 1 . . . . 70 PHE CA . 19113 1 317 . 1 1 71 71 PHE CB C 13 40.331 0.000 . 1 . . . . 70 PHE CB . 19113 1 318 . 1 1 71 71 PHE N N 15 125.178 0.052 . 1 . . . . 70 PHE N . 19113 1 319 . 1 1 72 72 THR H H 1 8.278 0.009 . 1 . . . . 71 THR H . 19113 1 320 . 1 1 72 72 THR CA C 13 58.387 0.000 . 1 . . . . 71 THR CA . 19113 1 321 . 1 1 72 72 THR CB C 13 69.864 0.000 . 1 . . . . 71 THR CB . 19113 1 322 . 1 1 72 72 THR N N 15 117.629 0.076 . 1 . . . . 71 THR N . 19113 1 323 . 1 1 73 73 PRO C C 13 174.956 0.000 . 1 . . . . 72 PRO C . 19113 1 324 . 1 1 73 73 PRO CA C 13 62.892 0.000 . 1 . . . . 72 PRO CA . 19113 1 325 . 1 1 73 73 PRO CB C 13 31.176 0.000 . 1 . . . . 72 PRO CB . 19113 1 326 . 1 1 74 74 THR H H 1 8.105 0.015 . 1 . . . . 73 THR H . 19113 1 327 . 1 1 74 74 THR C C 13 175.377 0.000 . 1 . . . . 73 THR C . 19113 1 328 . 1 1 74 74 THR CA C 13 59.955 0.058 . 1 . . . . 73 THR CA . 19113 1 329 . 1 1 74 74 THR CB C 13 72.853 0.000 . 1 . . . . 73 THR CB . 19113 1 330 . 1 1 74 74 THR N N 15 110.450 0.129 . 1 . . . . 73 THR N . 19113 1 331 . 1 1 75 75 GLU H H 1 9.128 0.005 . 1 . . . . 74 GLU H . 19113 1 332 . 1 1 75 75 GLU C C 13 178.139 0.000 . 1 . . . . 74 GLU C . 19113 1 333 . 1 1 75 75 GLU CA C 13 58.656 0.053 . 1 . . . . 74 GLU CA . 19113 1 334 . 1 1 75 75 GLU CB C 13 29.198 0.079 . 1 . . . . 74 GLU CB . 19113 1 335 . 1 1 75 75 GLU N N 15 118.762 0.071 . 1 . . . . 74 GLU N . 19113 1 336 . 1 1 76 76 LYS H H 1 7.884 0.004 . 1 . . . . 75 LYS H . 19113 1 337 . 1 1 76 76 LYS C C 13 177.108 0.006 . 1 . . . . 75 LYS C . 19113 1 338 . 1 1 76 76 LYS CA C 13 56.318 0.072 . 1 . . . . 75 LYS CA . 19113 1 339 . 1 1 76 76 LYS CB C 13 33.275 0.023 . 1 . . . . 75 LYS CB . 19113 1 340 . 1 1 76 76 LYS N N 15 113.964 0.119 . 1 . . . . 75 LYS N . 19113 1 341 . 1 1 77 77 ASP H H 1 7.233 0.008 . 1 . . . . 76 ASP H . 19113 1 342 . 1 1 77 77 ASP C C 13 175.323 0.025 . 1 . . . . 76 ASP C . 19113 1 343 . 1 1 77 77 ASP CA C 13 55.371 0.083 . 1 . . . . 76 ASP CA . 19113 1 344 . 1 1 77 77 ASP CB C 13 42.703 0.044 . 1 . . . . 76 ASP CB . 19113 1 345 . 1 1 77 77 ASP N N 15 118.279 0.082 . 1 . . . . 76 ASP N . 19113 1 346 . 1 1 78 78 GLU H H 1 8.717 0.013 . 1 . . . . 77 GLU H . 19113 1 347 . 1 1 78 78 GLU C C 13 175.120 0.007 . 1 . . . . 77 GLU C . 19113 1 348 . 1 1 78 78 GLU CA C 13 54.780 0.011 . 1 . . . . 77 GLU CA . 19113 1 349 . 1 1 78 78 GLU CB C 13 31.857 0.008 . 1 . . . . 77 GLU CB . 19113 1 350 . 1 1 78 78 GLU N N 15 123.504 0.080 . 1 . . . . 77 GLU N . 19113 1 351 . 1 1 79 79 TYR H H 1 9.536 0.006 . 1 . . . . 78 TYR H . 19113 1 352 . 1 1 79 79 TYR C C 13 175.613 0.004 . 1 . . . . 78 TYR C . 19113 1 353 . 1 1 79 79 TYR CA C 13 56.545 0.027 . 1 . . . . 78 TYR CA . 19113 1 354 . 1 1 79 79 TYR CB C 13 42.160 0.088 . 1 . . . . 78 TYR CB . 19113 1 355 . 1 1 79 79 TYR N N 15 124.071 0.058 . 1 . . . . 78 TYR N . 19113 1 356 . 1 1 80 80 ALA H H 1 8.899 0.015 . 1 . . . . 79 ALA H . 19113 1 357 . 1 1 80 80 ALA C C 13 173.925 0.033 . 1 . . . . 79 ALA C . 19113 1 358 . 1 1 80 80 ALA CA C 13 50.906 0.016 . 1 . . . . 79 ALA CA . 19113 1 359 . 1 1 80 80 ALA CB C 13 23.182 0.049 . 1 . . . . 79 ALA CB . 19113 1 360 . 1 1 80 80 ALA N N 15 121.454 0.115 . 1 . . . . 79 ALA N . 19113 1 361 . 1 1 81 81 CYS H H 1 9.180 0.003 . 1 . . . . 80 CYS H . 19113 1 362 . 1 1 81 81 CYS C C 13 171.374 0.000 . 1 . . . . 80 CYS C . 19113 1 363 . 1 1 81 81 CYS CA C 13 52.663 0.000 . 1 . . . . 80 CYS CA . 19113 1 364 . 1 1 81 81 CYS CB C 13 43.039 0.015 . 1 . . . . 80 CYS CB . 19113 1 365 . 1 1 81 81 CYS N N 15 120.087 0.084 . 1 . . . . 80 CYS N . 19113 1 366 . 1 1 82 82 ARG H H 1 9.461 0.010 . 1 . . . . 81 ARG H . 19113 1 367 . 1 1 82 82 ARG C C 13 174.225 0.002 . 1 . . . . 81 ARG C . 19113 1 368 . 1 1 82 82 ARG N N 15 128.687 0.106 . 1 . . . . 81 ARG N . 19113 1 369 . 1 1 83 83 VAL H H 1 9.182 0.001 . 1 . . . . 82 VAL H . 19113 1 370 . 1 1 83 83 VAL C C 13 173.627 0.032 . 1 . . . . 82 VAL C . 19113 1 371 . 1 1 83 83 VAL CA C 13 60.332 0.015 . 1 . . . . 82 VAL CA . 19113 1 372 . 1 1 83 83 VAL CB C 13 34.979 0.042 . 1 . . . . 82 VAL CB . 19113 1 373 . 1 1 83 83 VAL N N 15 128.351 0.066 . 1 . . . . 82 VAL N . 19113 1 374 . 1 1 84 84 ASN H H 1 9.148 0.005 . 1 . . . . 83 ASN H . 19113 1 375 . 1 1 84 84 ASN C C 13 173.019 0.022 . 1 . . . . 83 ASN C . 19113 1 376 . 1 1 84 84 ASN CA C 13 50.961 0.029 . 1 . . . . 83 ASN CA . 19113 1 377 . 1 1 84 84 ASN CB C 13 41.065 0.014 . 1 . . . . 83 ASN CB . 19113 1 378 . 1 1 84 84 ASN N N 15 123.626 0.121 . 1 . . . . 83 ASN N . 19113 1 379 . 1 1 85 85 HIS H H 1 7.804 0.008 . 1 . . . . 84 HIS H . 19113 1 380 . 1 1 85 85 HIS C C 13 175.419 0.036 . 1 . . . . 84 HIS C . 19113 1 381 . 1 1 85 85 HIS CA C 13 56.748 0.055 . 1 . . . . 84 HIS CA . 19113 1 382 . 1 1 85 85 HIS CB C 13 35.415 0.040 . 1 . . . . 84 HIS CB . 19113 1 383 . 1 1 85 85 HIS N N 15 122.905 0.072 . 1 . . . . 84 HIS N . 19113 1 384 . 1 1 86 86 VAL H H 1 8.117 0.004 . 1 . . . . 85 VAL H . 19113 1 385 . 1 1 86 86 VAL C C 13 175.493 0.011 . 1 . . . . 85 VAL C . 19113 1 386 . 1 1 86 86 VAL CA C 13 64.366 0.063 . 1 . . . . 85 VAL CA . 19113 1 387 . 1 1 86 86 VAL N N 15 125.416 0.089 . 1 . . . . 85 VAL N . 19113 1 388 . 1 1 87 87 THR H H 1 7.530 0.011 . 1 . . . . 86 THR H . 19113 1 389 . 1 1 87 87 THR C C 13 174.876 0.000 . 1 . . . . 86 THR C . 19113 1 390 . 1 1 87 87 THR CA C 13 63.068 0.019 . 1 . . . . 86 THR CA . 19113 1 391 . 1 1 87 87 THR CB C 13 69.807 0.000 . 1 . . . . 86 THR CB . 19113 1 392 . 1 1 87 87 THR N N 15 110.725 0.089 . 1 . . . . 86 THR N . 19113 1 393 . 1 1 88 88 LEU H H 1 8.118 0.006 . 1 . . . . 87 LEU H . 19113 1 394 . 1 1 88 88 LEU CA C 13 53.251 0.000 . 1 . . . . 87 LEU CA . 19113 1 395 . 1 1 88 88 LEU CB C 13 41.765 0.000 . 1 . . . . 87 LEU CB . 19113 1 396 . 1 1 88 88 LEU N N 15 123.559 0.117 . 1 . . . . 87 LEU N . 19113 1 397 . 1 1 90 90 GLN H H 1 7.581 0.020 . 1 . . . . 89 GLN H . 19113 1 398 . 1 1 90 90 GLN CA C 13 52.964 0.000 . 1 . . . . 89 GLN CA . 19113 1 399 . 1 1 90 90 GLN CB C 13 29.166 0.000 . 1 . . . . 89 GLN CB . 19113 1 400 . 1 1 90 90 GLN N N 15 117.589 0.035 . 1 . . . . 89 GLN N . 19113 1 401 . 1 1 91 91 PRO C C 13 176.098 0.000 . 1 . . . . 90 PRO C . 19113 1 402 . 1 1 92 92 LYS H H 1 8.875 0.004 . 1 . . . . 91 LYS H . 19113 1 403 . 1 1 92 92 LYS C C 13 174.926 0.044 . 1 . . . . 91 LYS C . 19113 1 404 . 1 1 92 92 LYS CA C 13 54.843 0.003 . 1 . . . . 91 LYS CA . 19113 1 405 . 1 1 92 92 LYS CB C 13 34.307 0.021 . 1 . . . . 91 LYS CB . 19113 1 406 . 1 1 92 92 LYS N N 15 125.485 0.074 . 1 . . . . 91 LYS N . 19113 1 407 . 1 1 93 93 ILE H H 1 8.602 0.006 . 1 . . . . 92 ILE H . 19113 1 408 . 1 1 93 93 ILE C C 13 175.978 0.001 . 1 . . . . 92 ILE C . 19113 1 409 . 1 1 93 93 ILE CA C 13 60.177 0.000 . 1 . . . . 92 ILE CA . 19113 1 410 . 1 1 93 93 ILE CB C 13 38.142 0.034 . 1 . . . . 92 ILE CB . 19113 1 411 . 1 1 93 93 ILE N N 15 125.383 0.076 . 1 . . . . 92 ILE N . 19113 1 412 . 1 1 94 94 VAL H H 1 9.114 0.007 . 1 . . . . 93 VAL H . 19113 1 413 . 1 1 94 94 VAL C C 13 175.501 0.031 . 1 . . . . 93 VAL C . 19113 1 414 . 1 1 94 94 VAL CA C 13 60.953 0.084 . 1 . . . . 93 VAL CA . 19113 1 415 . 1 1 94 94 VAL CB C 13 33.086 0.008 . 1 . . . . 93 VAL CB . 19113 1 416 . 1 1 94 94 VAL N N 15 129.795 0.075 . 1 . . . . 93 VAL N . 19113 1 417 . 1 1 95 95 LYS H H 1 8.938 0.004 . 1 . . . . 94 LYS H . 19113 1 418 . 1 1 95 95 LYS C C 13 176.541 0.001 . 1 . . . . 94 LYS C . 19113 1 419 . 1 1 95 95 LYS CA C 13 56.398 0.065 . 1 . . . . 94 LYS CA . 19113 1 420 . 1 1 95 95 LYS CB C 13 32.620 0.057 . 1 . . . . 94 LYS CB . 19113 1 421 . 1 1 95 95 LYS N N 15 128.112 0.075 . 1 . . . . 94 LYS N . 19113 1 422 . 1 1 96 96 TRP H H 1 9.102 0.005 . 1 . . . . 95 TRP H . 19113 1 423 . 1 1 96 96 TRP HE1 H 1 10.714 0.000 . 1 . . . . 95 TRP HE1 . 19113 1 424 . 1 1 96 96 TRP C C 13 174.025 0.030 . 1 . . . . 95 TRP C . 19113 1 425 . 1 1 96 96 TRP CA C 13 58.158 0.078 . 1 . . . . 95 TRP CA . 19113 1 426 . 1 1 96 96 TRP CB C 13 27.622 0.021 . 1 . . . . 95 TRP CB . 19113 1 427 . 1 1 96 96 TRP N N 15 123.058 0.086 . 1 . . . . 95 TRP N . 19113 1 428 . 1 1 96 96 TRP NE1 N 15 129.803 0.000 . 1 . . . . 95 TRP NE1 . 19113 1 429 . 1 1 97 97 ASP H H 1 8.529 0.005 . 1 . . . . 96 ASP H . 19113 1 430 . 1 1 97 97 ASP C C 13 176.148 0.004 . 1 . . . . 96 ASP C . 19113 1 431 . 1 1 97 97 ASP CA C 13 52.278 0.021 . 1 . . . . 96 ASP CA . 19113 1 432 . 1 1 97 97 ASP CB C 13 42.730 0.016 . 1 . . . . 96 ASP CB . 19113 1 433 . 1 1 97 97 ASP N N 15 132.440 0.055 . 1 . . . . 96 ASP N . 19113 1 434 . 1 1 98 98 ARG H H 1 7.773 0.008 . 1 . . . . 97 ARG H . 19113 1 435 . 1 1 98 98 ARG C C 13 176.041 0.029 . 1 . . . . 97 ARG C . 19113 1 436 . 1 1 98 98 ARG CA C 13 57.462 0.000 . 1 . . . . 97 ARG CA . 19113 1 437 . 1 1 98 98 ARG CB C 13 29.040 0.085 . 1 . . . . 97 ARG CB . 19113 1 438 . 1 1 98 98 ARG N N 15 123.030 0.050 . 1 . . . . 97 ARG N . 19113 1 439 . 1 1 99 99 ASP H H 1 8.618 0.005 . 1 . . . . 98 ASP H . 19113 1 440 . 1 1 99 99 ASP C C 13 173.915 0.032 . 1 . . . . 98 ASP C . 19113 1 441 . 1 1 99 99 ASP CA C 13 54.616 0.074 . 1 . . . . 98 ASP CA . 19113 1 442 . 1 1 99 99 ASP CB C 13 41.134 0.088 . 1 . . . . 98 ASP CB . 19113 1 443 . 1 1 99 99 ASP N N 15 120.537 0.111 . 1 . . . . 98 ASP N . 19113 1 444 . 1 1 100 100 MET H H 1 7.889 0.008 . 1 . . . . 99 MET H . 19113 1 445 . 1 1 100 100 MET C C 13 180.034 0.000 . 1 . . . . 99 MET C . 19113 1 446 . 1 1 100 100 MET CA C 13 56.866 0.000 . 1 . . . . 99 MET CA . 19113 1 447 . 1 1 100 100 MET CB C 13 36.046 0.000 . 1 . . . . 99 MET CB . 19113 1 448 . 1 1 100 100 MET N N 15 122.341 0.105 . 1 . . . . 99 MET N . 19113 1 stop_ save_ save_assigned_chemical_shifts_2 _Assigned_chem_shift_list.Sf_category assigned_chemical_shifts _Assigned_chem_shift_list.Sf_framecode assigned_chemical_shifts_2 _Assigned_chem_shift_list.Entry_ID 19113 _Assigned_chem_shift_list.ID 2 _Assigned_chem_shift_list.Sample_condition_list_ID 1 _Assigned_chem_shift_list.Sample_condition_list_label $sample_conditions_1 _Assigned_chem_shift_list.Chem_shift_reference_ID 1 _Assigned_chem_shift_list.Chem_shift_reference_label $chemical_shift_reference_1 _Assigned_chem_shift_list.Chem_shift_1H_err . _Assigned_chem_shift_list.Chem_shift_13C_err . _Assigned_chem_shift_list.Chem_shift_15N_err . _Assigned_chem_shift_list.Chem_shift_31P_err . _Assigned_chem_shift_list.Chem_shift_2H_err . _Assigned_chem_shift_list.Chem_shift_19F_err . _Assigned_chem_shift_list.Error_derivation_method . _Assigned_chem_shift_list.Details . _Assigned_chem_shift_list.Text_data_format . _Assigned_chem_shift_list.Text_data . loop_ _Chem_shift_experiment.Experiment_ID _Chem_shift_experiment.Experiment_name _Chem_shift_experiment.Sample_ID _Chem_shift_experiment.Sample_label _Chem_shift_experiment.Sample_state _Chem_shift_experiment.Entry_ID _Chem_shift_experiment.Assigned_chem_shift_list_ID 1 '2D 1H-15N HSQC' 1 $sample_1 isotropic 19113 2 2 '3D HNCA' 1 $sample_1 isotropic 19113 2 3 '3D HN(CO)CA' 1 $sample_1 isotropic 19113 2 4 '3D HNCACB' 1 $sample_1 isotropic 19113 2 5 '3D HN(CO)CACB' 1 $sample_1 isotropic 19113 2 6 '3D HNCO' 1 $sample_1 isotropic 19113 2 7 '3D HCACO' 1 $sample_1 isotropic 19113 2 stop_ loop_ _Atom_chem_shift.ID _Atom_chem_shift.Assembly_atom_ID _Atom_chem_shift.Entity_assembly_ID _Atom_chem_shift.Entity_ID _Atom_chem_shift.Comp_index_ID _Atom_chem_shift.Seq_ID _Atom_chem_shift.Comp_ID _Atom_chem_shift.Atom_ID _Atom_chem_shift.Atom_type _Atom_chem_shift.Atom_isotope_number _Atom_chem_shift.Val _Atom_chem_shift.Val_err _Atom_chem_shift.Assign_fig_of_merit _Atom_chem_shift.Ambiguity_code _Atom_chem_shift.Occupancy _Atom_chem_shift.Resonance_ID _Atom_chem_shift.Auth_entity_assembly_ID _Atom_chem_shift.Auth_asym_ID _Atom_chem_shift.Auth_seq_ID _Atom_chem_shift.Auth_comp_ID _Atom_chem_shift.Auth_atom_ID _Atom_chem_shift.Details _Atom_chem_shift.Entry_ID _Atom_chem_shift.Assigned_chem_shift_list_ID 1 . 1 1 3 3 GLN H H 1 8.224 0.000 . 1 . . . . 2 GLN H . 19113 2 2 . 1 1 3 3 GLN N N 15 122.234 0.000 . 1 . . . . 2 GLN N . 19113 2 3 . 1 1 4 4 ARG H H 1 9.692 0.000 . 1 . . . . 3 ARG H . 19113 2 4 . 1 1 4 4 ARG N N 15 123.395 0.000 . 1 . . . . 3 ARG N . 19113 2 5 . 1 1 5 5 THR H H 1 8.512 0.000 . 1 . . . . 4 THR H . 19113 2 6 . 1 1 5 5 THR N N 15 120.911 0.000 . 1 . . . . 4 THR N . 19113 2 7 . 1 1 7 7 LYS H H 1 9.358 0.000 . 1 . . . . 6 LYS H . 19113 2 8 . 1 1 7 7 LYS N N 15 124.080 0.000 . 1 . . . . 6 LYS N . 19113 2 9 . 1 1 8 8 ILE H H 1 8.413 0.000 . 1 . . . . 7 ILE H . 19113 2 10 . 1 1 8 8 ILE N N 15 122.397 0.000 . 1 . . . . 7 ILE N . 19113 2 11 . 1 1 9 9 GLN H H 1 9.082 0.000 . 1 . . . . 8 GLN H . 19113 2 12 . 1 1 9 9 GLN N N 15 124.210 0.000 . 1 . . . . 8 GLN N . 19113 2 13 . 1 1 10 10 VAL H H 1 9.428 0.000 . 1 . . . . 9 VAL H . 19113 2 14 . 1 1 10 10 VAL N N 15 124.077 0.000 . 1 . . . . 9 VAL N . 19113 2 15 . 1 1 11 11 TYR H H 1 8.750 0.000 . 1 . . . . 10 TYR H . 19113 2 16 . 1 1 11 11 TYR N N 15 123.304 0.000 . 1 . . . . 10 TYR N . 19113 2 17 . 1 1 12 12 SER H H 1 9.110 0.000 . 1 . . . . 11 SER H . 19113 2 18 . 1 1 12 12 SER N N 15 113.730 0.000 . 1 . . . . 11 SER N . 19113 2 19 . 1 1 13 13 ARG H H 1 8.937 0.000 . 1 . . . . 12 ARG H . 19113 2 20 . 1 1 13 13 ARG N N 15 122.754 0.000 . 1 . . . . 12 ARG N . 19113 2 21 . 1 1 14 14 HIS H H 1 8.356 0.000 . 1 . . . . 13 HIS H . 19113 2 22 . 1 1 14 14 HIS N N 15 114.131 0.000 . 1 . . . . 13 HIS N . 19113 2 23 . 1 1 16 16 ALA H H 1 9.017 0.000 . 1 . . . . 15 ALA H . 19113 2 24 . 1 1 16 16 ALA N N 15 127.440 0.000 . 1 . . . . 15 ALA N . 19113 2 25 . 1 1 18 18 ASN H H 1 8.934 0.000 . 1 . . . . 17 ASN H . 19113 2 26 . 1 1 18 18 ASN N N 15 123.466 0.000 . 1 . . . . 17 ASN N . 19113 2 27 . 1 1 19 19 GLY H H 1 8.976 0.000 . 1 . . . . 18 GLY H . 19113 2 28 . 1 1 19 19 GLY N N 15 109.097 0.000 . 1 . . . . 18 GLY N . 19113 2 29 . 1 1 20 20 LYS H H 1 7.987 0.000 . 1 . . . . 19 LYS H . 19113 2 30 . 1 1 20 20 LYS N N 15 121.623 0.000 . 1 . . . . 19 LYS N . 19113 2 31 . 1 1 21 21 SER H H 1 8.460 0.000 . 1 . . . . 20 SER H . 19113 2 32 . 1 1 21 21 SER N N 15 120.327 0.000 . 1 . . . . 20 SER N . 19113 2 33 . 1 1 22 22 ASN H H 1 9.037 0.000 . 1 . . . . 21 ASN H . 19113 2 34 . 1 1 22 22 ASN N N 15 127.084 0.000 . 1 . . . . 21 ASN N . 19113 2 35 . 1 1 23 23 PHE H H 1 10.557 0.000 . 1 . . . . 22 PHE H . 19113 2 36 . 1 1 23 23 PHE N N 15 120.788 0.000 . 1 . . . . 22 PHE N . 19113 2 37 . 1 1 25 25 ASN H H 1 8.520 0.000 . 1 . . . . 24 ASN H . 19113 2 38 . 1 1 25 25 ASN N N 15 122.478 0.000 . 1 . . . . 24 ASN N . 19113 2 39 . 1 1 26 26 CYS H H 1 9.738 0.000 . 1 . . . . 25 CYS H . 19113 2 40 . 1 1 26 26 CYS N N 15 120.673 0.000 . 1 . . . . 25 CYS N . 19113 2 41 . 1 1 27 27 TYR H H 1 9.801 0.000 . 1 . . . . 26 TYR H . 19113 2 42 . 1 1 27 27 TYR N N 15 129.549 0.000 . 1 . . . . 26 TYR N . 19113 2 43 . 1 1 28 28 VAL H H 1 9.016 0.000 . 1 . . . . 27 VAL H . 19113 2 44 . 1 1 28 28 VAL N N 15 126.682 0.000 . 1 . . . . 27 VAL N . 19113 2 45 . 1 1 29 29 SER H H 1 8.999 0.000 . 1 . . . . 28 SER H . 19113 2 46 . 1 1 29 29 SER N N 15 117.610 0.000 . 1 . . . . 28 SER N . 19113 2 47 . 1 1 30 30 GLY H H 1 8.479 0.000 . 1 . . . . 29 GLY H . 19113 2 48 . 1 1 30 30 GLY N N 15 108.155 0.000 . 1 . . . . 29 GLY N . 19113 2 49 . 1 1 31 31 PHE H H 1 7.432 0.000 . 1 . . . . 30 PHE H . 19113 2 50 . 1 1 34 34 SER H H 1 9.013 0.000 . 1 . . . . 33 SER H . 19113 2 51 . 1 1 34 34 SER N N 15 112.556 0.000 . 1 . . . . 33 SER N . 19113 2 52 . 1 1 35 35 ASP H H 1 7.398 0.000 . 1 . . . . 34 ASP H . 19113 2 53 . 1 1 35 35 ASP N N 15 121.399 0.000 . 1 . . . . 34 ASP N . 19113 2 54 . 1 1 37 37 GLU H H 1 8.215 0.000 . 1 . . . . 36 GLU H . 19113 2 55 . 1 1 37 37 GLU N N 15 126.161 0.000 . 1 . . . . 36 GLU N . 19113 2 56 . 1 1 38 38 VAL H H 1 7.897 0.000 . 1 . . . . 37 VAL H . 19113 2 57 . 1 1 38 38 VAL N N 15 125.153 0.000 . 1 . . . . 37 VAL N . 19113 2 58 . 1 1 40 40 LEU H H 1 9.120 0.000 . 1 . . . . 39 LEU H . 19113 2 59 . 1 1 40 40 LEU N N 15 121.606 0.000 . 1 . . . . 39 LEU N . 19113 2 60 . 1 1 41 41 LEU H H 1 9.047 0.000 . 1 . . . . 40 LEU H . 19113 2 61 . 1 1 41 41 LEU N N 15 120.527 0.000 . 1 . . . . 40 LEU N . 19113 2 62 . 1 1 43 43 ASN H H 1 9.866 0.000 . 1 . . . . 42 ASN H . 19113 2 63 . 1 1 43 43 ASN N N 15 128.389 0.000 . 1 . . . . 42 ASN N . 19113 2 64 . 1 1 44 44 GLY H H 1 8.924 0.000 . 1 . . . . 43 GLY H . 19113 2 65 . 1 1 44 44 GLY N N 15 102.539 0.000 . 1 . . . . 43 GLY N . 19113 2 66 . 1 1 45 45 GLU H H 1 7.922 0.000 . 1 . . . . 44 GLU H . 19113 2 67 . 1 1 45 45 GLU N N 15 120.977 0.000 . 1 . . . . 44 GLU N . 19113 2 68 . 1 1 46 46 ARG H H 1 8.782 0.000 . 1 . . . . 45 ARG H . 19113 2 69 . 1 1 46 46 ARG N N 15 124.638 0.000 . 1 . . . . 45 ARG N . 19113 2 70 . 1 1 47 47 ILE H H 1 8.947 0.000 . 1 . . . . 46 ILE H . 19113 2 71 . 1 1 47 47 ILE N N 15 128.935 0.000 . 1 . . . . 46 ILE N . 19113 2 72 . 1 1 48 48 GLU H H 1 8.596 0.000 . 1 . . . . 47 GLU H . 19113 2 73 . 1 1 48 48 GLU N N 15 126.479 0.000 . 1 . . . . 47 GLU N . 19113 2 74 . 1 1 49 49 LYS H H 1 8.087 0.000 . 1 . . . . 48 LYS H . 19113 2 75 . 1 1 49 49 LYS N N 15 119.671 0.000 . 1 . . . . 48 LYS N . 19113 2 76 . 1 1 50 50 VAL H H 1 7.940 0.000 . 1 . . . . 49 VAL H . 19113 2 77 . 1 1 50 50 VAL N N 15 123.881 0.000 . 1 . . . . 49 VAL N . 19113 2 78 . 1 1 51 51 GLU H H 1 8.479 0.000 . 1 . . . . 50 GLU H . 19113 2 79 . 1 1 51 51 GLU N N 15 126.668 0.000 . 1 . . . . 50 GLU N . 19113 2 80 . 1 1 52 52 HIS H H 1 8.119 0.000 . 1 . . . . 51 HIS H . 19113 2 81 . 1 1 52 52 HIS N N 15 111.827 0.000 . 1 . . . . 51 HIS N . 19113 2 82 . 1 1 53 53 SER H H 1 9.143 0.000 . 1 . . . . 52 SER H . 19113 2 83 . 1 1 53 53 SER N N 15 116.731 0.000 . 1 . . . . 52 SER N . 19113 2 84 . 1 1 54 54 ASP H H 1 8.584 0.000 . 1 . . . . 53 ASP H . 19113 2 85 . 1 1 54 54 ASP N N 15 118.497 0.000 . 1 . . . . 53 ASP N . 19113 2 86 . 1 1 55 55 LEU H H 1 8.685 0.000 . 1 . . . . 54 LEU H . 19113 2 87 . 1 1 55 55 LEU N N 15 126.000 0.000 . 1 . . . . 54 LEU N . 19113 2 88 . 1 1 56 56 SER H H 1 6.943 0.000 . 1 . . . . 55 SER H . 19113 2 89 . 1 1 56 56 SER N N 15 117.970 0.000 . 1 . . . . 55 SER N . 19113 2 90 . 1 1 57 57 PHE H H 1 6.907 0.000 . 1 . . . . 56 PHE H . 19113 2 91 . 1 1 57 57 PHE N N 15 112.286 0.000 . 1 . . . . 56 PHE N . 19113 2 92 . 1 1 58 58 SER H H 1 8.959 0.000 . 1 . . . . 57 SER H . 19113 2 93 . 1 1 58 58 SER N N 15 115.064 0.000 . 1 . . . . 57 SER N . 19113 2 94 . 1 1 60 60 ASP H H 1 7.563 0.000 . 1 . . . . 59 ASP H . 19113 2 95 . 1 1 60 60 ASP N N 15 117.007 0.000 . 1 . . . . 59 ASP N . 19113 2 96 . 1 1 61 61 TRP H H 1 7.857 0.000 . 1 . . . . 60 TRP H . 19113 2 97 . 1 1 61 61 TRP HE1 H 1 10.684 0.000 . 1 . . . . 60 TRP HE1 . 19113 2 98 . 1 1 61 61 TRP N N 15 110.884 0.000 . 1 . . . . 60 TRP N . 19113 2 99 . 1 1 61 61 TRP NE1 N 15 130.300 0.000 . 1 . . . . 60 TRP NE1 . 19113 2 100 . 1 1 62 62 SER H H 1 8.312 0.000 . 1 . . . . 61 SER H . 19113 2 101 . 1 1 62 62 SER N N 15 116.999 0.000 . 1 . . . . 61 SER N . 19113 2 102 . 1 1 63 63 PHE H H 1 8.423 0.000 . 1 . . . . 62 PHE H . 19113 2 103 . 1 1 63 63 PHE N N 15 121.277 0.000 . 1 . . . . 62 PHE N . 19113 2 104 . 1 1 64 64 TYR H H 1 7.658 0.000 . 1 . . . . 63 TYR H . 19113 2 105 . 1 1 64 64 TYR N N 15 109.964 0.000 . 1 . . . . 63 TYR N . 19113 2 106 . 1 1 65 65 LEU H H 1 9.478 0.000 . 1 . . . . 64 LEU H . 19113 2 107 . 1 1 65 65 LEU N N 15 120.816 0.000 . 1 . . . . 64 LEU N . 19113 2 108 . 1 1 66 66 LEU H H 1 8.686 0.000 . 1 . . . . 65 LEU H . 19113 2 109 . 1 1 66 66 LEU N N 15 121.984 0.000 . 1 . . . . 65 LEU N . 19113 2 110 . 1 1 67 67 TYR H H 1 9.318 0.000 . 1 . . . . 66 TYR H . 19113 2 111 . 1 1 67 67 TYR N N 15 127.835 0.000 . 1 . . . . 66 TYR N . 19113 2 112 . 1 1 68 68 TYR H H 1 9.035 0.000 . 1 . . . . 67 TYR H . 19113 2 113 . 1 1 68 68 TYR N N 15 116.346 0.000 . 1 . . . . 67 TYR N . 19113 2 114 . 1 1 69 69 THR H H 1 8.470 0.000 . 1 . . . . 68 THR H . 19113 2 115 . 1 1 69 69 THR N N 15 112.467 0.000 . 1 . . . . 68 THR N . 19113 2 116 . 1 1 70 70 GLU H H 1 8.531 0.000 . 1 . . . . 69 GLU H . 19113 2 117 . 1 1 70 70 GLU N N 15 129.217 0.000 . 1 . . . . 69 GLU N . 19113 2 118 . 1 1 71 71 PHE H H 1 8.730 0.000 . 1 . . . . 70 PHE H . 19113 2 119 . 1 1 71 71 PHE N N 15 125.128 0.000 . 1 . . . . 70 PHE N . 19113 2 120 . 1 1 72 72 THR H H 1 8.257 0.000 . 1 . . . . 71 THR H . 19113 2 121 . 1 1 72 72 THR N N 15 117.402 0.000 . 1 . . . . 71 THR N . 19113 2 122 . 1 1 74 74 THR H H 1 8.122 0.000 . 1 . . . . 73 THR H . 19113 2 123 . 1 1 74 74 THR N N 15 110.282 0.000 . 1 . . . . 73 THR N . 19113 2 124 . 1 1 76 76 LYS H H 1 7.887 0.000 . 1 . . . . 75 LYS H . 19113 2 125 . 1 1 76 76 LYS N N 15 113.839 0.000 . 1 . . . . 75 LYS N . 19113 2 126 . 1 1 77 77 ASP H H 1 7.243 0.000 . 1 . . . . 76 ASP H . 19113 2 127 . 1 1 77 77 ASP N N 15 118.128 0.000 . 1 . . . . 76 ASP N . 19113 2 128 . 1 1 79 79 TYR H H 1 9.526 0.000 . 1 . . . . 78 TYR H . 19113 2 129 . 1 1 79 79 TYR N N 15 124.014 0.000 . 1 . . . . 78 TYR N . 19113 2 130 . 1 1 80 80 ALA H H 1 8.931 0.000 . 1 . . . . 79 ALA H . 19113 2 131 . 1 1 80 80 ALA N N 15 121.319 0.000 . 1 . . . . 79 ALA N . 19113 2 132 . 1 1 81 81 CYS H H 1 9.192 0.000 . 1 . . . . 80 CYS H . 19113 2 133 . 1 1 81 81 CYS N N 15 120.004 0.000 . 1 . . . . 80 CYS N . 19113 2 134 . 1 1 82 82 ARG H H 1 9.486 0.000 . 1 . . . . 81 ARG H . 19113 2 135 . 1 1 82 82 ARG N N 15 128.742 0.000 . 1 . . . . 81 ARG N . 19113 2 136 . 1 1 83 83 VAL H H 1 9.184 0.000 . 1 . . . . 82 VAL H . 19113 2 137 . 1 1 83 83 VAL N N 15 128.166 0.000 . 1 . . . . 82 VAL N . 19113 2 138 . 1 1 84 84 ASN H H 1 9.167 0.000 . 1 . . . . 83 ASN H . 19113 2 139 . 1 1 84 84 ASN N N 15 123.594 0.000 . 1 . . . . 83 ASN N . 19113 2 140 . 1 1 85 85 HIS H H 1 7.822 0.000 . 1 . . . . 84 HIS H . 19113 2 141 . 1 1 85 85 HIS N N 15 122.876 0.000 . 1 . . . . 84 HIS N . 19113 2 142 . 1 1 86 86 VAL H H 1 8.113 0.000 . 1 . . . . 85 VAL H . 19113 2 143 . 1 1 86 86 VAL N N 15 125.337 0.000 . 1 . . . . 85 VAL N . 19113 2 144 . 1 1 87 87 THR H H 1 7.543 0.000 . 1 . . . . 86 THR H . 19113 2 145 . 1 1 87 87 THR N N 15 110.524 0.000 . 1 . . . . 86 THR N . 19113 2 146 . 1 1 88 88 LEU H H 1 8.130 0.000 . 1 . . . . 87 LEU H . 19113 2 147 . 1 1 88 88 LEU N N 15 123.340 0.000 . 1 . . . . 87 LEU N . 19113 2 148 . 1 1 90 90 GLN H H 1 7.624 0.000 . 1 . . . . 89 GLN H . 19113 2 149 . 1 1 90 90 GLN N N 15 117.449 0.000 . 1 . . . . 89 GLN N . 19113 2 150 . 1 1 92 92 LYS H H 1 8.887 0.000 . 1 . . . . 91 LYS H . 19113 2 151 . 1 1 92 92 LYS N N 15 125.303 0.000 . 1 . . . . 91 LYS N . 19113 2 152 . 1 1 93 93 ILE H H 1 8.610 0.000 . 1 . . . . 92 ILE H . 19113 2 153 . 1 1 93 93 ILE N N 15 125.326 0.000 . 1 . . . . 92 ILE N . 19113 2 154 . 1 1 94 94 VAL H H 1 9.131 0.000 . 1 . . . . 93 VAL H . 19113 2 155 . 1 1 94 94 VAL N N 15 129.766 0.000 . 1 . . . . 93 VAL N . 19113 2 156 . 1 1 95 95 LYS H H 1 8.943 0.000 . 1 . . . . 94 LYS H . 19113 2 157 . 1 1 95 95 LYS N N 15 128.112 0.000 . 1 . . . . 94 LYS N . 19113 2 158 . 1 1 96 96 TRP H H 1 9.117 0.000 . 1 . . . . 95 TRP H . 19113 2 159 . 1 1 96 96 TRP HE1 H 1 10.723 0.000 . 1 . . . . 95 TRP HE1 . 19113 2 160 . 1 1 96 96 TRP N N 15 122.976 0.000 . 1 . . . . 95 TRP N . 19113 2 161 . 1 1 96 96 TRP NE1 N 15 129.678 0.000 . 1 . . . . 95 TRP NE1 . 19113 2 162 . 1 1 97 97 ASP H H 1 8.541 0.000 . 1 . . . . 96 ASP H . 19113 2 163 . 1 1 97 97 ASP N N 15 132.378 0.000 . 1 . . . . 96 ASP N . 19113 2 164 . 1 1 98 98 ARG H H 1 7.772 0.000 . 1 . . . . 97 ARG H . 19113 2 165 . 1 1 98 98 ARG N N 15 122.978 0.000 . 1 . . . . 97 ARG N . 19113 2 166 . 1 1 99 99 ASP H H 1 8.623 0.000 . 1 . . . . 98 ASP H . 19113 2 167 . 1 1 99 99 ASP N N 15 120.350 0.000 . 1 . . . . 98 ASP N . 19113 2 168 . 1 1 100 100 MET H H 1 7.906 0.000 . 1 . . . . 99 MET H . 19113 2 169 . 1 1 100 100 MET N N 15 122.104 0.000 . 1 . . . . 99 MET N . 19113 2 stop_ save_